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Abstract 
 
The Tec family kinases Itk and Rlk have been previously shown to have 
an important role in signaling downstream of the T cell receptor [TCR].  Almost all 
of the work done in the past on these two kinases looked at their role in 
conventional αβ T cells, specifically CD4+ T cells.  These studies demonstrated 
functions for Itk [primarily] and Rlk in T cell development, activation, and 
differentiation.  However, despite the wealth of knowledge on conventional CD4+ 
T cells, prior to the work presented here little to no studies addressed the role of 
Tec family kinases on CD8+ or innate T cell development.  My studies show a 
clear role for Itk [and in some cases Rlk] in innate T cell development; whether it 
be deprecating, in the case of innate CD8+ T cells or some subsets of γδ T cells, 
or beneficial, in the case of NKT cells.  I show that Itk has a crucial role in 
conventional CD8+ T cell development, as absence of Itk [or Itk and Rlk] causes 
strongly reduced numbers of conventional CD8+ T cells and a vigorous 
enhancement of an innate-like CD8+ T cell population.  In NKT cells, my work 
demonstrates that Itk [and to a lesser extent Rlk] is required for terminal 
maturation, survival, and cytokine secretion.  Finally, on γδ T cells Itk is important 
in maintaining the Th1 cytokine secretion profile usually associated with these 
cells, and regulating the development of CD4+ or NK1.1+ γδ T cells.  Taken 
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together, this work clearly illustrates an important role for Tec family kinases in 
innate T cell development and function.  
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Chapter I Attributions and Copyright information 
 
Some of the material in the intro [particularly in the Tec family kinase section] 
was derived from the Felices et al. 2007 Advances in Immunology review (1).   
All of the material derived was from sections originally written by me. 
 
Felices, M., M. Falk, Y. Kosaka, and L. J. Berg. 2007. Tec kinases in T cell and 
mast cell signaling. Advances in immunology 93:145-184. 
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Innate versus adaptive immunity 
 
 The immune system has been classically divided into two arms, the innate 
immune response and the adaptive immune response.  The innate immune 
response provides rapid, non-specific responses to invading pathogens without 
conferring protective immunity.  A large group of cells with varied functions and 
tissue distributions make up the innate immune system.  Amongst these are mast 
cells, phagocytes [including macrophages, neutrophils, and dendritic cells], 
basophils and eosinophils, NK cells, NKT cells, γδ T cells, CD8αα T cells, non-
classical MHC class Ib restricted CD8+ T cells, B1 B cells and marginal zone B 
cells.  On the other hand, the adaptive immune response provides delayed, 
specific responses to pathogens which will eventually engender memory and 
long lasting protective immunity to that pathogen.  The adaptive immune 
response is composed of “conventional” αβ T cells [CD4+ or CD8+] and B cells. 
 The distinction between innate and adaptive immunity is less clear cut 
than the original dogma dictated, with several subsets of cells containing 
characteristics of both arms (2).  For instance γδ T cells, NKT cells, m2B cells, 
and B1 B cells all require RAG mediated rearrangement in order to develop, a 
criteria usually associated with adaptive immunity.  Likewise, NK cells and 
neutrophils can posses both variable and memory immune receptors, also 
associated with the adaptive arm (3, 4).  Human γδ T cells have been shown to 
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be capable of upregulating costimulatory molecules typically involved in B cell 
help, a hallmark previously thought to be restricted to conventional CD4+ T cells 
(5).  This and other data seems to indicate that certain subsets of cells cannot 
easily be placed in the innate arm or the adaptive arm, but rather belong to both.  
Perhaps the best way to think of the immune response is not as two separate 
branches of cells responding with different kinetics and functions, but rather as a 
continuum of signals leading to resolution of a pathogen and protective immunity.  
Of particular interest to the work presented here is the development and function 
of certain subsets of innate T cells, specifically innate CD8+ T cells, NKT cells, 
and γδ T cells. 
 
Innate T cell subsets 
 
 Although there are several unconventional T cell subsets, including 
CD8αα T cells, MR1 restricted CD8+ T cells and FOXP3+CD4+CD25+ regulatory T 
cells, this thesis will focus solely on three innate T cell subsets: innate CD8+ T 
cells [specifically H2-M3 restricted], NKT cells, and γδ T cells.  Other than their 
ability to respond quickly and their expression of NK1.1 [only in some subsets 
when looking at the γδ cells], these innate groups of T cells are quite different.  
One common factor between these three subsets is their involvement in 
responses to bacterial pathogens (6-8). 
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 CD8+ T cells can be selected by the classical MHC class Ia, which gives 
rise to conventional CD8+ T cells, or by the non-classical MHC class Ib, which 
can select subsets of non-conventional CD8+ T cells capable of rapidly 
responding to conserved pathogenic antigens (9-13).  H2-M3 is one of the class 
Ib molecules, and it presents N-formylated peptides to MHC class Ib restricted 
CD8+ T cells [addressed as H2-M3 restricted T cells henceforth] (14).  H2-M3 
restricted T cell response to Listeria monocytogenes peaks much quicker than 
the conventional [class Ia restricted] CD8+ T cell response (6).  In accordance to 
the speedy kinetics, these cells also have characteristics of innate immune 
subsets such as selection on hematopoietic cells, CD44hi expression [even in 
uninfected mice], and quick capability to secrete IFNγ and promote Th1 priming 
(13, 15-17).  Despite all these functional studies, data on H2-M3 restricted T cells 
is lacking. 
 NKT cells have been studied to a much greater extent than H2-M3 
restricted T cells.  The majority of mouse NKT cells express an invariant T cell 
receptor [TCR] containing the Vα14-Jα18 pairing, with a limited Vβ pairing, and 
recognize lipid antigens in the context of CD1d (18, 19).  The NKT cells referred 
to and studied throughout this thesis are indeed this invariant group of NKT cells.  
NKT cells are positively selected on CD1d and SLAM molecules and go on to 
acquire several “memory-like” markers during their development (20-22).  NKT 
cell maturation is split up into three stages denoted by the expression of CD44 
and NK1.1: in stage 1 NKT cells express low levels of CD44 and NK1.1, in stage 
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2 they express high levels of CD44, and stage 3 they express high levels of 
CD44 and NK1.1 [as well as several other NK markers] (21).   From early phases 
of their development NKT cells are capable of quickly secreting IL-4 and they 
acquire the capability to secrete IFNγ later on, once they have upregulated 
NK1.1 marking their terminal maturation (23-25).  The ability to secrete cytokines 
quickly makes NKT cells great immune modulators involved in diseases ranging 
from viral and bacterial infections, to autoimmunity and tumor responses (26). 
 The third group of innate T cells discussed in this thesis, γδ T cells, is not 
restricted by MHC and can recognize soluble proteins and non-protein antigens 
of endogenous origin (27).  They constitute a small fraction of the lymphocytes in 
the blood and peripheral organs, but can compose up to half of the lymphocytes 
in the epithelial rich tissues, such as the skin, reproductive track, and the 
intestine.  γδ T cells are the first lymphocytes lineages generated during fetal 
development and originate through a coordinated temporal program which will 
give rise to different Vγ subsets, populating different tissues [such as the skin, 
uterus, lung, etc.] (28-31).  Function of the γδ T cells seems to be dictated by 
their tissue distribution and Vγ usage.  γδ T cells have a biased Th1 [IFNγ] 
secretion profile, but they are capable of secreting Th2 cytokines such as IL-4 
(27).  Besides functioning as a first line of defense at the epithelial rich tissues, 
γδ cells can be involved in modulation of innate and adaptive immune responses, 
can aid in viral and bacterial infections, can regulate epithelial integrity and 
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turnover, might have a role in elimination of stressed or transformed cells, and 
have the potential of functioning as antigen presenting cells (32-45). 
 
Molecules involved in innate T cell selection/generation 
 
 Innate and adaptive T cell subsets all generate from thymic lymphoid 
progenitors, although their lineage bifurcation may occur at different stages of 
development.  Where commitment to the γδ T cell subset occurs early on in 
development in the DN stage during the DN2-DN3 transition [albeit there is some 
controversy about the specific divergence point (46)], NKT cells and innate CD8+ 
T cells arise from DP thymocytes, much like mature “conventional” αβ T cells.  
One key difference between innate and conventional T cells is that the latter is 
dependent on classical MHC class I and class II molecules presented on cortical 
epithelial cells (47) while the former is mostly dependent on non-classical MHC 
molecules presented on hematopoietic cells (10, 12, 13, 27, 48-50). 
 Although advances have been made, the molecular circuitry that dictates 
innate versus conventional T cell bifurcation remains quite complicated, and in 
some cases, like H2-M3 restricted T cells, a complete mystery [Figure 1].  For γδ 
T cells only one gene has thus far been described to be involved in γδ specific 
bifurcation, the transcription factor SOX13 (51).  Interestingly a slew of signaling  
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Figure 1:  molecular signature involved in innate versus adaptive T cell 
development 
Innate and adaptive T cells develop from double negative [DN] thymocytes.  
Transition to the double positive [DP] state requires several signaling 
components including ZAP70, LCK, SLP76, LAT, and GADS.  γδ T cells develop 
prior to entry in the DP stage and are dependent on SOX13 expression for their 
lineage decision.  Conventional CD4+ T cells depend on expression of GATA3 
and Th-POK for their differentiation from DPs.  NKT cells have been shown to 
depend on several signaling molecules to differentiate from DPs including: SAP, 
FYN, SLAM family members, RUNX1, ROR-γt, PKCθ, IKK2, NF-κb, IFR1, ETS1, 
BATF [BATF actually mimics inhibition of AP-1], GATA3, T-bet, and as will be 
shown later on, Itk and Rlk.  As will be described in chapter 2, development of 
conventional CD8+ T cells is also dependent on Itk and Rlk.  It is not yet known 
what factors are required for the development of innate CD8+ T cells like the H2-
M3 restricted cells. 
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components found to be dispensable for conventional αβ T cell development 
have been shown to have important roles in the development of NKT cells.  For 
instance the Fyn-SAP-SLAM family axis has been shown to be indispensible for 
initial NKT cell development, while it does not seem to have a role in 
conventional αβ T cell development (20, 52-56).  Much like with the 
aforementioned axis, a deficiency in the transcription factors Runx1 and RORγt 
seems to cause a specific defect in early NKT cell selection/development (57, 
58).  Several other molecules have also been specifically associated with early 
and later stages of NKT cell development including: PKCθ (59, 60), Vav-1 (61), 
IKK2 (59) and members of the NF-κB family (62), IRF1 (63), ETS1 (64), BATF [in 
the context of AP-1 inhibition] (65, 66), GATA-3 [particularly in generation of 
CD4+ NKTs] (67), and T-bet [necessary for terminal maturation] (68).  
Interestingly, until recent work from our lab and others, no signaling molecules 
had been identified that were required for generation of conventional T cells, but 
Itk and Rlk seem to have a role in the linage decision of conventional versus 
innate CD8+ T cells (69-74).  This issue as well as Tec family kinases will be 
described in much greater detail later on. 
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TCR signaling in development of innate T cell subsets 
 
 The subject of TCR signal strength and its role in the development of 
innate T cell subsets is still poorly understood and in some cases controversial.  
Regardless of the cell type, one possibility is that conventional versus innate T 
cell lineage bifurcation is dependent on strength of signals transduced by the 
TCR.  H2-M3 restricted T cells and NKT cells are both selected on non-classical 
MHC-Ib expressed on hematopoietic cells while conventional αβ T cells are 
selected on classical MHC expressed on the thymic epithelia.  Differences in 
expression of selecting molecules for conventional and innate T cells could result 
in differences in the robustness of signaling leading up to a lineage decision 
[innate versus conventional].  In fact cell-surface expression of non-conventional 
MHC class Ib molecules on thymic cortical cells has been shown to be lower than 
expression of classical MHC molecules on the thymic epithelia (9, 75).  In the 
case of NKT cells, maintaining low levels of expression might be required in 
order to keep the cells from undergoing negative selection due to [most likely] 
excessive signaling (76).  Selection of NKT cells on thymic epithelial cells 
[mimicking classical MHC selection] is also inefficient (77).  This is probably due 
to two factors, increased expression of CD1d, leading to negative selection, and 
lack of expression of SLAM family members on the cortical epithelia, which as 
previously mentioned is critical for NKT development (20).  Differences in 
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strength of interactions between classical and non-classical MHCs and the cells 
they select could also have a very important role in the selection process, but no 
studies have been done thus far to address this question. 
 Selection of γδ T cells versus conventional αβ T cells has been studied to 
a much greater extent, but the field still remains controversial with two models for 
lineage bifurcation, selection versus instruction.  The selection model dictates 
that αβ and γδ lineage commitment occurs independent of TCR signaling prior to 
the onset of the TCR while the instruction model dictates that commitment is 
determined by the TCR isotype [i.e.: pre-TCR instructs DN thymocytes to 
become αβ while γδTCR instructs them to become γδ cells] (78, 79).  There is 
evidence available for both model.  For instance, expression of rearranged 
TCRβ, TCRγ and TCRδ together in thymic precursors does not seem to have 
much effect on the developmental outcome, favoring the selective model (80).  
On the other hand, in a study where γδTCR signal strength was altered, it was 
shown that increasing the strength of the γδTCR favored γδ T cell development 
while decreasing it favored αβ T cell development, supporting the instructive 
model (81).  There are several more studies supporting either model, but due to 
caveats existing for the studies supporting both sides the question has yet to be 
resolved.  This question is complicated by the fact that a γδ T cell selecting 
ligand and cell type has yet to be determined for the most part.  Two exceptions 
to this are G8-TCRγδ+ T cells, which are selected directly by class Ib molecules 
[T10b and T22b], and epidermal γδ T cells, which have recently been shown to be 
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selected by an immuloglobulin-like protein encoded by Skint1 (82, 83).  One 
more component required for proper γδ T cell development is double positive 
[DP] thymocytes.  Although independent of TCR signaling, these cells provide 
signaling through lymphotoxin β receptor pathways (84).  Absence of these 
signals during development results later on in defective activation of γδ cells in 
the spleen. 
Taken together all this data paint a confusing picture, but it does seem 
clear that in NKT cells and γδ T cells modulation of TCR signal strength can 
influence the outcome of development and function of innate subsets.  This 
thesis focuses on how ablation of Tec family kinases, which as explained in the 
next section enhance TCR signaling, alters the development and function of 
innate T cell subsets, and in the case of CD8+ T cells, shifts their development to 
an innate H2-M3-like CD8+ T cell. 
 
Tec family kinases structure 
 
Five Tec kinase family members have been described in mammalian cells.  
These kinases are highly expressed in hematopoietic cells, including B cells (85-
88), T cells (85, 89-93), and mast cells (94-96).  The Tec kinase family members 
share a number of structural features [Figure 2].  Each has a C-terminal kinase 
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domain, preceded by a Src homology [SH]-2 domain and an SH3 domain, much 
like Src family PTKs (97).  However, unlike the Src kinases, Tec family kinases, 
with the exception of Bmx, possess a proline rich region [PRR] at the N-terminal 
side of the SH3 domain; interestingly, Btk and Tec have two of these regions, 
whereas Itk and Rlk have only one.  At the N-terminal side of the PRR, in Itk, Btk, 
and Tec, there is a Zn2+-binding region known as the Btk homology [BH] motif.  
The combination of the BH and the PRR has been labeled the Tec homology 
[TH] domain.  Finally, at the N-terminal end, all Tec family kinases, with the 
exception of Rlk, possess a pleckstrin homology [PH] domain; in Rlk, the N-
terminal region contains a cysteine-string motif (98).  These structural 
differences, specifically the difference in PRRs and N-terminal domains, may 
contribute to the distinct functions of each Tec kinase. 
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Figure 2:  structure of Tec family kinases 
Tec family kinases share several structural similarities including their catalytic C 
terminal kinase domain, and two Src homology domains [SH2 and SH3].  While 
Btk and Tec contain two proline rich repeat [PRR] regions, Itk and Rlk only 
contain one.  The only Tec family kinase which does not contain a Btk homology 
domain [BH] or a N-terminal plextrin homology [PH] region is Rlk, which instead 
possesses a string of N-terminal cysteine repeats. 
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Tec family kinase expression 
 
 Tec family kinases are predominantly expressed in hematopoietic cells; 
however, each individual Tec kinase has a distinct cell type-specific pattern of 
expression.  In addition, each cell type has a hierarchy of expression levels and 
functions for the Tec kinases expressed in that cell.   Of the three Tec kinases 
expressed in T cells, Itk, Rlk, and Tec, Itk appears to have the predominant role 
in TCR signaling.  Itk is expressed in thymocytes and mature T cells, and is 
found at maximal levels in the mature adult thymus (90, 92, 93, 99, 100).  Similar 
to Itk, Rlk is expressed in thymocytes and mature resting T cells; however, Rlk 
mRNA levels are 3-10 fold lower than the levels of Itk mRNA in resting T cells 
(91, 96, 101, 102).  Furthermore, unlike Itk, Rlk is dramatically downregulated at 
both the mRNA and protein levels upon TCR stimulation (91, 96).  The third Tec 
kinase expressed in T cells, Tec, is expressed at much lower levels in resting T 
cells, with mRNA levels ~100-fold lower than that of Itk (98).  Interestingly, Tec is 
upregulated in T cells 2-3 days following their stimulation, suggesting a more 
important role for Tec in T cell effector function and restimulation, rather than in T 
cell development or initial activation (103). 
 Tec kinase levels are also individually regulated during T helper cell 
differentiation [Figure 3].  When naïve CD4+ T cells differentiate into T helper [Th] 
cells, Itk levels increase ~2-3-fold in Th2 cells, which express the master 
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transcription factor GATA3, versus Th1 cells, which express the master 
transcription factor T-bet, consistent with the known role of Itk in Th2 responses 
(101, 102).  Similar to Itk, Tec is expressed at two-fold higher levels in Th2 cells 
than in Th1 cells; however, in this latter case, the functional significance of this 
differential expression is not known, as Tec-deficient mice have no reported T 
cell signaling defects (103).  In contrast to Itk and Tec, Rlk is down-regulated 
following naïve CD4+ T cell activation, and is re-expressed in Th1 cells, but not 
Th2 cells; these data have suggested a specific role for Rlk in Th1 responses 
(91, 102, 104). 
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Figure 3:  Itk and Rlk expression in CD4+ T cells upon differentiation 
Itk and Rlk are both expressed in naïve CD4+ T cells, albeit Itk is expressed at 
higher levels.  Upon activation Itk is upregulated and while Rlk is strongly 
downregulated.  Th2 differentiation, mediated by IL-4, causes ablation of Rlk 
expression while Itk levels remain high [2-3 fold higher than basal levels].  It 
should also be mentioned that Tec expression is also upregulated 2-fold on Th2 
cells when compared to Th1 cells.  These cells also express the Th2 master 
transcription factor GATA3.  In contrast Th1 differentiation, mediated by IL-12/IL-
27, IFNγ and IL-18, results in upregulation of Rlk while Itk goes back to being 
expressed at basal [naïve] levels.  These cells also express the Th1 master 
transcription factor T-bet. 
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Subcellular localization of Tec family kinases: membrane recruitment 
 
Each Tec family kinase shows a distinct pattern of subcellular localization 
[Figure 4].  At steady state levels Itk and Tec are found in the cytoplasm; 
following activation of Phosphoinositide-3-kinase [PI3K] and the generation of 
phosphatidylinositol 3,4,5-triphosphate  [PIP3] at the plasma membrane, Itk and 
Tec are recruited to the membrane via their PH domains  (105-107).  In contrast, 
Rlk, which lacks a PH domain, is constitutively associated with the plasma 
membrane via its palmitoylated cysteine-string motif.  Thus, while Itk and Tec 
both require PI3K activity for plasma membrane association, Rlk lipid raft 
association is PI3K-independent (108). 
Following TCR stimulation and the activation of PI3K, Itk recruitment to the 
membrane requires its PH domain, and is independent of other domain 
interactions (105, 109).  Deletion of the Itk PH domain abolishes TCR activation-
induced colocalization of Itk with the TCR complex at the plasma membrane and 
also prevents the subsequent tyrosine phosphorylation and activation of Itk.  
Substitution of the PH domain of Itk with a membrane localization [e.g., 
myristylation] sequence from Lck restores Itk membrane localization, but does 
not allow TCR signal-induced tyrosine phosphorylation of Itk, indicating a more 
complex role for the PH domain than simple plasma membrane association 
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(105).  Possible roles for the PH domain include recruitment to the immediate 
vicinity of the activated receptor, or a more structural role in Itk activation.  
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Figure 4:  Membrane localization of Tec family kinases 
A]  The larger isoform of Rlk [RLK-L] is constitutively localized to the plasma 
membrane through palmitoylation of the cysteine string motif at the amino 
terminus [1].  Upon T cell receptor [TCR] engagement [2], Rlk proteins in the 
vicinity of the TCR are activated by Fyn through phosphorylation of the Rlk 
kinase domain.   
B]  Prior to B cell receptor [BCR] engagement, Btk is cytosolic.  Following BCR 
stimulation [1], Lyn activates PI3K [2], leading to the production of PIP3 [3].  Btk is 
then recruited to the plasma membrane through interaction of its PH domain with 
PIP3 [4].  Lyn phosphorylates and activates Btk [5].   
C]  Prior to TCR engagement, Itk is cytosolic.  Following TCR stimulation [1], Lck 
activates PI3K [2], leading to the production of PIP3 [3].  Itk is recruited to the 
plasma membrane through interaction of its PH domain with PIP3 [4].  Lck then 
phosphorylates and activates Itk [5].   
D]  Following TCR engagement [1], Lck activates PI3K [2], leading to the 
production of PIP3 [3].  Tec is then recruited into vesicles at the plasma 
membrane that contain signaling components such as Lck and PLC- [4].  Tec is 
then recruited to PIP3 through its PH domain [5] where it can be activated 
[presumably by Lck in T cells and Lyn in B cells] [6]. 
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The regulation of Tec recruitment to the plasma membrane following TCR 
stimulation has some distinct features compared to Itk.  Like Itk, Tec can be 
recruited to the membrane through the interaction of its PH domain with PIP3.  
However, the interaction of the Tec PH domain with PIP3 must be different from 
that of the other Tec kinases, as illustrated by the behavior of PH domain 
substitution mutants.  For instance, substitution of the glutamic acid residue at 
position 41 with lysine in the Btk PH domain has been shown to increase Btk 
binding to PIP3; in contrast, the comparable mutation in the PH domain of Tec 
[E42K] reduces Tec binding to PIP3 (107).  In addition, while the Tec PH domain 
is required for tyrosine phosphorylation of Tec, membrane recruitment could also 
be mediated by the Tec SH2 domain (107).  Finally, one recent study found that 
the PH domain of Tec is dispensable for Tec accumulation at the plasma 
membrane, and instead identified the SH3 domain as essential for accumulation 
of Tec at the immunological synapse (110).  Interestingly, these authors also 
found that a functional Tec PH domain is required for proper activation of Tec 
following TCR stimulation, but suggest that membrane accumulation of Tec is not 
PI3K-dependent. 
An interesting report indicates that in B cells, Btk can promote its own 
sustained activation by a positive feedback loop (111).  Btk binds to PI5-kinase, 
transporting it to the membrane following activation; at the membrane, 
Phosphotidylinositol 5 kinase [PI5K] converts PI[4]P into PI[4,5]P2, thereby 
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providing a renewable source of substrate for PI3K, and prolonging the activation 
signal.  
Since membrane localization is a prerequisite for Tec kinase function in 
antigen receptor signaling pathways, these signals can be terminated by 
inhibition of membrane recruitment.  For Itk, recruitment to the plasma membrane 
is negatively-regulated by the lipid phosphatase, PTEN, which removes 
phosphates from the D3 position of phosphoinositides, and thereby reduces the 
levels of PIP3 at the membrane (106).  In PTEN-deficient cells, such as the Jurkat 
T cell tumor line, Itk is constitutively localized to the plasma membrane and 
hyperresponsive to TCR stimulation (106).  This mechanism for negative 
regulation sets Itk apart from Rlk, which has no dependence on 
phosphoinositides for membrane localization.  Membrane localization of Tec, in 
contrast, is regulated by the SHIP family of inositol phosphatases (112).  The 
proposed mechanism for this regulation is similar to that of PTEN, involving 
dephosphorylation of PIP3 leading to decreased PH domain-mediated 
recruitment of Tec to the plasma membrane.  However, unlike the indirect 
regulation of Itk by PTEN, Tec also seems to directly interact with SHIP1 and 
SHIP2, an interaction that is dependent on the Tec SH3 domain (112).  Based on 
this observation, it is possible that in conditions of PI3K-independent recruitment 
of Tec to the membrane, interaction of SHIP with the Tec SH3 domain might be 
sufficient to preclude Tec membrane localization.  One final feature that sets Tec 
apart from other family members is its unique subcellular localization upon TCR-
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induced activation.  Whereas Itk appears diffusely localized at the immunological 
synapse, Tec has a more punctuate localization pattern at the T-cell-APC 
interface, indicative of its presence in vesicular structures (103).  Formation and 
maintenance of these Tec-containing vesicles requires TCR signaling through 
Src-family kinases and PI3K (113).  These vesicles also contain the early 
endosomal antigen 1 [EEA1] marker as well as signaling components such as 
Lck and the Tec substrate PLC-γ1.  In theory, this packaging of signaling 
components facilitates signaling through Tec.  No such assembly of signaling 
components has been described for any of the other Tec family kinases. 
 
Subcellular localization of Tec family kinases:  nucleus 
 
Several reports have also indicated that Tec kinases may have an important role 
in the nucleus of T cells [Figure 5].  In this regard, the data for Rlk is the most 
compelling.  Two isoforms of Rlk, that arise from alternative sites of translation 
initiation on the same mRNA have been described (114). The larger 58 kDa 
isoform is cytoplasmic, and localizes to lipid rafts through the cysteine-string 
motif upon palmitoylation.  The shorter 52 kDa isoform lacks the cysteine-string 
motif and localizes to the nucleus when expressed in the absence of the larger 
form. Consistent with these data, a mutation that abolishes palmitoylation in the 
cysteine-string motif of the larger isoform allows this protein to migrate to the 
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nucleus.  However, in spite of the fact that both isoforms contain a nuclear 
localization sequence [residues 57-71], both proteins are found only in the 
cytoplasm when coexpressed, suggesting a direct physical interaction between 
the two isoforms.  While the data demonstrating the ability of Rlk to traffic to the 
nucleus are compelling, little is known about the function of nuclear Rlk.  One 
report indicated that Rlk could bind to the IFN- promoter region.  Combined with 
its upregulation in Th1 cells, these findings suggest an important function for Rlk 
in Th1 cell development and signaling (104). 
Some data also indicate that Itk may traffic to the nucleus.  In CD3-
stimulated Jurkat T cells, a small proportion of the total Itk protein was found in 
the nucleus.  In this case, the nuclear localization was mediated by karyopherin 
alpha [Rch 1], a nuclear transporter binding to the Itk SH3 domain via its 
proline-rich region [PRR] (115).  This finding is somewhat surprising, as Rch1 is 
generally required for the nuclear import of proteins containing a basic-type 
[classical] nuclear localization signal, which is lacking in Itk.  Nonetheless, 
expression of a PRR mutant of Rch1 in Jurkat cells prevented nuclear 
translocation of Itk as well as mitogen-induced IL-2 production by these T cells.  
These data suggest that the nuclear fraction of Itk may play a role during T cell 
activation.  Consistent with this notion, one report indicates that Itk might directly 
interact with and phosphorylate T-bet, a constitutively nuclear transcription factor 
that regulates IFNγ transcription (116).  This report also mentions that this 
phosphorylation might be critical for direct cross-regulation of T-bet to GATA3.  
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Absence of T-bet phosphorylation, or absence of Itk, lead to an abolishment of T-
bet co-immunoprecipitation with GATA3, thus decreasing the ability of T-bet to 
directly inhibit GATA3 binding to the DNA.  Btk has also been shown to migrate 
to the nucleus in B cells, but due to the subject of this thesis this will not be 
elaborated in further detail (117-122). 
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Figure 5:  proposed nuclear localization of Tec family kinases in T cells 
A]  Upon TCR engagement [1], the short form of Rlk [RLK-S], usually found in a 
complex with the long form [RLK-L], migrates to the nucleus [2-green].  Once in 
the nucleus RLK-S binds to the promoter region of the IFNγ gene [3-green].   
B]  Upon TCR engagement [1], the SH3 region of Itk interacts with the PRR 
region of the nuclear transporter Kayopherin alpha [Rch 1α] [2-yellow].  The Itk-
Rch1α complex translocates into the nucleus [3-yellow].  In the nucleus, Itk may 
bind T-bet, a master regulator of IFNγ transcription [4-yellow], and perhaps 
phosphorylate it.   
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Tec family kinase signaling downstream of the TCR 
 
Although some of the details vary, the antigen receptor signaling pathways in T 
cells [Figure 6], B cells, and mast cells share a similar overall scheme.  Briefly, 
following receptor engagement, a Src family tyrosine kinase [Lck in T cells] is 
activated and phosphorylates receptor subunits, leading to the recruitment and 
activation of a Syk family kinase [ZAP-70 in T cells] (123-126).  Activated Tec 
family kinases are then recruited to the receptor signaling complexes through 
interactions with adapter proteins of the SLP-76 [SH2-domain-containing 
leukocyte protein of 76 kDa] and LAT [linker for activation of T cells] families 
(109, 127-129).  Once at the membrane, Tec family kinases are activated 
through phosphorylation by Src family kinases [again Lck in T cells], and in turn, 
phosphorylate and activate PLC-γ (130-132).  PLC-γ catalyzes catabolism of 
PI[4,5]P2 into inositol-1,4,5-triphosphate [IP3] and diacylglycerol [DAG] (133).  IP3 
is required for intracellular Ca2+ release, which triggers sustained calcium influx 
that activates downstream effectors like the NFAT transcription factors (134, 
135).  DAG activates members of the PKC [protein kinase C] family, as well as 
RASGRP [RAS guanyl-releasing protein], leading to the activation of JNK [JUN 
amino-terminal kinase] and ERK1/ERK2 [extracellular-signal-regulated kinase] 
and thereby regulating the transcription factor, AP-1 (126, 136).  This model is 
supported by data from Tec kinase-deficient lymphocytes and mast cells, which 
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show defects in antigen-receptor mediated PLC-γ phosphorylation, IP3 
production, Ca2+ influx, ERK and JNK activation, and the downstream activation 
of transcription factors, NFAT and AP1 (123, 124, 131, 137-140).  Very little work 
has been done on the role of Tec family kinases in innate T cell signaling, 
development, and function.  What little work is out there will be highlighted in the 
introduction and discussion sections of each of the subsequent individual data 
chapters dealing with a specific innate T cell subset, starting with “innate-like” 
CD8+ T cells. 
 
  
34 
 
Figure 6:  role of Itk downstream of TCR engagement 
Upon TCR engagement both Lck and ZAP-70 are quickly activated and 
phosphorylate Slp-76 and LAT, causing the formation of a signaling nucleating 
complex to which Itk binds.  Itk is phosphorylated and activated by Lck, and goes 
on to phosphorylate and activate PLC-γ.  Activated PLC-γ catalyzes PIP2 into IP3 
and DAG giving rise to intracellular [IC] calcium fluxes, and the ensuing NFAT 
activation, and PKC and RASGRP activation, and the ensuing AP-1 activation. 
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Intro 
 
As alluded to in the general introduction T cell development in the thymus 
is regulated by multiple independent signals that derive from interactions 
between thymocytes and thymic stromal cells, in the case of conventional T cells, 
or thymocytes and cells of hematopoietic origin, in the case of innate T cells.  
These include signals mediated by the T cell antigen receptor [TCR] or pre-TCR, 
as well as cytokine signals.  Signals mediated by SLAM family receptors also 
have a critical role in the development of some innate T cell subsets (20-22, 73).  
At each stage of thymocyte maturation, the appropriate magnitude and duration 
of these signals are critical for the proper progression of cells from one 
developmental stage to the next.  The quality and strength of the signal will also 
be affected by the type of cell [stromal or hematopoietic] providing this signal.  
Signals through the TCR and pre-TCR are particularly critical for the 
development of αβTCR+ T cells.  In particular, as thymocytes progress from the 
CD4+CD8+ double positive [DP] stage to the CD4+ or CD8+ single positive [SP] 
stage, the specificity of the TCR, as well as the strength of signaling through this 
receptor, play a key role in determining the lineage of T cell that develops.  Thus, 
conventional CD4+ or CD8+ cells, CD4+ NKT cells, CD8+ H2-M3-specific cells, 
and CD4+CD25+ regulatory T cells all arise from distinct types of TCR signaling 
(13, 141-145). 
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The signaling pathways that distinguish all of these alternative 
developmental lineages have not been well-described.  For the maturation of 
conventional T cells, several signaling molecules proximal to the TCR have been 
implicated in the modulation of TCR signaling.  Among them are the 
MAP-kinases Erk, Jnk, and p-38.  Activation of the Erk/MAP-kinase signaling 
pathway is important for the positive selection of thymocytes, as impairment of 
Erk activation selectively affects positive, but not negative selection.  The Jnk 
and p-38 pathways are seemingly more important for the regulation of thymocyte 
negative selection (146, 147).  In addition, the activity of the tyrosine kinase 
p56Lck is critical for conventional T cell development, and also plays a role in 
determining CD4 versus CD8 lineage commitment (148).  NKT cell development, 
on the other hand,  is not dependent on Ras-MAP kinase signaling nor on Lck, 
but does required the src-family kinase, Fyn and the adapter protein SAP (52-
56).  It is not too clear however if Fyn is only required downstream of SLAM 
family signaling or if it’s also critical downstream of the TCR in NKT cells, but in 
mature conventional T cells Fyn is activated upon TCR engagement.  
Interestingly, CD4+ T cells selected on thymocytes [not stromal cells], that are not 
invariant NKT cells, also have the same requirements for Fyn and SAP (149).  It 
should be mentioned that like NKT cells, these cells can produce cytokines, IL-4 
and IFNγ, quickly without any kind of differentiation.  These findings illustrate the 
role of distinct T cell signaling proteins in directing lineage decisions within 
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conventional T development, or in conventional versus innate T cell 
development.  
Itk and Rlk have also been shown to be important during T cell 
development, and in particular, have been implicated in setting the thresholds of 
positive and negative selection.  Specifically, positive selection of CD4+ SP 
thymocytes is impaired in Itk-/- and Itk-/-Rlk-/- mice, a fact reflected by the lower 
percentages and total numbers of CD4+ SP thymocytes and peripheral cells 
(150).  Moreover, the absence of Itk lowers the positive selection efficiency of 
MHC Class II-specific TCR transgenic T cells as compared to wild-type littermate 
controls.  Additional studies with MHC Class I restricted Itk-/- and Itk-/-Rlk-/- H-Y 
TCR transgenic male mice demonstrated that there is a shift from negative 
selection to positive selection in these mice (151). These studies implicate Tec 
kinases in determining the magnitude of TCR signaling and thereby influencing 
the fate of conventional TCR αβ+ thymocytes.   
Prior to the work presented in the following results and discussion 
sections, the role of Itk and Rlk in CD8+ T cell development was unclear.  
Contrary to the decrease in percentage and total numbers of CD4+ SP 
thymocytes in the thymi of Itk-/- and Itk-/-Rlk-/- mice, there is an increase in both 
the percentage and total number of CD8+ SP thymocytes in these mice.  Given 
the importance of Itk and Rlk in the modulation of the signaling threshold for 
positive selection, it had been hypothesized that the generation of the increased 
numbers of CD8+ SP thymocytes in the Itk-/- and Itk-/-Rlk-/- mice may be due to a 
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switch in lineage commitment from the CD4+ to the CD8+ SP lineage (152).  This 
was studied using MHC II restricted TCR transgenics on a variety of selecting 
backgrounds but never was an increase in either the percentages or total 
numbers of CD8+ SP thymocytes observed in any of these mice in the absence 
of Itk, suggesting that lineage switching is not occurring in the Itk-/- mice (150). 
The aforementioned studies did not resolve the role of Itk and Rlk in CD8+ 
T cell differentiation, as they provided no explanation for the increased numbers 
of CD8+ SP thymocytes in Itk-/- and Itk-/-Rlk-/- mice.  These data suggested the 
possibility that Itk and/or Rlk play a distinct role in the CD8+ T cell maturation 
process compared to their function in signaling pathways required for CD4+ T cell 
differentiation.  In accordance to this, our lab also observed that the CD8+ SP 
thymocytes in Itk-/- (150) and Itk-/-Rlk-/- mice have a mature and activated 
phenotype similar to that of homeostatically-expanded or memory T cells, and 
also similar to T cells selected on nonclassical MHC class I-b molecules (13).  
Due to this information we set out to further investigate the CD8+ CD44hi SP 
thymocytes in Itk-/- and Itk-/-Rlk-/- mice, particularly how they come about.  Data 
presented in this chapter shows that the CD8+ T cells in the Tec family deficient 
mice [Itk-/- and Itk-/-Rlk-/-] are phenotypically and functionally distinct from what are 
considered “conventional” CD8+ T cells.  Several of the differences mimic 
characteristics seen in innate T cells such as expression of CD122 and NK1.1, in 
addition to high levels of CD44, the capability to produce IFNγ directly ex vivo, as 
well as complete dependence on IL-15 for development in the thymus and 
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maintenance in the periphery.  The CD8+ SP thymocytes in these mice also 
express high levels of the T-box transcription factor, eomesodermin.  In addition 
to this, another publication released at the same time also indicated that the 
CD8+ SP thymocytes in the Itk-/- and Itk-/-Rlk-/- deficient mice are selected by 
hematopoietic cells rather than the thymic stromal cells (71).  Finally, a more 
recent article indicates that selection of CD8+ SP cells in these mice is dependent 
on SAP (73).  All these data illustrates a critical role for Itk and Rlk in the 
signaling pathway leading to conventional CD8+ T cell differentiation. 
 
Results 
 
Memory cell phenotype of CD8+ T cells in the thymus and periphery of Itk-/- and 
Itk-/-Rlk-/- mice 
The Tec kinases Itk and Rlk have been implicated in the TCR signals 
leading to positive selection (150, 153).  Therefore, it came as a surprise to 
discover that the proportions and total numbers of CD8+ single positive [SP] 
thymocytes in Itk-/- and Itk-/-Rlk-/- mice are not reduced compared to that of wild-
type mice [Figures 7, 8 and 12].  In addition, the fractions of CD8+ T cells in the 
peripheries of Itk-/- and Itk-/-Rlk-/- mice are comparable to those seen in wild-type 
mice, and in the thymus, Itk-/- and Itk-/-Rlk-/- have significantly increased 
percentages and total numbers of CD8+ SP cells [Figure 7 and ref. (152)]; % 
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CD8+ SP thymocytes:  wild-type, 3.5±0.3, Itk-/-, 11.3±0.6, p<0.0001; absolute 
numbers CD8+ SP thymocytes: wild-type, 5.6±0.8x106, Itk-/- 14.0±0.2x 106, 
p<0.0019].  
In addition to the increased numbers of CD8+ thymocytes in Itk-/- and 
Itk-/-Rlk-/- mice, analysis of activation marker profiles reveals that the majority of 
these cells have a mature and previously-activated phenotype [Figure 7A, C and 
ref. (150)].  These thymocytes are CD44hi, CD122+, HSAlo, and NK1.1int, but are 
also CD69lo and CD25lo [Figure 7A, C and data not shown], indicating their 
similarity to memory T cells that usually reside in the periphery.  Like the CD8+ 
SP thymocytes, approximately 85% of the CD8+ T cells in the periphery of Itk-/- 
and Itk-/-Rlk-/- mice are also CD44hi and have increased expression of other 
memory markers such as CD122 and NK1.1, while still expressing high levels of 
CD62L [Figure 7B, D]. However, like the CD8+ SP thymocytes, these peripheral 
CD44hi CD8+ T cells do not express other markers of acute activation, such as 
CD25 or CD69 [data not shown]. 
Previously-activated/memory peripheral CD8+ CD44hi T cells are 
characterized by their ability to secrete effector cytokines immediately ex vivo in 
response to stimulation.  To determine whether the CD8+ CD44hi SP cells in the 
thymus and spleen of Itk-/- and Itk-/-Rlk-/- mice are functionally, as well as 
phenotypically, similar to previously-activated peripheral T cells, we examined  
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Figure 7:  CD8+ T cells in Itk-/- and Itk-/-Rlk-/- mice resemble 
previously-activated T cells 
[A, B] Dot-plots show CD4 vs. CD8 profiles of wild-type, Itk-/- and Itk-/-Rlk-/- [A] 
thymocytes or [B] lymph node cells.  Numbers in each quadrant indicate 
percentages of each subpopulation.  The histograms below show [A] CD44, 
CD122 and HSA expression on gated CD8+ TCRhi SP thymocytes or [B] CD44, 
CD122 and CD62L expression on gated CD8+ TCRhi lymph node cells.  Numbers 
indicate percentage of CD44hi, CD122hi, HSAlo, or CD62Lhi cells, respectively.  
Data are representative of one of two experiments. 
[C, D] Dot-plots show CD8 vs. CD44 profiles of five-week-old wild-type, Itk-/- and 
Itk-/-Rlk-/- [C] thymocytes or [D] splenocytes.  Numbers by each region indicate 
percentages of each subpopulation.  The dot-plots below show TCR versus 
NK1.1 staining on gated CD8+CD44lo [blue] or CD8+CD44hi [red] populations.  
Data are representative of three independent experiments. 
 [E] Thymocytes [top row] and splenocytes [bottom row] from wild-type, Itk-/- and 
Itk-/-Rlk-/- mice were stimulated with PMA and ionomycin for 5 h and IFNγ 
production was assessed by intracellular staining.  Dot-plots show IFNγ vs. CD44 
staining on gated CD8+ cells.  Numbers in each quadrant indicate percentages of 
each subpopulation.   
[F] Thymocytes from wild-type, Itk-/- and Itk-/-Rlk-/- mice were stimulated with IL-15 
for 48 h and the levels of Bcl-xL were determined by intracellular staining.  
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Histograms show Bcl-xL expression on gated CD8+ thymocytes.  The wild-type 
sample is depicted by the thick black line, Itk-/- by the thin red line and Itk-/-Rlk-/- by 
the dashed blue line.  Data are representative of two independent experiments. 
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their ability to secrete the effector cytokine, IFNγ.  In response to ex vivo 
stimulation with PMA and ionomycin, a large proportion of Itk-/- and Itk-/-Rlk -/- 
CD8+ CD44hi SP thymocytes and peripheral T cells produce IFNγ [Figure 7E].  As 
this population of cells is absent from wild-type thymi, there was no 
corresponding effector cytokine production by wild-type CD8+ SP thymocytes 
[Figure 7E].  Another functional characteristic of CD8+ memory T cells is their 
ability to upregulate Bcl-xL in response to IL-15 (154).  To assess this response, 
we incubated thymocytes from wild-type, Itk-/-, and Itk-/-Rlk-/- mice in media 
containing IL-15 for 36 h.  As shown in Figure 7F, the CD8+ SP thymocytes from 
Itk-/- and Itk-/-Rlk-/- mice exhibit a dramatic upregulation of Bcl-xL in response to 
IL-15 compared to that seen with wild type CD8+ SP thymocytes.  Based on 
these findings, we conclude that the CD8+ CD44hi cells in the thymus of Itk-/- and 
Itk-/-Rlk-/- mice are functionally, as well as phenotypically, similar to 
previously-activated/memory peripheral CD8+ T cells.      
 
The CD8+ CD44hi T cell population is first detectable in day 4 post-natal thymus 
of Itk-/- mice 
The finding that CD8+ SP thymocytes in Itk-/- and Itk-/-Rlk-/- mice resemble 
previously-activated/memory peripheral CD8+ T cells raised the question of the 
developmental origin of these cells.  For instance, does this population of cells 
arise first in the thymus and then migrate to the periphery, or are these cells 
actually peripheral activated/memory CD8+ T cells that have recirculated back 
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into the thymus?  As a first step in examining this issue, we assessed the 
emergence of the CD8+ CD44hi cell phenotype in Itk-/- mice by performing a 
longitudinal study of CD8+ SP thymocyte and peripheral T cell development from 
birth through the first seven weeks of life.  As shown in Figure 8A, an increased 
proportion of CD8+ CD44hi thymocytes first appears at four days after birth in Itk-/- 
mice compared to wild type controls.  Furthermore, from the age of two weeks 
onward, total CD8+ SP thymocytes accumulate, both in percentage and absolute 
numbers, in Itk-/- mice as compared to controls [Figure 8B].  The increased 
numbers of CD8+ SP thymocytes in Itk-/- mice is accompanied by a transient 
deficit in the numbers of peripheral CD8+ T cells in these mice relative to wild 
type controls.  This deficit persists until the mice are ~7-8 weeks of age [Figure 
8B].  These kinetic data suggest that CD8+ CD44hi T cells first arise in the thymus 
of Itk-/- mice.  
Interestingly, the CD8+ cells emerging into the periphery of both wild-type 
and Itk-/- mice at early time points [1-2 weeks after birth] have distinctly similar 
CD44hi profiles [Figure 8C].  This is likely due to the fact that the first migrants 
into the periphery of young mice undergo lymphopenia-induced proliferation in 
response to the “space” in the peripheral lymphoid organs, a phenomenon that is 
accompanied by CD44 up-regulation (155).  These CD44hi cells remain to 
constitute the fraction of previously-activated cells typical of peripheral lymphoid 
organs (156).  However, the frequency of these cells gradually diminishes in wild-
type spleens, as cells continually migrate from the thymus into the periphery,  
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Figure 8: The altered phenotype of Itk-/- CD8+ thymocytes is detectable by 
day 4 post-gestation 
[A] Wild-type and Itk-/- neonatal day 1.5 [left two panels] and day 4 [right two 
panels] thymocytes were stained with antibodies to CD4 and CD8.  The numbers 
in each quadrant indicate the percentage of cells in each subpopulation.  
Histograms of CD44 expression on gated CD8+ SP thymocytes are depicted 
below.  Numbers indicate the percentage of CD8+ SP thymocytes expressing 
high levels of CD44.   
[B] The percentages and total numbers of CD8+ SP thymocytes and peripheral T 
cells developing in wild-type, Itk-/-, and Itk-/-Rlk-/- mice were assessed at the 
indicated time points from birth to adulthood.  Data were generated in a blind 
manner, and genotypes were determined afterwards. Data are compiled from a 
minimum of two experiments per time point with a minimum of two mice of each 
genotype per time point.   
[C] CD44 expression on gated CD8+ thymocytes and splenocytes from 1-week, 
2-week. 3-week, and 6-week old mice.  Numbers indicate the percentage of 
CD44hi cells among the gated population.  Data are representative of a minimum 
of two experiments, each performed with a minimum of 3 mice per group. 
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filling up space and preventing further proliferation of the newly emigrated cells 
from the thymus [Figure 8C].  The preferential accumulation of CD44hi CD8+ SP 
thymocytes in the thymi of Itk-/- mice as compared to wild-type mice, as well as 
the persistence of this population over time in the periphery of Itk-/- mice, strongly 
suggests that the activated/memory CD8+ phenotype typical of Itk-/- mice 
develops first in the thymus.  
 
Cell-instrinsic defects lead to the altered phenotype of CD8+ thymocytes in Itk-/- 
and Itk-/-Rlk-/- mice 
 In addition to homeostatic proliferation, CD8+ T cells have been shown to 
upregulate CD44 expression and to become phenotypically and functionally 
mature in response to cytokines.  In particular, the CD8+ T cell populations found 
in both IL-7 (157) and IL-15 (158) transgenic mice that overexpress these 
cytokines are strikingly similar to the CD8+ T cells present in Itk-/- and Itk-/-Rlk-/- 
mice.  Therefore, we chose to examine whether the altered development of Itk-/- 
and Itk-/-Rlk-/- CD8+ T cells was due to defects intrinsic to the developing T cells, 
or alternatively, due to an altered cytokine environment in Itk-/- and Itk-/-Rlk-/- mice.  
To address this question, we generated bone marrow chimeric mice in which 
wild-type, Itk-/-, or Itk-/-Rlk-/- bone marrow was injected into lethally-irradiated wild-
type congenic mice.  As shown in Figure 9, following reconstitution, the 
emergence of CD44hi cells in the CD8+ SP compartment of the thymus is readily  
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Figure 9: Altered CD8+ T cell differentiation in the absence of Tec family 
kinases is intrinsic to bone marrow-derived cells 
Wild-type, Itk-/-, and Itk-/-Rlk-/- bone marrow chimeric mice were analyzed 12 
weeks following reconstitution.  Dot plots show CD4 versus CD8 staining on 
donor-derived cells [CD45.2+].  The numbers in each quadrant indicate the 
percentage of cells in each subpopulation.  The histograms below show CD44 
expression on CD45.2+ CD8+ SP thymocytes. Numbers indicate the percentage 
of CD44hi cells among the gated population.  Data are representative of four wild-
type, four Itk-/-, and eight Itk-/-Rlk-/- chimeras analyzed. 
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apparent in mice reconstituted with Itk-/- or Itk-/-Rlk-/- bone marrow, but not in 
thymi of mice reconstituted with wild-type bone marrow.  These findings indicate 
that the altered CD8+ T cell development in the absence of Itk, or Itk and Rlk, is 
not due to abnormalities of Itk-/- or Itk-/-Rlk-/- non-hematopoietic stromal cells. 
 
Itk-/- CD44hi CD8+ T cells are not actively proliferating and do not preferentially 
home to the thymus  
CD44 expression on peripheral CD8+ T cells is upregulated following 
antigen-specific activation and expansion, or alternatively, after cells have 
undergone lymphopenia-induced proliferation (159, 160).  To determine whether 
Itk-/- CD8+ SP thymocytes and peripheral T cells were actively proliferating, we 
analyzed BrdU incorporation of CD8+ CD44hi cells in the thymus and spleen of 
Itk-/- mice.  Mice were injected with BrdU and analyzed 12 h later.  As the majority 
of thymocyte proliferation occurs following pre-TCR stimulation, BrdU is primarily 
incorporated by CD3-4-8- thymocytes and cells in transition to the CD4+8+ [double 
positive; DP] stage; following this transition, the majority of DP thymocytes are 
not in cycle (161).  It has also been reported that a small proportion of SP 
thymocytes proliferate following positive selection (162).  Similarly, in the 
periphery of unimmunized non-lymphopenic mice, there is normally very little 
proliferation of naïve T cells.  Following BrdU injection, a clear population of 
BrdU+ DP thymocytes is apparent in both wild-type and Itk-/- mice, demonstrating  
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Figure 10: Itk-/- CD8+ cells are not actively proliferating and do not 
preferentially migrate to the thymus 
[A] Mice were injected with BrdU and incorporation was assessed 12 h later to 
determine the percentage of cells actively proliferating in wild-type [solid blue 
line] and Itk-/- [solid pink line] mice.  The dashed line shows cells from uninjected 
mice stained with the anti-BrdU antibody.  Numbers indicate the percentage of 
cells of each genotype in the positive gate. 
[B] Wild-type CD8+ CD44lo, Itk-/- CD8+ CD44lo, and Itk-/- CD8+ CD44hi cells [all 
CD45.2+] were adoptively transferred into CD45.1+ wild-type congenic mice and 
the presence of the transferred cells in various organs was analyzed 7 days later.  
Numbers represent the percentage of CD45.2+ cells in each organ at the time of 
analysis.  Results are representative of one of two experiments with three mice 
per condition. 
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that comparable levels of BrdU were present in both mice [Figure 10A].  When 
CD8+ SP thymocytes were examined, we detected little proliferation in the 
mature HSAlo CD8+ SP fraction of either thymus, and interestingly, the fraction of 
BrdU+ HSAlo CD8+ SP cells in the Itk-/- thymus was even smaller than in the wild-
type thymus.  Analysis of the peripheral splenic CD8+ T cells also revealed no 
increased proliferation of the Itk-/- cells compared to the wild-type controls [Figure 
10A].  These data indicate that Itk-/- CD8+ thymocytes and peripheral T cells are 
not accumulating due to increased proliferation either in the thymus or the 
spleen.  
Although conventional T cells do not typically acquire a CD44hi phenotype 
in the thymus, they can gain access to the thymus as a result of recirculation 
from the periphery (163, 164).  To examine the possibility that peripheral Itk-/- 
CD8+ CD44hi cells were preferentially homing to thymus from the periphery, we 
assessed the trafficking patterns of Itk-/- cells following adoptive transfer into wild-
type congenic recipients.  For these experiments, purified wild type or Itk-/- CD8+ 
thymocytes [CD45.2+] were injected into CD45.1+ congenic wild-type mice, and 
the ability of these transferred cells to migrate back to the thymus of the 
recipients was assessed.  As shown in Figure 10B, even though the transferred 
Itk-/- CD8+ CD44hi cells were easily detectable in the spleen and lymph nodes of 
the recipient mice, no transferred cells could be found in the thymus of the host 
mice.  This was also the case for CD8+ CD44lo thymocytes purified from either 
Itk-/- or wild-type mice.  These data indicate that the accumulation of CD8+ CD44hi 
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cells in the thymi of Itk-/- mice is not due to preferential migration of peripheral 
Itk-/- CD8+ CD44hi cells to the thymus. 
 
Normal CD8+ T cell differentiation is restored in Itk-/- OT-1 TCR transgenic mice 
 Altogether these data suggest that the unusual CD8+ phenotype we 
observe in Itk-/- mice is likely due to altered development of CD8+ T cells in the 
thymus.  Previously we have shown that the avidity of the TCR on developing 
CD4+ thymocytes influences the outcome of positive selection in Itk-deficient 
mice.  For instance, development of mature CD4+ T cells is dramatically impaired 
when the cells express a low avidity TCR, whereas the number of mature CD4+ T 
cells that develop when the cells express a high avidity TCR is comparable to 
that observed in Itk-sufficient mice (150).  This is in agreement with studies of 
TCR signaling in Itk-/- peripheral T cells, which have shown that the absence of 
Itk causes more substantial defects when the stimulus is sub-optimal (102, 138, 
165).  Thus, we were interested in determining if the defects in CD8+ T cell 
development observed in Itk-/- mice arise as a result of impaired TCR signaling 
during positive selection.  If this were the case, one would predict that the 
accumulation of CD44hi CD8+ SP thymocytes would not occur in Itk-/- mice 
crossed to an MHC class I-specific TCR transgenic line, if the TCR chosen is 
very efficiently selected in the thymus.   
 To test this possibility, we crossed Itk-/- mice to the TCR transgenic OT-1+ 
line.  Previous data have indicated that the OT-1 TCR has a relatively high avidity 
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for positively-selecting ligands in the thymus (166).  In support of this notion, we 
found that the maturation of CD8+ T cells with high levels of the OT-1 TCR was 
only slightly reduced in the absence of Itk [Figure 11].  This is in contrast to 
previous data showing that the CD8+ T cells expressing the H-Y TCR fail to be 
selected in the absence of Itk (151, 153).  Furthermore, as compared to non-
TCR-transgenic Itk-/- mice, which accumulate mature HSAlo cells in the thymus, 
OT-1 Itk-/- mice have CD8+ SP thymocytes that are comparable to those found in 
both OT-1 TCR transgenic and non-transgenic Itk-sufficient mice [Figure 11 and 
Figure 7A].  In addition, the CD44 profiles of wild-type versus Itk-/- OT-1+ CD8+ 
SP thymocytes and peripheral CD8+ T cells were identical [Figure 11 and data 
not shown].  Thus, when positive selection signals are largely independent of Itk, 
CD8+ differentiation proceeds normally, and there is no accumulation of CD44hi 
CD8+ SP thymocytes or peripheral T cells.  These results are consistent with 
those obtained by Broussard et al., in which these defects in CD8+ T cell 
development were suppressed by the expression of a hypersensitive allele of 
ERK2 in Itk-deficient mice (71). 
 
The altered CD8+ T cell development in Itk-/- mice is dependent on IL-15 
The data described above strongly suggest that CD44hi CD8+ T cells arise 
first in the thymus and then accumulate in the periphery in Itk-/- mice, and that 
their appearance depends on reduced TCR signaling during selection.  In 
addition, the data of Broussard et al. indicate that large populations of CD8+  
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Figure 11:  CD8+ OT-I TCR transgenic Itk-/- T cells develop normally  
[A] Thymocytes and [B] lymph node cells from eight-week old OT-I Itk+/- and OT-I 
Itk-/- mice were analyzed for expression of CD4 and CD8 [top row].  In the 
dot-plots below, gated CD8+ populations were examined for the expression of the 
transgenic TCR by staining with anti-Vα2 and anti-Vβ5.  The numbers in each 
quadrant indicate the percentage of cells in each subpopulation.  Histograms 
[bottom row] show HSA expression on CD8+ SP thymocytes and CD44 
expression on the CD8+ lymph nodes cells.  Data are representative of four mice 
of each genotype analyzed. 
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thymocytes still develop when Itk-/- and Itk-/-Rlk-/- bone marrow are used to 
reconstitute irradiated β2m-/- hosts (71).  Positive selection mediated by MHC  
molecules expressed on hematopoietic cells, rather than on radiation-resistant 
thymic stroma, is a characteristic of alternative lineages of αβ TCR+ T cells, such 
as NKT cells and H2-M3-restricted T cells, which are specific for ligands bound to 
nonclassical MHC class I-b molecules (13, 49, 50).  In addition, where it has 
been examined, these T cell lineages are also exquisitely dependent on IL-15 for 
their maintenance in the periphery (167-169). 
To test the notion that Itk-/- CD8+ CD44hi T cells represent an IL-15-
dependent lineage, we crossed Itk-/- mice to IL-15-/- mice.  As shown in Figure 
12A, both the percentage and absolute numbers of CD8+ SP thymocytes are 
reduced in Itk-/- IL-15-/- mice to a level nearing that seen in wild type mice.  
Moreover, the remaining CD8+ SP thymocytes in Itk-/- IL-15-/- mice show a normal 
profile of CD44 expression.  Furthermore, Itk-/- IL-15-/- mice are nearly devoid of 
CD8+ T cells in the periphery [Figure 12B].  In terms of absolute cell numbers, 
Itk-/- IL-15-/- mice have a 23-fold reduction in peripheral CD8+ T cells compared to 
wild type mice, and a 7-fold reduction compared to IL-15-sufficient Itk-/- mice.  
This is in contrast to the ~2-fold loss in total CD8+ T cell numbers and ~3-fold 
reduction in numbers of CD8+ CD44hi T cells in single IL-15-deficient mice 
compared to wild type controls.  Thus, Itk-/- CD8+ CD44hi T cells are far more 
dependent on IL-15 than their wild type counterparts, including wild type 
memory-phenotype CD8+ T cells, and in this regard, more closely resemble NKT  
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Figure 12:  CD8+ T cells are abolished in the absence of Itk and IL-15   
[A] Thymocytes and [B] lymph node cells isolated from wild-type, Itk-/-, IL-15-/- and 
Itk-/-IL-15-/- mice were stained for expression of CD4, CD8 and CD44.  Dot-plots 
show CD4 versus CD8 staining [top row] and CD8 versus CD44 staining [bottom 
row], with the numbers in each region indicating the percentage of cells in each 
subpopulation.  The graphs below show the absolute cell numbers ± SEM for 
each subpopulation.  Data are generated from a minimum of six mice from four 
independent experiments per group. 
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cells than they do conventional TCRαβ+ CD8+ T cells (167).  Together, these 
data strongly suggest that the CD44hi CD8+ SP phenotype observed in Itk-/- mice 
develops first in the thymus, and that the maintenance of these cells in peripheral 
lymphoid organs is stringently dependent on IL-15.   
 
Eomesodermin is expressed at high levels in Itk-/- and Itk-/-Rlk-/- thymocytes 
undergoing positive selection 
One striking aspect of the altered phenotype of Itk-/- and Itk-/-Rlk-/- CD8+ SP 
thymocytes is their ability to produce IFNγ when stimulated immediately ex vivo.  
Since CD8+ T cell effector function is associated with expression of the T-box 
transcription factor, Eomesodermin [Tbr2] (170), we investigated whether Itk-/- 
and Itk-/-Rlk-/- thymocytes showed altered expression of Eomesodermin.  For this 
experiment, mRNA was prepared from sorted DP, CD4+ SP, and CD8+ SP 
thymocytes isolated from wild type, Itk-/-, and Itk-/-Rlk-/- mice.  Eomesodermin 
transcript levels were then determined by real-time quantitative RT-PCR.  As 
shown in Figure 13A, all three subsets of wild type thymocytes express low levels 
of Eomesodermin mRNA.  In contrast, Itk-/- and Itk-/-Rlk-/- CD8+ SP thymocytes 
have ~100-fold increased levels of Eomesodermin mRNA compared to wild type 
controls.  Since IFNγ transcription in CD8+ T cells can also be regulated by the 
related transcription factor, T-bet (171), and furthermore, we have previously 
shown that T-bet expression is disregulated in Itk-/- CD4+ T cells (102), we also 
examined the levels of T-bet mRNA in Itk-/- and Itk-/-Rlk-/- CD8+ SP thymocytes.   
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Figure 13:  CD8+ thymocytes from Itk-/- and Itk-/-Rlk-/- mice express high 
levels of Eomesodermin   
[A] Thymocytes from wild type, Itk-/-, and Itk-/-Rlk-/- mice were sorted into 
CD4+CD8+ [DP], CD4-CD8- SP [CD4] and CD4+CD8- SP [CD8] cell populations.  
In [B], CD4+8+ DP and CD4-8+ SP cells were further sorted into TCRβlo CD69- 
and TCRβhi CD69+ populations.  In [C] cells were sorted in the same way as in 
[B] but animals utilized were OT-I positive and WT or OT-I positive and Itk-/-.  
Total RNA was then isolated, cDNA prepared, and real-time quantitative PCR 
performed for Eomesodermin and -actin.  The y-axis values represent 
eomesodermin transcript levels normalized to the -actin values determined for 
each sample.  Error bars are the SD of values obtained from triplicate reactions.   
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In contrast to the findings with Eomesodermin, we found no increased expression 
of T-bet mRNA in both Itk-/- and Itk-/-Rlk-/- CD8+ SP thymocytes relative to wild 
type control cells [data not shown]. 
To determine the precise stage in CD8+ thymocyte development at which 
Eomesodermin transcripts are up-regulated, we further sorted thymocytes into 
pre-positive selection DP [CD4+CD8+ TCRlo CD69lo], DP undergoing positive 
selection [CD4+CD8+ TCRhi CD69hi], newly-arising CD8+ SP [CD4-CD8+ TCRhi 
CD69hi] and more mature CD8+ SP [CD4-CD8+ TCRhi CD69lo] subsets.  As can 
be seen in Figure 13B, Eomesodermin mRNA is first up-regulated in Itk-/- and Itk-/-
Rlk-/- DPs undergoing positive selection compared to wild type DPs at this stage 
of maturation [12-16-fold increase in Itk-/- and Itk-/-Rlk-/- TCRhi CD69hi DPs 
compared to wild type].  As DP cells transition into the CD8+ SP lineage, the 
increased expression of Eomesodermin becomes even more striking, resulting in 
20-50-fold increases in Eomesodermin mRNA in Itk-/- and Itk-/-Rlk-/- TCRhi CD69hi 
CD8+ SPs compared to wild type control cells.  These data demonstrate that the 
maturation of CD8+ SP thymocytes in the absence of Itk, or Itk and Rlk, is 
accompanied by a dramatic up-regulation of Eomesodermin transcripts, thereby 
accounting for the activated/memory cell phenotype and functional behavior of 
these cells. 
Crossing the Itk-/- to OT-1 transgenics, which as shown on Figure 11 
abolishes the memory [CD44hi] phenotype, does not seem to completely abolish 
the increased expression of Eomesodermin in the later stages of CD8 T cell 
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maturation [Figure 13C, DP-CD69hi on].  It should be noted that the changes 
seen in the Itk-/- versus the WT are now much milder: in the DP-CD69hi about 2-
fold increase in the OT-1+ versus 12-fold increase in the OT-1-; in the 
CD8+CD69hi about 3-fold increase in the OT-1+ versus 20-fold increase in the 
OT-1-; and in the mature CD8+CD69lo about 20-fold increase in the OT-1+ versus 
about 100-fold increase in the OT-1-.  Although it is somewhat perplexing that 
increasing the TCR signal with the OT-1 receptor does not completely abolish the 
change in Eomesodermin expression in the Itk-/- CD8+ T cells, it is somewhat 
reassuring that the changes seen are much lower, indicating that signal strength 
is a large component of the phenotype. 
 
Discussion 
 
Given the data presented in this chapter and the evidence indicating that 
the CD8+ T cells in the Itk-/- and Itk-/-Rlk-/- cells are selected by a hematopoietic 
cells and a SAP dependent signaling pathway, it seems clear that the 
conventional CD8+ T cell lineage choice is extremely reliant on signaling through 
Tec family kinases Itk and Rlk (71, 73).  Here we show that the majority of CD8+ 
SP thymocytes and peripheral T cells that arise in Itk-/- and Itk-/-Rlk-/- mice are 
distinct from conventional TCRαβ+ CD8+ T cells.  As opposed to normal naive 
CD8+ T cells, the Itk-/- and Itk-/-Rlk-/- CD8+ T cells resemble previously-
activated/memory CD8+ T cells, which in addition to being CD44hi and CD62Lhi, 
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also express increased levels of the activation/memory markers, CD122 and 
NK1.1.  Further supporting their status as effector or memory cells, Itk-/- and 
Itk-/-Rlk-/- CD8+ thymocytes and peripheral T cells produce IFNγ in response to 
simulation immediately ex vivo.  In addition, the maturation of these cells and 
their maintenance in the periphery are totally dependent on IL-15.  What 
distinguishes these cells from conventional, peripheral memory CD8+ T cells is 
that these features are not acquired by the cells as a result of peripheral 
activation signals, but instead arise during a process of intrathymic development 
which is dependent on SAP for selection [on hematopoietic cells] and CD28 for 
acquisition of the innate-like phenotype (71, 73). 
In all of these aspects, Itk-/- and Itk-/-Rlk-/- CD8+ thymocytes and peripheral 
T cells bear a striking similarity to nonconventional T cell lineages, such as cells 
specific for nonclassical MHC class I-b molecules.  One subset of such cells is 
NKT cells that are specific for glycolipids bound to the CD1d molecule.  The 
CD8+ T cells in Itk-/- and Itk-/-Rlk-/- mice share many common features with NKT 
cells, including the expression of many maturation and activation markers [HSAlo, 
CD44hi, CD122hi, NK1.1+] (172).  In addition, the Itk-/- and Itk-/-Rlk-/- CD8+ SP 
thymocytes are abundantly selected in bone marrow chimeric mice in which only 
the hematopoietic donor cells, but not the host thymic stromal cells, express 
MHC class I molecules.  This positive selection behavior is a characteristic of 
NKT cells, and distinctly different from that of conventional CD8+ T cells, 
particularly the dependence on SAP (20-22, 49, 73).  Finally, we show that the 
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peripheral maintenance of Itk-/- CD8+ T cells is stringently dependent on IL-15, 
another characteristic feature of NKT cells (167). 
In spite of these strong correlations, it seems unlikely that Itk-/- and 
Itk-/-Rlk-/- CD8+ T cells are bona fide NKT cells.  NKT cells that are specific for 
ligands bound to the CD1d molecule are found in the CD4+ and CD4-8- subsets, 
but not among the CD8+ T cell population (172).  In addition, CD8+ SP 
thymocytes in Itk-/- and Itk-/-Rlk-/- mice fail to stain with CD1d/α-gal-cer tetramers 
(1).  Another possibility is that Itk-/- and Itk-/-Rlk-/- CD8+ T cells might be specific 
for the MHC class I-b molecule, H2-M3.  H2-M3-specific T cells share many of 
the features of CD1d-specific NKT cells, including an activated/memory 
phenotype, the ability to make cytokines directly ex vivo, and the ability to be 
selected on MHC class I molecules expressed on hematopoietic cells in the 
thymus; however H2-M3-specific T cells are CD8+ (13, 15, 16).  Based on these 
similarities, it is possible that Itk-/- and Itk-/-Rlk-/- CD8+ T cells consist of H2-M3-
specific cells, although this hypothesis seems unlikely due to the large numbers 
of CD8+ T cells in Itk-/- and Itk-/-Rlk-/- mice. 
We propose that Itk-/- and Itk-/-Rlk-/- CD8+ SP thymocytes develop as a 
result of altered TCR signals that resemble, or mimic, those that normally select 
MHC class I-b-specific cells.  Consistent with this notion, our analysis of OT-1 Itk-
/- mice, as well as the analysis of ERKSEM Itk-/- mice by Broussard et al, indicate 
that the development of CD8+ SP thymocytes with this unusual phenotype is 
resolved when sustained TCR signaling during thymic development is less 
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dependent on Itk.  Furthermore, selection of the innate-like cells in the Itk-/- mice 
is dependent on selection on hematopoietic cells, as forcing selection on MHC 
expressed by the thymic stroma prevents the innate phenotype (73).  Finally, 
although selection of the innate-like CD8+ T cells is not dependent on CD28 
signaling, generation of the innate phenotype requires its expression.  Therefore, 
we hypothesize that Itk-/- and Itk-/-Rlk-/- CD8+ SP thymocytes undergo altered 
lineage differentiation in response to reduced TCR-mediated signals.  
One insight into the mechanism leading to altered lineage differentiation is 
the profound up-regulation of Eomesodermin expression in Itk-/- and Itk-/-Rlk-/- 
CD8+ SP thymocytes.  This transcription factor is known to regulate CD8+ T cell 
effector functions, such as the ability to produce IFNγ upon TCR stimulation. Our 
data indicate that increased expression of Eomesodermin is readily detectable in 
the subset of Itk-/- and Itk-/-Rlk-/- DP thymocytes that are in the process of 
receiving positive selection signals.  Boosting the signaling through expression of 
a stronger TCR [OT-1] severely reduced the upregulation of eomesodermin, but 
not to WT levels.  These findings strongly support the conclusion that Itk, and 
potentially Rlk, play an important role during CD8+ T cell differentiation, and that 
altered thymic development is responsible for the memory cell phenotype of Itk-/- 
and Itk-/-Rlk-/- CD8+ SP thymocytes and T cells.  These results also raise the 
interesting possibility that increased expression of Eomesodermin may be 
responsible, at least in part, for this phenotype.    
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Taken together, these data suggest the following model [Figure 14].  Weaker 
TCR signaling during positive selection of MHC class I-specific thymocytes in the 
absence of Itk or Itk and Rlk promotes selection mediated by hematopoietic cells, 
through a SAP dependent mechanism, and the up-regulation of Eomesodermin.  
Eomesodermin then directly induces CD122 expression (173), thereby 
enhancing the responsiveness of these cells to cytokines, such as IL-15.  In 
response to IL-15, Itk-/- and Itk-/-Rlk-/- CD8+ SP thymocytes up-regulate Bcl-2 
(150, 158) increasing their survival and promoting their differentiation into CD8+ 
effector cells.  High levels of Eomesodermin further contribute to the 
differentiation of CD8+ T cells with immediate effector function capabilities, such 
as the ability to produce IFNγ.  In addition, these findings suggest the intriguing 
possibility that a similar series of events regulates the maturation of MHC class I-
b-specific T cells in response to weaker positive selection signals on the poorly-
expressed MHC class I-b molecules.  A role for Eomesodermin in the 
development and/or function of H2-M3-specific CD8+ T cells may therefore be a 
fruitful avenue of investigation for future studies. 
 
  
76 
 
Figure 14:  Conventional versus innate CD8+ T cell differentiation model   
The presence of Tec family kinases Itk and Rlk in DP thymocytes helps boost 
signals through the TCR, allowing for selection in thymic stromal cells mediated 
by classical MHC-I.  This leads to selection of naïve conventional CD8+ T cells 
[CD44lo, CD122-, and uncapable of quick IFNγ secretion] which haven’t 
significantly upregulated eomesodermin.  The generation of effector memory 
[through TCR mediated activation] on these cells leads to upregulation of 
eomesodermin, CD44, CD122, and the ability to quickly secrete IFNγ. 
Absence of Tec family kinases Itk and Rlk, on the other hand, leads to a weaker 
signal and preferred selection on cells of hematopoietic origin.  This selection is 
dependent on MHC-I and signaling through SLAM family members [mediated by 
SAP].  Selection is not dependent on CD28, but CD28 is needed for the innate 
phenotype of the cells.  Early during the selection process eomesodermin is 
quickly upregulated.  Selection leads to formation of innate CD8+ T cells with high 
expression of CD44, CD122, and the ability to quickly secrete IFNγ without any 
prior stimulations. 
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Intro 
 
NKT cells are an innate subset of αβTCR+ T cells that express surface 
markers characteristic of both T cells and NK cells, and can rapidly produce large 
amounts of cytokines such as INFγ, IL-4 and IL-10 (26, 175).  The great majority 
of murine NKT cells express an invariant TCR Vα and Jα combination [Vα14-
Jα18] that is preferentially paired with a restricted TCR beta chain [mostly Vβ8.2 
or Vβ7], and recognize lipid antigens in the context of CD1d (18, 19).  These cells 
develop in the thymus from CD4+8+ [DP] thymocyte progenitors, and are 
positively selected by interactions with other CD1d+/SLAM+ DP cortical 
thymocytes (20, 22).  Upon positive selection, NKT cells acquire markers 
characteristic of memory T cells, such as CD44 (21).   
Previous studies have identified three differentiation stages of NKT cells in 
the thymus subsequent to their expression of a mature TCR that binds to CD1d-
tetramer: stage 1, in which they have low expression of CD44 and NK1.1; stage 
2, in which they acquire high expression of CD44; and stage 3, in which they 
acquire expression of NK1.1 as well as several other NK markers (21).  
Accompanying these changes in surface markers, NKT cells undergo a 
proliferative expansion between stages one and two, during which they already 
posses the ability to produce IL-4.  At stage three, the cells are also competent to 
produce IFNγ (23-25).  Interestingly, the NK1.1- NKT cells leave the thymus to 
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populate the periphery, where they can further mature into NK1.1+ NKT cells, 
while the more mature NK1.1+ NKT cells generated in the thymus remain in the 
thymus to become a long-lived non-dividing resident population (23, 24, 176).  
Furthermore, upregulation of NK1.1 on peripheral NKT cells, which denotes their 
terminal differentiation, is CD1d dependent (177), whereas the survival and 
homeostasis of these cells depends on IL-15 (168, 178). 
 Several cytokines, transcription factors, and signaling molecules have 
been implicated in the development and survival of NKT cells.  As mentioned 
above, IL-15 is involved in NKT survival and proliferation in the periphery, while 
Csf-2 [granulocyte-macrophage colony-stimulating factor] is required for NKT cell 
differentiation and cytokine secretion (179).  Members of the NF-κB transcription 
factor family have also been implicated in proliferation and survival of NKT cells 
(62).  During development in the thymus, the SLAM [signaling lymphocytic 
activating molecule] family of receptors, the adaptor protein SAP [SLAM-
associated protein], and the SRC-family tyrosine kinase Fyn have all been 
implicated in a signaling axis required for selection of NKT cells (20, 53-56).  In 
addition, PKCθ [protein kinase θ], VAV1, IRF1 [interferon-regulatory factor 1], 
ETS1, ELF4 [E74-like factor 4 or MEF], RUNX1 [runt-related transcription factor 
1] and RORγt [retinoic-acid-receptor-related orphan receptor-γt] have been 
shown to have significant roles in NKT cell development, function and survival 
(57-61, 63, 180).   
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Of interest, Th1 and Th2 transcriptional regulators, T-bet and GATA-3, 
respectively, have also been shown to have prominent roles in NKT development 
and homeostasis.  For instance, In T-bet-deficient mice, the development of NKT 
cells in the thymus is blocked prior to upregulation of NK1.1 [i.e., prior to stage 3], 
leading to decreased numbers of NKT cells in the thymus and periphery (68).  
These mice also have defects in NKT cell migration, survival and effector 
functions, findings that are consistent with the prominent role of T-bet in CD122 
expression and IFNγ transcription in T cells (181).  Mice deficient in GATA-3 
exhibit decreases in peripheral NKT cell numbers due to increased cell death, as 
well as alterations in NKT cell surface marker expression both in the thymus and 
the periphery; GATA-3-deficient NKT cells also show decreased cytokine 
secretion (67).  It has recently been shown that a member of the NFAT family, 
NFAT2, has a more prominent role in IL-4 cytokine secretion by NKT cells than 
GATA-3 (182).  Interestingly, Tec family kinases have been shown to modulate 
NFAT activation (137). 
As mentioned in the general intro the Tec family of non-receptor tyrosine 
kinases has been shown to play a significant role in signaling downstream of the 
T cell receptor (1, 98).  Three members of this family are expressed in 
conventional αβTCR+ T cells: Itk, Rlk and Tec.  T cells from animals deficient in 
Itk have defects in TCR-induced PLC-γ phosphorylation, calcium flux generation, 
MAP kinase activation, and NFAT and AP-1 activation.  These defects are 
exacerbated in T cells deficient for both Itk and Rlk, indicating possible 
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redundancy amongst the Tec family kinases.  Itk-/- and Itk-/-Rlk-/- mice also have 
impaired development of conventional CD4+ and CD8+ T cells in the thymus (70, 
183).   
Although Itk and Rlk are dispensable for the development of CD8+ “innate” 
T cells (69, 71-73), as discussed in the previous chapter, the role of Tec family 
kinases has not been thoroughly studied in other subsets of “innate” T cells, such 
as NKT cells.  One previous study demonstrated a role for Itk in NKT cell 
development, indicating impaired progression of Itk-/- NKT cells to stage three 
and a resulting decrease in NKT cell numbers (184).  Recently, another group 
has shown impaired function of Itk-/- NKT cells (185). In this chapter we confirm 
the developmental defect in NKT cells in Itk-/- mice, and show that this defect is 
exacerbated in the absence of both Itk and Rlk.  We also confirm the functional 
defect in Itk-/- NKT cells and demonstrate that NKT cell function is further 
impaired in Itk-/-Rlk-/- NKT cells, which produce virtually no effector cytokines in 
response to activation either in vitro or in vivo.  Interestingly, expression of the T 
box transcription factor T-bet is reduced in NKT cells from Itk-/- mice, and even 
further reduced in Itk-/-Rlk-/- NKT cells.  CD122 expression is also impaired on 
Tec kinase-deficient NKT cells, leading to reduced NKT cell survival in the 
periphery.  These data implicate a critical role for Tec family kinases in NKT cell 
development, function, and survival. 
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Results 
 
Itk, Rlk and Tec are expressed in NKT cells 
Three Tec family kinases are expressed in conventional αβ TCR+ T cells, 
Itk, Rlk, and Tec.  The hierarchy of expression of these kinases correlates with 
their known importance in T cell signaling, with Itk mRNA being expressed at the 
highest levels, followed by Rlk, and then Tec [Figure 15A] (1).  To assess relative 
Tec kinase expression levels in NKT cells, thymic NKT cells were purified from 
wild type mice based on CD1d/αGAL tetramer [hereafter referred to as CD1d-
tetramer]-binding, and RNA was isolated and used for quantitative real-time RT-
PCR to measure the levels of Itk, Rlk, and Tec mRNA.  As shown in Figure 15A, 
NKT cells show a similar hierarchy of expression of Tec family kinases compared 
to conventional αβ T cells, with Itk mRNA being expressed at the highest levels 
[similar to levels found in peripheral T cells], followed by Rlk and then Tec. 
Tec family kinases are known to have altered patterns of expression 
during differentiation of CD4+ T cells.  For instance, Rlk is down-regulated 
following TCR stimulation, and is re-expressed in Th1 cells, but not Th2 cells.  In 
contrast, Itk is up-regulated in Th2 cells relative to Th1 cells (183).  Terminal 
differentiation of NKT cells is characterized by the up-regulation of NK1.1 (21).  
To determine if Tec family kinases are differentially expressed following terminal 
differentiation of NKT cells, CD1d-tetramer-binding T cells were isolated from the  
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Figure 15: NKT cells express Tec family kinases Itk, Rlk, and Tec   
[A]  NKT cells were sorted from the thymus of wild type mice by gating on CD1d-
tetramer+ HSAlo cells while CD8+CD4- T cells were sorted from both the thymus 
[Thy] and spleen [Sp] of mice for comparison.  The levels of Itk [blue], Rlk [red] 
and Tec [yellow] mRNA were determined by real-time quantitative PCR.  
[B-G]  Thymocytes and splenocytes were harvested from wild type mice, 
enriched, gated on CD1d-tetramer+ HSAlo cells and further sorted based on 
expression of NK1.1 and analyzed for Itk mRNA [B, E], Rlk mRNA [C, F], and 
Tec mRNA [D, G].  Data were normalized to the expression of β-actin mRNA in 
each sample and are representative of two [B-G] or three [A] experiments. 
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thymus and spleen, and separated into NK1.1- and NK1.1+ populations.  Itk 
[Figure 15B], Rlk [Figure 15C] and Tec [Figure 15D] mRNA were all up-regulated 
in the NK1.1+ compared to the NK1.1- population in the thymus.  Surprisingly, 
both subsets of peripheral NKT cells [NK1.1+ and NK1.1-] express similar levels 
of each Tec kinase mRNA, comparable to the levels seen in thymic NK1.1+ cells 
[Figure 15E, F, and G].  As the only NKT cells known to emigrate from the 
thymus are the NK1.1- cells (23, 24, 176), this latter finding suggests that thymic 
emigration, in addition to terminal maturation, may induce Tec kinase up-
regulation.   
 
Altered distribution of NKT cell subsets in Tec family kinase-deficient mice 
 In a previous study utilizing Itk-/- mice, a deficiency in NKT cell numbers 
was seen as early as 6-8 weeks in the spleen and after 20 weeks of age in both 
the thymus and the spleen (184).  To further address the role of Tec kinases in 
NKT cells, we examined whether a similar deficiency occurs in the absence of 
Rlk, and if the decrease in NKT cell numbers observed in the absence of Itk is 
exacerbated in Itk-/-Rlk-/- mice.  We found that in our Itk-/- mice, the decrease in 
NKT cell numbers could be seen both in the thymus and the spleen as early as 6 
weeks of age [Figure 16A-F and data not shown].  While this is a more profound 
difference than that observed in the previous study (184), it is important to note 
that our Itk-/- mice were analyzed after 13 generations of backcrossing to  
88 
 
Figure 16: Tec kinase-deficient mice have reduced numbers of NKT cells in 
the thymus and spleen 
[A, B]  Cells were prepared from thymi [A] and spleens [B] of wild type, Itk-/-, Rlk-/- 
and Itk-/-Rlk-/- mice and stained for CD1d-tetramer and anti-HSA.  Regions in 
each dot-plot indicate the percentage of CD1d-tetramer+ HSAlo cells.   
[C-F]  Percentages and absolute numbers of NKT cells, based on CD1d-
tetramer+ HSAlo staining, were compiled for the thymus [C, E] and spleen [D, F].  
Each data point represents a different animal and red bars represent the mean.  
Statistical significance between two populations demarked by an asterisk.  
Numbers of animals analyzed are indicated at the bottom of [E] and [F].   
[G, H]  Thymocytes from wild type [black], Itk-/- [red], and Itk-/-Rlk-/- [blue] mice 
were stained for CD4 and CD8, and gated CD4+CD8+ cells were analyzed for 
CD1d [G] or SLAM [H] expression.  Data are representative of six mice analyzed 
per genotype in two independent experiments. 
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C57Bl/10, whereas the Itk-/- mice used previously were backcrossed for 5 
generations.  We then analyzed Rlk-/- mice, and found a slight decrease in the 
percentage of NKT cells compared to wild type mice in both the thymus and 
periphery [Figure 16A-D]; however, this decrease in percentage did not translate 
into a decrease in NKT cell numbers in the absence of Rlk [Figure 16E-F].  In 
contrast, Itk/Rlk double-deficient mice had reduced percentages and numbers of 
NKT cells in the thymus when compared to wild type [7-fold reduced in number], 
as well as to Itk-/- mice [3-fold reduced in number], indicating potential 
redundancy between Itk and Rlk in NKT cells [Figure 16A, C, E].  Itk-/-Rlk-/- mice 
also had reduced percentages and numbers of splenic NKT cells compared to 
wild type [Figure 16B, D, F].  Despite a slight but consistent decrease in NKT cell 
percentages in the spleen between the Itk-/- and Itk-/-Rlk-/- mice, there was no 
significant difference in absolute numbers in this comparison [Figures 16B, D, F], 
perhaps due to the increased overall splenic and thymic cellularity seen in Itk-/-
Rlk-/- when compared to the Itk-/- mice. 
 Since NKT cell progenitors in the thymus cannot be identified prior to the 
up-regulation of their invariant TCR, it is difficult to investigate the positive 
selection of this subset directly.  Therefore, we examined whether or not 
molecules known to be involved in the positive selection of NKT cells are 
expressed at normal levels in the Itk-/- and Itk-/-Rlk-/- mice.  To this end, we 
stained DP cortical thymocytes, the cells that provide positive selection 
interactions for NKT cells, with antibodies to CD1d and SLAM [CD150] (20, 22).  
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Both CD1d [Figure 16G] and SLAM [Figure 16H] are expressed at comparable 
levels on DP thymocytes from wild type, Itk-/- and Itk-/-Rlk-/- mice, indicating that 
altered expression of these molecules is not responsible for the decreased 
number of NKT cells developing in the absence of Itk, or Itk and Rlk. 
Although it is not certain that CD150 is the SLAM family member involved 
in NKT cell selection in the thymus, it is thus far the only one reported to be 
expressed on the surface of cortical thymocytes (186).  Nonetheless, there is 
indirect evidence indicating that SLAM [CD150] might be dispensable for NKT 
cell development, as slam-/- mice can produce IL-4 quickly post anti-CD3 
activation, a response typically attributed to NKT cells (182).  Alternatively, 
genetic evidence obtained in nonobese diabetic [NOD] mice, which are deficient 
in NKT cells, indicates that both SLAM and NTB-A may provide instructive 
signals for development of NKT cells (187).  Other studies have shown that Ly9 
[CD229], another SLAM family member, is not required for NKT cell development 
(188).  Thus, while our data indicate that alterations in SLAM [CD150] expression 
in the absence of Itk, or Itk and Rlk, are not responsible for the observed 
deficiency in NKT cell selection [Figure 16H], we cannot exclude the possibility 
that other SLAM family members are involved in Itk-/- and Itk-/-Rlk-/- mice. 
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Tec family kinase-deficient NKT cells exhibit an immature phenotype 
 Cell surface markers distinguishing the stages of NKT cell development 
are well characterized (21, 184).  Immature NKT cells, prior to the up-regulation 
of NK1.1 [fraction 1 and fraction 2] have high expression of the CD4 co-receptor.  
Following terminal maturation, CD4 is down-regulated, and NKT cells are either 
CD4+CD8- or CD4-CD8-.  CD44 up-regulation occurs in fraction 2, prior to the up-
regulation of NK1.1.  The final stage of maturation in NKT cells [stage 3] is 
accompanied by the up-regulation of NK1.1, CD69, and several additional NK 
cell receptors.  CD4+ or CD4-, CD44hi, NK1.1- NKT cells are exported from the 
thymus to the periphery, where they become NK1.1+ following additional 
stimulation requiring CD1d (21). 
 Thymocytes and splenocytes were isolated from wild type, Itk-/- and Itk-/-
Rlk-/- mice, gated on HSAlo CD1d-tetramer-positive cells and analyzed for several 
developmental markers.  When compared to wild type thymic NKT cells, CD4 
expression on Itk-/- and Itk-/-Rlk-/- NKT cells remained high, similar to that seen on 
immature wild type NKT cells, and few to no CD4-CD8- NKT cells were present in 
the thymus of Itk-/- and Itk-/-Rlk-/- mice [Figure 17A].  CD44 expression on all of 
the thymic NKT cells was comparable; however, expression of terminal 
maturation markers NK1.1 and CD69 was reduced on Itk-/- thymic NKT cells, and 
even more severely impaired on Itk-/-Rlk-/- NKT cells [Figure 17A].  This pattern of 
differences between wild type, Itk-/- and Itk-/-Rlk-/- NKT cells was also observed for 
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the surface markers NKG2D, Ly49C/I, Ly49G2 and Ly49F expression [Figure 
17A].  Recently an earlier stage of NKT cell development has been described in 
which cells are either HSAhiDPlo or HSAhiCD4+/hi (189).  As this stage precedes 
early developmental expansion, we considered the possibility that the substantial 
decrease in NKT cell numbers seen in Itk-/- and Itk-/-Rlk-/- mice was due to a block 
at this stage.  If this were the case, we would expect to find increased numbers of 
HSAhi NKT cells in the thymus of Itk-/- and Itk-/-Rlk-/- mice compared to wild-type 
mice.  To assess this issue, we identified NKT cells based on CD1d-tetramer 
staining, and compared numbers of HSAhi and HSAlo thymocytes in wild type, Itk-
/-, and Itk-/-Rlk-/- mice.  As shown in Figure 17C, we did not find increased 
numbers of HSAhi thymic NKT cells in the Itk-/- or Itk-/-Rlk-/- mice relative to wild-
type, arguing against a block at this stage.  Furthermore, similar decreases in the 
Itk-/- and Itk-/-Rlk-/- HSAlo and HSAhi NKT cell populations are seen when 
compared to wild-type, suggesting that the decrease in overall NKT cell numbers 
is likely due to a block preceding the HSAhi stage.  While the data shown in 
Figure 17C derives from mice analyzed at 6-8 weeks of age, Itk-/- and Itk-/-Rlk-/- 
mice analyzed at 3 weeks of age also show no apparent block at the HSAhi stage 
of NKT cell development. 
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Figure 17: Tec kinase-deficient NKT cells exhibit impaired maturation 
[A, B]  Thymocytes [A] and splenocytes [B] were harvested from wild type [black], 
Itk-/- [red] and Itk-/-Rlk-/- [blue] mice, stained, gated on CD1d-tetramer+ HSAlo cells, 
and analyzed for expression of CD4, CD44, NK1.1, CD69, NKG2D, Ly49C/I, 
Ly49G2, and Ly49F.  Data are representative of nine mice analyzed per 
genotype in three independent experiments. 
[C]  Thymocytes were harvested from 6-8 week old mice, were gated on CD1d-
tetramer+, and analyzed for expression of HSA.  Total numbers of HSAlo [left 
panel] and HSAhi [right panel] NKT cells are displayed [mean±S.D.].  Data are 
pooled from 12 mice per group. 
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 Splenic NKT cells in Itk-/- and Itk-/-Rlk-/- mice also showed a less mature 
phenotype than that of wild type NKT cells.  CD4 expression on splenic NKT cells 
from Itk-/- and Itk-/-Rlk-/- remained high, indicating reduced maturation; however all 
mice showed a comparable proportion of CD4-CD8- splenic NKT cells [Figure 
17B].  Of interest, CD44 expression, which did not differ between the three 
genotypes of thymic NKT cells, is abnormal on the splenic NKT cells, with the Itk-
/- and Itk-/-Rlk-/- mice showing a substantial proportion of CD44lo NKT cells.  
Accompanying this reduced proportion of CD44hi NKT cells, Itk-/- and Itk-/-Rlk-/- 
mice cells also have significant numbers of splenic NKT cells with low levels of 
NK1.1, CD69, and NKG2D [Figure 17B). In general the Itk-/-Rlk-/- mice exhibit a 
more severe defect than the Itk-/- mice.  Finally, no differences were seen for the 
other Ly49 markers, most likely due to lower expression of these on NKT cells in 
the spleen [Figure 17B] (190).  Overall these data show that Itk-/- NKT cells fail to 
progress efficiently to the most mature stage of NKT cell development, and that 
this defect is exacerbated in the absence of Itk and Rlk, further supporting the 
notion of redundancy between Itk and Rlk in the maturation of NKT cells.   
 
Tec family kinase-deficient NKT cells are functionally impaired 
 NKT cells are well known for their ability to rapidly produce effector 
cytokines following initial stimulation (26).  Furthermore, the pattern of cytokines 
produced by NKT cells alters as the cells mature.  Prior to NK1.1 up-regulation, 
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NKT cells can produce IL-4, but little or no IFNγ.  Following up-regulation of 
NK1.1, NKT cell cytokine production shifts to favor production of IFNγ over IL-4 
(184).  Given the less mature phenotype of Itk-/- and Itk-/-Rlk-/- NKT cells, we 
reasoned that these cells might produce IL-4, but little IFNγ.  To examine this 
issue, we used a previously characterized assay (191).  Briefly, wild type, Itk-/- or 
Itk-/-Rlk-/- mice were injected i.v. with anti-CD3 antibody, and 90 minutes later 
splenocytes were harvested, cultured for 2 hours, and supernatants examined for 
cytokines by ELISA.  Previous studies have shown that, in this short-term assay, 
the only cells capable of producing IFNγ and IL-4 are NKT cells (191).  As shown 
in Figure 18, IFNγ [Figure 18A] and IL-4 [Figure 18B] are secreted by wild-type 
NKT cells.  Secretion of IFNγ by Itk-/- splenocytes was substantially reduced, and 
was undetectable by Itk-/-Rlk-/- splenocytes [Figure 18A].  Similarly, IL-4 secretion 
by Itk-/- splenocytes was decreased, whereas no IL-4 was detected in the cultures 
of Itk-/-Rlk-/- splenocytes [Figure 18B].  It should be noted that decreased 
numbers of splenic NKT cells in the Itk-/- and Itk-/-Rlk-/- mice may account for a 
portion of the decreased cytokine production observed; however, the magnitude 
of the reduction in IFNγ and IL-4 observed far outweighs the 50-60% decrease in 
proportions of NKT cells seen in the spleens of these mice. 
 To confirm these results with a second assay system that is more targeted 
to activation of NKT cells, we injected wild type, Itk-/- or Itk-/-Rlk-/- mice i.v. with 
αGAL or PBS as a control, and examined cytokine production by intracellular 
cytokine staining 2hrs and 3hrs following injection (192).  Splenocytes from the 
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injected mice were stained with CD1d-tetramer and anti-HSA antibodies, or with 
anti-NK1.1 and anti-TCRβ antibodies, permeabilized and stained with antibodies 
to IL-4 and IFNγ.  Using this staining scheme, NKT cell [CD1d-tetramer+, HSAlo] 
and NK cell [TCRβneg, NK1.1+] populations can each be identified, allowing us to 
assess NKT cell activation as well as priming of NK cells by the INFγ produced 
by the NKT cells [Figure 18C].  After 2 hrs of αGAL stimulation in vivo, a 
significant proportion of the wild type NKT cells are producing both IL-4 and IFNγ 
[16%] or IFNγ alone [17%].  At 3 hrs, the wild type NKT cells are predominantly 
producing IFNγ [24%], rather than both IFNγ plus IL-4 [10%].  Cytokine-
producing NKT cells are decreased in Itk-/- mice at both 2 hrs [IL-4/IFNγ=1% and 
IFNγ=2%] and 3 hrs [IL-4/IFNγ=2% and IFNγ=2%] post-αGAL injection.  In the 
Itk-/-Rlk-/- mice, the defect in cytokine production by NKT cells is further 
exacerbated. It is worth noting that we did observe small decreases in TCR 
expression on the activated NKT cells, particularly in the wild type mice [data not 
shown]; however, this alteration did not impair our ability to identify the activated 
NKT cells for purposes of assessing cytokine production.  Finally, as expected 
due to the lack of IFNγ production by Itk-/- and Itk-/-Rlk-/- NKT cells, priming of the 
NK cells in these mice was also impaired, with 48% of the wild type NK cells 
producing IFNγ, while only 2% of Itk-/- and Itk-/-Rlk-/- NK cells produced IFNγ at 
the 3hr time point [Figure 8C].  In addition to the reduced IFNγ production by Itk-/- 
and Itk-/-Rlk-/- NKT cells, it is likely that the reduced numbers of NKT cells in these 
mice are contributing to the impaired priming of NK cells.  
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Figure 18: Tec kinase-deficient NKT cells are functionally impaired 
following in vivo activation  
[A, B]  Wild type, Itk-/- and Itk-/-Rlk-/- mice were injected i.v. with 1 µg anti-CD3 
antibody.  Splenocytes were harvested after 90 minutes, incubated in vitro for 2 
hours, and supernatants were analyzed for an IFNγ [A] or IL-4 [B] by ELISA.  
Each data point represents one mouse and the red bar indicates the mean.  Data 
are representative of three experiments.   
[C]  Wild type, Itk-/- or Itk-/-Rlk-/- mice were injected with PBS or 2 µg of α-
Galactosylceramide [αGAL] and spleens were harvested after two or three hours 
[three hours for the PBS].  Cells were either stained with CD1d-tetramer and anti-
HSA or with anti-NK1.1 and anti-TCRβ antibodies.  NKT cells [CD1d-tetramer+ 
HSAlo] and NK cells [NK1.1+TCRβ-] were analyzed for intracellular IL-4 and IFNγ 
production. The three rows of dot-plots show gated NKT and NK cell populations 
from wild type [top], Itk-/- [middle] and Itk-/-Rlk-/- [bottom].  Data are representative 
of results from two independent experiments each with two mice per time point. 
[D]  Thymocytes were harvested from wild type, Itk-/- and Itk-/-Rlk-/- mice and were 
activated with PMA [10 ng/ml] and Ionomycin [2000 ng/ml] for 4 hrs; Golgi stop 
was added for the last 3 hrs of incubation.  Cells were then surface stained for 
CD1d-tetramer and anti-HSA, fixed and permeabilized, and stained with 
antibodies to IL-4 and IFNγ.  Dot-plots show gated CD1d-tetramer+ HSAlo cells.  
Data are representative of results from four independent experiments. 
100 
 
 
101 
 
To further examine the functional capabilities of Itk-/- and Itk-/-Rlk-/- NKT 
cells, thymic NKT cells were activated in vitro with anti-CD3 antibody, and 
cytokine production was assessed.  These studies produced similar results to the 
ex vivo analysis described above, indicating impaired cytokine production by Itk-/- 
compared to wild type NKT cells, and a more severe defect seen in Itk-/-Rlk-/- 
versus Itk-/- cells [data not shown].  Bypassing any proximal defects in TCR 
signaling by stimulating cells with PMA and ionomycin indicated that slightly 
reduced proportions of Tec kinase-deficient NKT cells were capable of producing 
effector cytokines when compared to wild type NKT cells [Figure 18D].  This 
reduction is substantially less in magnitude than that observed when triggering 
Itk-/- and Itk-/-Rlk-/- NKT cells through the TCR using anti-CD3 antibody or αGAL, 
indicating that the majority of the defect in cytokine production is due to a defect 
in proximal TCR signaling.  This experiment also confirmed that the less mature 
phenotype of Itk-/- and Itk-/-Rlk-/- NKT cells corresponds to a bias towards IL-4 
production versus the predominant IFNγ production observed from wild type NKT 
cells.  As can be seen in Figure 18D, only 58% of the cytokine-producing wild-
type NKT cells made IL-4, whereas 68% and 82% of the cytokine-producing NKT 
cells in the Itk-/- and Itk-/-Rlk-/-, respectively, made IL-4; these data also indicate a 
corresponding decrease in IFNγ production by Itk-/- and Itk-/-Rlk-/- NKT cells.  
These results correlate well to a recent report by Au-Yeung et al. in which Itk-/- 
NKT cells were activated with αGAL and then stimulated in vitro with ionomycin, 
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also showing a shift in cytokine production towards IL-4 and away from IFNγ 
(185). 
 
Itk-/- and Itk-/-Rlk-/- NKT cells stimulated in vitro proliferate, but fail to accumulate 
 In an effort to determine the underlying cause of the decreased numbers 
of NKT cells in Itk-/- and the Itk-/-Rlk-/- mice, we examined the proliferative 
responses and survival of NKT cells following in vitro stimulation.  For these 
experiments, we adapted a previously-described NKT cell in vitro proliferation 
assay (193).  Briefly, splenocytes were harvested from wild type, Itk-/- and Itk-/-
Rlk-/- mice, labeled with CFSE, and incubated in vitro for 4 or 6 days with a variety 
of stimuli.  Cultures were initiated with 2x106 cells [pooled from three mice] of 
each genotype, and cell numbers were assessed at each time point.  The 
number of NKT cells for each sample was then calculated based on surface 
staining for CD1d-tetramer and HSA [HSAloCD1d-tetramer+].  Although the 
magnitude of the responses varied from experiment to experiment, the relative 
responses of wild-type versus Itk-/- and Itk-/-Rlk-/- NKT cells showed a consistent 
pattern between experiments.  In all experiments we saw reductions in the 
percentages, as well as absolute numbers of NKT cells detected at day 4, for all 
three genotypes analyzed.  This result reflects both a decrease in overall cell 
numbers at this timepoint, coupled with a downregulation of the TCR on the NKT 
cells, particularly those cultured with αGAL. 
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 The majority of NKT cells that received either no stimulus [NS], or were 
cultured with a low dose of IL-2 [20 ng/ml] alone, succumb to cell death [Figure 
19A].  Increasing the concentration of IL-2 to 2 µg/ml promotes the survival of 
wild-type NKT cells accompanied by proliferation, leading to a modest expansion 
of this population by day 6; in contrast neither Itk-/- nor Itk-/-Rlk-/- NKT cell 
populations expand under these conditions, in spite of the fact that some 
proliferative response is observed [Figure 19A, B].  Stimulation with IL-7 
promotes the survival of all wild-type and Itk-/- NKT cell populations above that 
seen in the absence of any stimulus [NS], but is less effective at maintaining Itk-/-
Rlk-/- NKT cells in culture.  These data indicate that Itk-/- and Itk-/-Rlk-/- NKT cells 
are more responsive to IL-7 than they are to IL-2 for in vitro survival. 
 In vitro stimulation with αGAL, either alone or together with IL-2, promotes 
a dramatic expansion of the wild type NKT cells by day 6 of culture [~20 fold; 
Figure 19A].  For Itk-/- NKT cells αGAL alone promotes a modest expansion [~2.5 
fold], which is slightly enhanced when combined with a low dose of IL-2 [~4 fold 
expansion].  Itk-/-Rlk-/- NKT cells did not expand at all following in vitro αGAL 
stimulation.  This lack of expansion of Itk-/- and Itk-/-Rlk-/- NKT cells cannot be 
attributed to a predominant defect in proliferation, as all three genotypes of NKT 
cells show comparable dilution of CFSE by day 6.  Instead, our findings indicate 
that Itk-/- and Itk-/-Rlk-/- NKT cells exhibit a profound deficiency in survival 
following in vitro stimulation. 
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Figure 19: In vitro expansion of Tec kinase-deficient NKT cells is impaired 
Pooled splenocytes from three wild type [black diamond], three Itk-/- [red square] 
and three Itk-/-Rlk-/- [blue triangle] mice were stained with CFSE and incubated 
with the stimuli indicated for 4 or 6 days.  
[A]  At each time point cells were harvested, counted, stained and analyzed for 
NKT cells by gating on CD1d-tetramer+ HSAlo cells.  Left column shows the 
percentages of CD1d-tetramer+ HSAlo cells, while the right column shows the 
absolute numbers of NKT cells detected at each time point.  
[B]  CFSE fluorescence of CD1d-tetramer+ HSAlo cells are shown for day 0 [short 
dashed lines], day 4 [long dashed lines] and day 6 [solid lines].   
Data shown are representative of three independent experiments. 
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Tec family kinase-deficient NKT cells show impaired survival and reduced CD122 
and T-bet expression 
 The data shown above suggest that Tec kinase-deficient NKT cells have a 
survival defect.  To test this notion more directly, we examined freshly-isolated ex 
vivo NKT cells for markers of apoptosis/death.  Thymocytes and splenocytes 
from wild type, Itk-/- and Itk-/-Rlk-/- NKT cells were analyzed for co-expression of 
Annexin V and 7AAD.  While no striking differences were seen in the 
percentages of apoptotic/dead NKT cells in the thymus [Figure 20A], we 
consistently observed an increased proportion of AnnexinV/7AAD+ NKT cells in 
the spleens of Itk-/- and Itk-/-Rlk-/- compared to wild type mice [Figure 20B].  As IL-
15 has a key role in peripheral maintenance of NKT cells (168, 178), we 
considered that defective survival of Itk-/- and Itk-/-Rlk-/- NKT cells might result 
from impaired expression of CD122, the IL-2/IL-15 receptor β-chain.  As shown in 
Figure 20C and D, CD122 was dramatically decreased on the Itk-/- and the Itk-/-
Rlk-/- NKT cells, both in the thymus and the spleen.  This reduced expression of 
CD122 correlated well with the numbers of NKT cells in the mice, as Itk-/-Rlk-/- 
NKT cells had lower expression of CD122 than NKT cells from Itk-/- mice.  
Further, this defect correlates with the peripheral survival data, and is consistent 
with the known role of IL-15 in the peripheral survival of all NKT cell subsets.  
Interestingly, this decrease in CD122 expression also correlates with the 
impaired up-regulation of NK1.1 in the Itk-/- and Itk-/-Rlk-/- NKT cells, and is 
consistent with the observation that IL-15-deficient mice have a marked decrease 
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in mature [NK1.1+] NKT cells, with no effect on the immature NKT cells present in 
the thymus (178).  Putting these data together may also account for why we fail 
to see an increase in apoptotic/dead NKT cells in the thymus of Itk-/- and Itk-/-Rlk-/- 
mice, as these thymi contain only small numbers of mature NKT cells, with few 
cells reaching the stage at which they would be susceptible to an absence of IL-
15. 
 Up-regulation of CD122 has been associated with the T-box transcription 
factors T-bet and Eomesodermin in conventional αβ TCR+ T cells (173).  
Furthermore, T-bet-deficient mice also have severe defects in NKT cell 
maturation, peripheral survival, and cytokine production.  Given the similarities 
seen between T-bet-/- and Itk-/- or Itk-/-Rlk-/- NKT cells, we investigated T-bet 
expression in these cells.  To this end, NKT cells were sorted from the wild type, 
Itk-/- and Itk-/-Rlk-/- mice, RNA was harvested and the samples were analyzed for 
T-bet mRNA expression using quantitative real-time RT-PCR.  A substantial 
reduction in T-bet mRNA was found in the NKT cells from the Itk-/- mice [3-4 fold 
decrease] compared to wild type NKT cells, with a more profound defect seen in 
NKT cells from the Itk-/-Rlk-/- mice [7-8 fold decrease] [Figure 20E].  Since T-bet 
expression is up-regulated during the final stage of NKT cell development, this 
result is not unexpected, as most Itk-/- and Itk-/-Rlk-/- NKT cells do not reach this 
stage of maturation.  However, we also found that a comparison between purified 
thymic NK1.1- NKT cells from the three types of mice also showed the same 
reduction in T-bet mRNA expression in Tec kinase-deficient cells versus wild  
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Figure 20: Impaired survival of Tec kinase-deficient NKT cells correlates 
with reduced CD122 and T-bet expression   
[A, B]  Thymocytes [A] and splenocytes [B] from three wild type, Itk-/- and Itk-/-Rlk-
/- mice were stained for CD1d-tetramer, HSA, Annexin V, and 7AAD.  Gated 
CD1d-tetramer+ HSAlo cells were analyzed for co-expression of Annexin V and 
7AAD.  The graph shows the mean percentage of Annexin V+ 7AAD+ NKT cells 
for each genotype.  Data are representative of three experiments.   
[C, D]  Gated CD1d-tetramer+ HSAlo thymocytes [C] or splenocytes [D] from wild 
type [black], Itk-/- [red], and Itk/Rlk-/- [blue] mice were analyzed for expression of 
CD122.  Data are representative of six mice of each genotype analyzed in two 
independent experiments.   
[E, F]  cDNA was prepared from sorted NKT cells isolated from the thymus of 
wild type, Itk-/- or Itk-/-Rlk-/- mice.  Samples were then analyzed for T-bet [E, blue 
bars], Eomesodermin [E, red bars], and GATA-3 [F] mRNA levels.  Graphs show 
data normalized to β-actin mRNA levels in each sample, and are representative 
of three independent experiments. 
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type [data not shown].  Interestingly, no decrease in T-bet expression was seen 
in a recent study comparing Itk-/- to wild-type NKT cells (185).  Both our study and 
that of Au-Yeung and colleagues used quantitative RT-PCR to assess T-bet 
mRNA levels in NKT cell populations; however, our experiments examined T-bet 
expression in thymic NKT cells, while the previous study examined splenic NKT 
cells.  We have also analyzed splenic NKT cell populations from wild-type and 
Itk-/- mice for T-bet expression, and find results consistent with those reported by 
Au-Yeung et al. (185), that T-bet mRNA is, if anything, slightly increased in Itk-/- 
compared to wild-type splenic NKT cells [data not shown].  In contrast, T-bet 
mRNA levels in the small number of Itk-/-Rlk-/- splenic NKT cells is decreased 
when compared to the wild type NKT cells [data not shown].  These findings 
suggest that peripheral NKT cell survival may require T-bet, leading to a strong 
selection for those cells able to up-regulate T-bet expression.  This hypothesis 
could account for the differences seen between thymic versus splenic Itk-/- NKT 
cells regarding T-bet mRNA levels, and also, the more severe loss of Itk-/-Rlk-/- 
NKT cells compared to those lacking Itk alone.    
Eomesodermin has also been shown to regulate CD122 expression in 
conventional T cells, similar to T-bet (173), yet is not normally expressed in NKT 
cells (68).  As described in the previous chapter we found aberrantly high 
expression of Eomesodermin in CD8+ thymocytes and T cells from Itk-/- and Itk-/-
Rlk-/- mice (69).  Therefore we also examined Itk-/- and Itk-/-Rlk-/- NKT cells for 
Eomesodermin mRNA expression.  While no Eomesodermin mRNA was 
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detected in the wild type or Itk-/-Rlk-/- NKT cells, we consistently found low levels 
of Eomesodermin mRNA in the Itk-/- NKT cells [Figure 20E].  Additionally, GATA-
3 has recently been implicated in regulating NKT peripheral survival, function and 
maturation, based on studies of GATA-3-deficient mice (67).  Although no 
consistent differences were seen in expression of GATA-3 between the wild type 
and Itk-/- NKT cells, confirming results from Au-Yeung and colleagues (185), a 
15-30% decrease was seen in the Itk-/-Rlk-/- NKT cells compared to those of wild-
type mice [Figure 20F].  Overall, the failure of Tec kinase-deficient NKT cells to 
regulate expression of these key transcription factors is likely to impact NKT cell 
survival, due to impaired CD122 expression, NKT cell effector functions, 
specifically IFNγ secretion, and NKT cell terminal maturation. 
 
Discussion 
 
 The role of Tec family kinases in conventional αβ T cell development, 
differentiation and function has been well documented (1, 98, 183).  Of the three 
family members expressed in T cells, Itk, Rlk and Tec, Itk has the predominant 
role in TCR-dependent thymic selection events, as well as in TCR-dependent 
activation of mature T cells.  In contrast, Tec appears to have no important role 
during T cell development or in the primary activation of naïve T cells (194).  
While the function of Rlk is still uncertain, a combined deficiency in Itk and Rlk 
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leads to more severely impaired signaling than a deficiency in Itk alone, 
indicating some redundancy between Itk and Rlk in conventional αβ T cells (139).  
Unlike the well-characterized role of Itk and Rlk in conventional T cells, little is 
currently known about the function of these kinases in non-conventional “innate” 
T cells, such as γδTCR+ T cells, NKT cells, and other subsets of CD8+ and CD4-
8- T cells with specificity for nonclassical MHC class I molecules.  One previous 
report showed decreased numbers of NKT cells in the thymus and periphery of 
Itk-deficient mice, and showed that Itk-/- NKT cells had reduced expression of 
NK1.1 (184), while a more recent study focused on cytokine secretion defects of 
Itk-/- NKT cells (185).  Based on the initial study indicating a possible role for Tec 
family kinases in NKT cells, we set out to determine whether Rlk could 
compensate for Itk in NKT cell development, and also whether the Tec kinases 
Itk and Rlk are required for other aspects of NKT cell biology, including effector 
function and peripheral homeostasis. 
 Overall, our data indicate that both Itk and Rlk together are critical for the 
terminal maturation, cytokine production, and peripheral survival of NKT cells.  
Interestingly, the phenotype we observe for NKT cells in Itk-/- and Itk-/-Rlk-/- mice 
shares strong similarities with defects observed in the absence of the cytokine IL-
15 (168, 178), and more strikingly, in the absence of the T-box transcription 
factor, T-bet (68); although the overall decrease in cell numbers is indicative of 
an early developmental block similar to that in the SAP and Fyn deficient mice 
[described later on].  As T-bet is known to regulate transcription of CD122, the IL-
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15 receptor β chain (173), the ability of NKT cells to respond to IL-15 would likely 
depend on prior T-bet expression.  Furthermore, a study aimed at identifying 
other genes regulated by T-bet in NKT cells identified a wide array of T cell 
effector molecules, including cytokines, chemokines, and cytolytic proteins, as 
well as survival factors (181).  Thus, T-bet together with IL-15 are essential for 
terminal maturation, development of effector function, and long-term survival of 
NKT cells. 
 One important function of T-bet is regulation of IFNγ transcription (195).  
This correlates well with the fact that NKT cell maturation to the NK1.1+ stage, 
which coincides with T-bet up-regulation, is accompanied by a switch in NKT cell 
effector cytokine production from IL-4 to IFNγ (184).  Thus, it is not surprising that 
Itk-/- and Itk-/-Rlk-/- NKT cells exhibit a severe defect in IFNγ production, as few of 
these cells progress to the NK1.1+ stage of NKT cell maturation.  While at first 
glance these findings appear inconsistent with a recent study showing modest 
reductions in IL-4 and IFNγ transcript levels in Itk-/- NKT cells (185), this earlier 
study examined only constitutive levels of IL-4 and IFNγ transcripts, and did not 
examine cytokine mRNA levels following NKT cell activation.  In fact, both 
studies agree that Itk-/- NKT cells are dramatically impaired in cytokine protein 
production in response to TCR stimulation, suggesting a defect in TCR-induced 
transcription at these cytokine loci.  
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As mentioned above, we also find a substantial defect in IL-4 production 
by Tec kinase-deficient NKT cells.  This latter defect is unlikely to be due to 
altered NKT cell maturation, but instead, is likely explained by impaired TCR 
signaling in the absence of Itk and Rlk.  In fact PMA/ionomycin activation, which 
bypasses proximal TCR signaling and the requirement for Tec kinases, largely 
restores IL-4 production to Itk-/- and Itk-/-Rlk-/- NKT cells.  Of interest, we also see 
low, but detectable expression of Eomesodermin mRNA in Itk-/-, but not Itk-/-Rlk-/-, 
NKT cells.  This finding may in part account for the increased ability of Itk-/- over 
Itk-/-Rlk-/- NKT cells to respond to in vivo stimulation by producing some IFNγ, and 
may also contribute to the IFNγ transcripts seen by Au-Yeung and colleagues 
(185) in freshly-isolated splenic Itk-/- NKT cells. 
 Based on our findings in comparison to published data, we propose that 
Itk and Rlk are required for the up-regulation of T-bet mRNA during the final 
stage of NKT cell maturation [Figure 21].  Should this be the case, it implicates 
TCR signaling in regulating T-bet expression, as Tec kinases are predominantly 
activated in T cells downstream of the TCR.  This notion is at odds with current 
evidence regarding the regulation of T-bet transcription, which in conventional 
CD4+ T cells has been shown to be dependent solely on IFNγ receptor signaling, 
and independent of TCR signaling (196).  Thus, an alternative possibility is that 
TCR signaling leading to activation of Itk and Rlk is required for NKT cell 
maturation, but not directly responsible for regulation of T-bet transcription.  As 
additional signaling proteins in the TCR pathway have been shown to be 
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important for NKT cell development, including PKCθ and Vav-1 (59-61), there is 
strong evidence supporting an ongoing role for TCR signaling in NKT cell 
maturation.  However, the precise mechanism of T-bet regulation in developing 
NKT cells remains to be determined. 
 In contrast to the defects in NKT cells observed in the absence of Itk and 
Rlk, a deficiency in the Src kinase, Fyn, leads to a more severe and earlier block 
in NKT cell ontogeny (52, 53).  Recently these data have been extended to 
include the adapter protein SAP, which activates and recruits Fyn to SLAM-family 
receptors (20, 54-56).  Interestingly Tec family kinases, specifically Btk and Itk, 
have been shown to bind to the Fyn SH3 domain through an amino terminal 
region that is conserved between these kinases (197, 198).  While these findings 
suggest a connection between Tec family kinases and the SLAM-SAP-Fyn 
pathway, this possibility seems unlikely.  Specifically, the defect in NKT cell 
numbers is much more severe in the Fyn-deficient mice, and occurs at an earlier 
stage of NKT cell maturation.  Similarities between the Fyn- and SAP-deficient 
mice, and mice lacking CD1d (175) or the transcription factors Runx1 and 
RORγt(57, 58), suggest instead that TCR plus SLAM-family receptor signaling 
are required for early steps in NKT cell positive selection, and that this 
developmental step is Tec kinase-independent [Figure 7].  However there is an 
early block in the Itk deficient and [especially] the Itk and Rlk doubly deficient 
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Figure 21: A model of pathways important for NKT cell development 
Invariant NKT cells [iNKT] are derived from DP [CD4+CD8+] thymocyte 
precursors.  These cells are selected by interactions with other DP thymocytes 
involving TCR binding to CD1d plus activation of a SLAM family receptor.  SLAM-
family receptor signals are transduced by SAP and Fyn.  Together, these two 
pathways induce transcription factors Runx1 and RORγt.  It still remains elusive 
whether or not there is a role for Tec family kinases at this early stage.  Once 
selected, immature NKT cells [CD44lo or CD44hi, NK1.1-] require further signals 
through the TCR plus cytokine signals [IL-15 and IL-7] to upregulate NK1.1 and 
achieve terminal maturation [CD44hi, NK1.1+].  For this transition, TCR signals 
require PKCθ, Tec kinases Itk and Rlk, and perhaps Vav-1.  The transcription 
factors T-bet, NF-κB, and AP-1 all have important roles in regulating this terminal 
maturation.  The transcription factor GATA-3 is important in generating CD4+ 
NKT cells at both the NK1.1- and NK1.1+ stages.  Homeostasis and survival of 
NKT cells is intrinsically dependent on the cytokine IL-15, whose receptor 
expression is tightly regulated by the transcription factor T-bet.  GATA-3, as well 
as Itk and Rlk, are also important for NKT cell survival and peripheral 
homeostasis.  DN, CD4-CD8-. 
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mice which precede the earliest identifiable NKT developmental stage [HSAhi].  
This would attribute another defect, besides the terminal maturation defect, to the 
absence of Tec family kinases.  Perhaps if all three Tec family kinases, Itk, Rlk 
and Tec, were missing in the NKT cells the defect seen would mimic that of the 
Fyn or SAP deficient mice.  Unfortunately a triple deficient mouse is not available 
yet and identification of early defects prior to upregulation of the TCR in NKT 
cells is quite difficult.    
 A final clue on the role of Tec kinases in NKT cell development comes 
from studies of the transcription factor, BATF [B cell-activating transcription 
factor] (65, 66).  BATF is an inhibitory component of the AP-1 family of 
transcription factors, which reduces AP-1 binding activity when expressed in T 
cells in a transgenic mouse model.  In these transgenic mice, conventional T cell 
development is normal; however, NKT cell numbers are substantially reduced.  
Similar to the phenotype of NKT cells in Tec kinase-deficient mice, the BATF-
transgenic NKT cells fail to undergo the final stage of maturation as measured by 
up-regulation of NK1.1.  This finding indicates that AP-1 activation plays a crucial 
role in the terminal maturation of NKT cells.  As Itk and Rlk are known to be 
essential for optimal AP-1 activation in conventional T cells (140), these data 
suggest that a similar pathway operates in NKT cells, and is required for the final 
step of NKT cell development. 
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 The role of Tec family kinases in innate immune cell subsets is an 
interesting and complex issue.  In one subset of T cells, αβ CD8+ T cells, Tec 
family kinases are required to promote development into the conventional T cell 
lineage; in the absence of Itk, or Itk and Rlk, CD8+ T cell development proceeds 
into an innate-like lineage (69-73).  In this chapter we show that in another 
subset of innate T cells, αβ NKT cells, Tec family kinases have a critical positive 
function in the development, maturation, function and survival of these cells.  
Together, these findings indicate that Itk and Rlk have a distinct function in each 
lineage of innate T cells.  In this context, the Tec family kinases may be required 
for optimal TCR signaling, and defects in this pathway may lead to alterations in 
lineage development in the thymus.  Alternatively, it remains possible that Itk and 
Rlk may be important for a distinct signaling pathway, such as that mediated by a 
costimulatory receptor, that differentially impacts NKT cell, conventional, and 
innate CD8+ T cell maturation. 
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Chapter IV: Itk is important in γδ 
T cell development and is 
needed to maintain the Th1 
profile of cytokine secretion in 
these cells 
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Intro 
 
 Itk has been shown to play a principal role, within the Tec family of non-
receptor tyrosine kinases, in signaling downstream of the T cell receptor(1, 98).  
Particularly, Itk deficient animals have defects in PLC-γ phosphorylation, calcium 
flux generation, MAP kinase activation, and AP-1 and NFAT activation.  Itk has 
also been linked with conventional αβ T cell development, selection, and 
function.  Of particular importance, Itk is involved in CD4+ T helper cell 
differentiation (183).  Assays, both in vitro and in vivo, looking at T-helper cell 
differentiation show impaired Th2 responses in the absence of Itk (102, 137, 139, 
140, 199).  Itk is also required for clearance of virus by CD8+ T cells 
independently of the role Itk has on CD4+ T cell help (200). 
 As described in chapters II and III, several studies have described a role 
for Itk in innate versus conventional αβ T cell development.  In the absence of Itk 
CD8+ T cells develop with an innate phenotype; specifically they are highly 
dependent on IL-15, express NK1.1, secrete cytokines directly ex vivo and are 
selected on hematopoietic cells (69-72).  A later study found that generation of 
these “innate-like” CD8+ T cells is dependent on the kinase domain of Itk (74).  
SAP is required for the selection of these “innate-like” CD8+ T cells in the Itk 
deficient mice while CD28 is required for acquisition of the innate characteristics 
found on these cells (73).  While absence of Itk seems to promote generation of 
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“innate-like” CD8+ T cells, it is detrimental to the generation of another innate 
subset, NKT cells.  Three studies have shown that Itk is involved in NKT cell 
selection, maturation, survival and cytokine secretion (174, 184, 185).  However, 
to date no work has been done on the role of Itk in a third subset of innate T 
cells, γδ T cells. 
γδ T cells are a well conserved subset of T cells which constitutes 1-5% of 
the lymphocytes in the blood and peripheral organs, but can account for up to 
50% of the lymphocytes in the epithelial rich tissues.  They can develop, in the 
absence of MHC restriction, from double negative thymocytes and can recognize 
soluble protein and non-protein antigens of endogenous origin.  γδ T cells are 
capable of secreting Th1 and Th2 cytokines (27).  Amongst the many functions 
attributed to γδ T cells, immune modulation of adaptive immunity, specifically 
humoral immunity, is of particular interest (45). 
Initial studies utilizing TCRα-/- mice showed B cell expansion, 
differentiation, and secretion of IgE and IgG1, which are both “T dependent 
isotypes”, indicating that another subset of cells could be providing B cell help 
(201).  TCRβ-/- deficient mice challenged repeatedly with parasitic infections 
could induce germinal center formation and increased antibody production, 
although not against the pathogen (202).  Utilizing a model of pulmonary allergic 
inflammation, decreased IgE and IgG1 were seen in mice that are deficient in γδ 
T cells when compared to wild type mice (203).  Upon immunization with a well-
124 
 
defined Ag in the absence of αβ T cells, γδ T cells can induce germinal center 
formation and Ig hypermutation, albeit the hypermutation occurs in a different set 
of B cells as usually seen when αβ T cells are present (204).  Even though they 
account for a very small number of γδ T cells, the CD4+ cells seem to be the 
subset of γδ T cells involved in GC formation, at least in Mycobacterium induced 
models of GC formation (205). 
Human γδ T cells can migrate into germinal centers and upregulate B-cell 
costimulatory molecules, including CD40L, OX40, CD70 and ICOS post TCR 
stimulation (5).  Furthermore, upon stimulation a subset of human γδ T cells can 
also express MHC-II, CD80/CD86 and CD40, as well as several adhesion 
molecules found normally in mature monocyte derived DCs, indicating that they 
could participate in humoral immunity by mimicking a professional APC (45, 206).  
Another way for γδ T cells to modulate humoral immunity is by regulation of 
maturation of DCs (207, 208).  Of interest a recent article has shown that human 
γδ T cells moving into GCs respond to TFH-derived IL-21 by producing CXCL10 
and CXCL13 aiding in the recruitment of more B cells, TFH cells, and monocytes 
to the GCs (209).  Taken together, all these studies indicate that γδ T cells can 
participate, directly or indirectly, in humoral immunity. 
Conventional αβ CD4+ T cells from Itk deficient mice can’t mount proper 
Th2 responses in vitro and in vivo (183).  As mentioned previously NKT cells in 
the Itk deficient mice also have a severe defect in cytokine production (174, 185).  
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Despite these results, the Itk deficient mice have a systemic phenotype 
demarking elevated Th2 responses, illustrated by the spontaneously high levels 
of IgE found in these mice (140).  IL-4 induced TCR mediated secretion, required 
for IgE class switching, can be found in three separate subsets of T cells: 
conventional αβ CD4+ T cells, NKT cells, and γδ T cells (210-212). 
In this chapter we show increased numbers of γδ T cells in the thymi and 
spleens of Itk deficient mice.  The increase in numbers is accompanied by an 
increase in the proportion of CD4+ γδ T cells [both thymus and spleen] and 
NK1.1+ γδ T cells [thymus only].  We also report a shift towards expression of the 
Th2 transcription factor GATA3 in the Itk deficient γδ T cells, which fits the strong 
increase in IL-4 secretion seen in the γδ T cells from these mice upon TCR 
engagement.  Congruent with the Th2 cytokine secretion seen on the Itk deficient 
γδ T cells, we also see elevated expression of markers usually associated with B 
cell help, such as ICOS and CD40L, on these cells.  Finally we show that 
absence of γδ T cells in the Itk deficient mice causes a strong decrease in the 
elevated levels of IgE (140) and spontaneously enriched germinal centers usually 
found on these mice.  Taken together this data shows that proper expression of 
Itk might have an important role in controlling γδ T cell mediated dysregulation of 
B cell help. 
 
Results 
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Itk deficient mice have increases in γδ T cells 
Work on Itk deficient animals has demonstrated that absence of Itk leads 
impaired selection and decreased numbers of conventional αβ CD4+ and CD8+ T 
cells as well as NKT cells (1, 54, 174, 184).  On the other hand absence of Itk 
seems to favor selection of “innate-like” CD8+ T cells denoted by the large 
increase in numbers of these cells seen in the Itk deficient mice (69, 71).  Much 
like these “innate-like” CD8+ T cells, selection of γδ T cells seems to be favored 
in the Itk deficient mice. 
As seen in Figure 22[A], a comparison between the distribution of wild 
type [top row] versus Itk deficient [bottom row] γδ T cells shows an increase in 
the proportion of γδ T cells found in the Itk deficient animals.  Specifically, there 
is a fourfold increase in the proportion of thymic Itk deficient γδ T cells [first 
column], and greater than a two fold increase in the proportion of splenic γδ T 
cells.  These values are statistically significant [Figure 22B and C] and they 
correspond to increases in the absolute numbers of γδ T cells found in these 
compartments [Figure 22D and E].  Of interest we also see an important increase 
in the proportion of mesenteric lymph node [mLN] γδ T cells in the Itk deficient 
mice, probably due to the stark decrease in αβ T cells found in this compartment.  
We see no differences in the proportions of γδ T cells from the intestinal 
intraepithelial lymphocytes [iIELs]. 
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Figure 22:  Itk deficient mice have increased proportions of γδ T cells in the 
thymus and spleen 
[A] Cells were prepared from thymus, spleen, mLN and iIELs of wild type, and Itk-
/- mice, and stained with anti-TCRγ and anti-TCRβ Abs.  Data are representative 
of 4 independent experiments with 2-3 mice per group for spleen and thymus and 
2 independent experiments with 2-3 mice per group for mLN and iIELs. 
[B-E] Percentages and absolute numbers of TCRγ+ cells, based on TCRγ+TCRβ- 
staining, were compiled for the thymus [B and D] and spleen [C and E].  
Statistical significance for thymus [B] is p<0.0001, [D] is p=0.0207; and for 
splenocytes [C] is p<0.0001, [E] is p=0.0087.  Each data point represents a 
different animal, and the bars represent the mean. Numbers of animals analyzed 
are indicated as N values at the bottom of B-E.  ***, extremely significant; **, very 
significant; *, significant. 
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Itk deficient mice contain increased proportions of CD4+ and NK1.1+ γδ T cells 
 Given the increase in proportion and numbers of γδ T cells in the Itk 
deficient animals we next set out to identify if this increase was due to a global 
increase of γδ T cell subsets, or if it was due to an enhancement of a specific γδ 
T cell subset.  We investigated proportions of Vγ2, Vγ1.1, and Vγ3 γδ T cells in 
the thymic and splenic compartments and found no discernable differences 
between the WT and Itk deficient animals [data not shown]. 
 Previous work on Itk deficient animals has identified important increases in 
the proportion of CD8+CD4- “innate-like” αβ T cells (69, 71).  These cells also had 
increased expression of NK1.1.  Paradoxically, another subset of innate αβ T 
cells in the Itk deficient animals, NKT cells, actually have decreases in NK1.1 
expression (174, 184, 185).  Due to this information we decided to study whether 
γδ T cells have normal proportions of CD8+ and NK1.1+ cells.  Although we found 
an increase in the proportion of Itk deficient CD8+CD4- γδ T cells in the thymus 
[Figure 23A, top row], particularly if MFI is taken into account, and spleen [Figure 
23A, bottom row], we found a surprisingly large increase in the proportion of 
CD4+CD8- γδ T cells both in the thymus [figure 23A and B, top row] and the 
spleen [Figure 23A and B, bottom row] of the Itk deficient mice.  The proportion 
of NK1.1+ γδ T cells in the Itk deficient mice was also increased in the thymus 
[figure 23C and D, top row] but not the spleen [Figure 23C and D, bottom row].  
However, if one takes into account the overall increase in Itk deficient γδ T cells  
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Figure 23: Itk deficient mice have altered γδ T cell subsets in the spleen 
and thymus 
Cells were prepared from thymi and/or spleens of wild type and Itk-/- mice, 
stained and gated on TCRγ+TCRβ- cells.  [A] TCRγ+TCRβ- cells were analyzed 
for CD4 and CD8 expression.  [B] Shows the percentage of CD4+TCRγ+ cells 
[n=8 in thymus and n=6 in spleen].  Each data point represents a different 
animal, and the bars represent the mean.  Statistical significance for CD4+TCRγ+ 
cells for thymus is p=0.0002 and for spleen is p=0.0022.  Data are representative 
of 2 independent experiments for the spleen and 3 independent experiments for 
the thymus with 2-3 mice per group.  [C] TCRγ+TCRβ- cells were analyzed for 
CD4 and NK1.1 expression.  [D] Shows the percentages of NK1.1+TCRγ+ cells 
[n=11 in thymus and n=9 in spleen].  Each data point represents a different 
animal, and the bars represent the mean.  Statistical significance for 
NK1.1+TCRγ+ cells for thymus is p<0.0001 and for spleen is p=0.5363. 
Experiments are representative of 4 independent experiments for the thymus and 
3 independent experiments for the spleen with 2-3 mice per group.  [E] Splenic 
TCRγ+TCRβ- cells were analyzed for CD5 and CD4 expression [left panels] and 
CD5 and NK1.1 expression [right panels].  Representative of 2 independent 
experiments with 3 mice per group.  ***, extremely significant; **, very significant; 
*, significant. 
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seen in this compartment [figure 22E], it is clear that the total number of NK1.1+ 
γδ T cells is increased.  Interestingly, even though there are few to none 
NK1.1+CD4+ γδ T cells in the thymi and spleens of WT mice, a large proportion of 
the Itk deficient NK1.1+ γδ T cells, over half in the spleen, are CD4+.  These 
increases in the CD4+, NK1.1+, and CD4+NK1.1+ populations might account for 
the increases in γδ T cells seen in the Itk deficient mice. 
 Increased proportions of CD4+ γδ T cells have also been demonstrated by 
abolishing expression of both TCRβ and CD5 at the same time (205).  This is not 
entirely unheard of as CD5 has been shown to suppress αβ CD4+ differentiation 
(213).  Due to these findings we decided to check if CD5 expression was 
decreased in the Itk deficient animals in order to allow for expansion of CD4+ γδ 
T cells.  Opposite to the results in the previous study, not only did the Itk deficient 
mice have a larger proportion of splenic γδ T cells expressing CD5, but nearly all 
the CD4+ γδ T cells Itk deficient mice expressed CD5 [Figure 23E, left panels].  
Similarly, most of the NK1.1+ splenic γδ T cells in the Itk deficient animal express 
CD5 whereas little over half of the WT NK1.1+ splenic γδ T cells express CD5 
[Figure 23E, right panels].  These discrepancies between the two studies might 
be accounted by the different mouse model systems used. 
 
Tec family kinase expression is decreased in NK1.1+ γδ T cells 
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 Due to the discrepancy in proportion and numbers of γδ T cells found in 
the Itk deficient mice, we decided to evaluate expression of Tec family kinases in 
γδ T cells.  To this end we sorted TCRγδ+TCRβ- and TCRβ+TCRγδ- and 
evaluated Itk, Rlk, and Tec mRNA levels [Figure 24A, B, and C, outer bars 
respectively].  Albeit decreased when compared to αβ T cells, the pattern of Tec 
family kinase expression in the γδ T cells remained the same, with Itk having the 
highest levels of expression followed by Rlk and then Tec.  Due to the increases 
in NK1.1+ γδ T cell numbers seen in Itk deficient mice, we also decided to 
evaluate Tec family kinase expression in NK1.1+ versus NK1.1- WT γδ T cells 
[Figure 24A, B, and C, center bars respectively].  Interestingly we saw a 
decrease in expression of all Tec family kinases in the NK1.1+ γδ T cells versus 
the NK1.1- γδ T cells. 
 
Basal levels of the GATA-3 are increased in Itk deficient γδ T cells 
 Previous work on Itk deficient animals has demonstrated altered 
expression of transcription factors involved in Th1 and Th2 cytokine secretion.  In 
the case of conventional αβ T cells, Itk deficient CD4+ cells show aberrant 
regulation of T-bet post stimulation yielding high levels of the transcription factor 
(102).  As discussed in chapter II, we found dysregulation of a T-box family 
member closely related to T-bet, Eomesodermin [also involved in Th1 cytokine 
secretion], leading to its high expression in the “innate-like” CD8+ T cells found in  
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Figure 24: γδ T cells have decreased Tec family kinase expression in 
NK1.1+ subsets and there is an increase in GATA-3 levels in Itk-/- γδ T cells 
[A-C] Pooled splenocytes and LNs were isolated from WT mice and sorted into 
γδ T cells, NK1.1- and NK1.1+ γδ T cells, and peripheral αβ T cells.  Levels of Itk 
[A], Rlk [B], and Tec [C] mRNA were determined by real-time quantitative PCR. 
[D-E] cDNA from NK1.1- [D] and NK1.1+ [E] γδ T cells were further analyzed for 
T-bet, eomesodermin, and GATA-3 mRNA levels.  Graphs show data normalized 
to β-actin mRNA levels in each sample, and are representative of two 
independent experiments. 
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the Itk deficient animals (69).  Finally, chapter III presented data showing 
decreased expression of T-bet in thymic NKT cells (174).  Based on this 
information and given the opposing role that T-bet has on GATA-3 we decided to 
evaluate expression of these transcription factors in the γδ T cells from the Itk 
deficient versus the WT mice (116, 214). 
 In order to asses expression of these transcription factors we sorted WT 
and Itk deficient γδ T cells into NK1.1 negative and positive fractions, and 
utilizing quantitative real time PCR we looked at the basal [non-activated] levels 
of expression of each transcription factor.  In the Itk deficient NK1.1- γδ T cell 
fraction [Figure 24D] we found decreases in the expression of T-box family 
members [3.5 fold for T-bet and 4.5 fold for Eomes], which are involved in Th1 
immunity, when compared to the WT.  On the other hand, we found a consistent 
increase in GATA-3 [2 fold], which is involved in Th2 immunity, when compared 
to the WT.  An increase in GATA-3 [3 fold] could also be seen in the Itk deficient 
NK1.1+ γδ T cell fraction [Figure 24E], but no important differences were seen for 
the T-box transcription factors in this fraction. 
 
Itk deficient γδ T cells are prone to Th2, but not Th1, cytokine secretion 
 The increases seen in Th2 versus Th1 transcription factors in the Itk 
deficient γδ T cells propelled us to investigate if there were also differences in the 
cytokine secretion profiles of these cells.  To ascertain this we first investigated 
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the IL-4 [Figure 25A] and IFNγ [Figure 25B] mRNA levels found in WT versus Itk 
deficient γδ T cells post TCR mediated activation.  Although basal levels of IFNγ 
mRNA were similar in the WT and Itk deficient γδ T cells, basal IL-4 mRNA was 
increased in the Itk deficient γδ T cells.  Consistent with the transcription factor 
data, we saw increases in IL-4 mRNA [over 10 fold] in the Itk deficient γδ T cells 
accompanied by decreases in IFNγ mRNA [over 3.5 fold] when comparing to the 
WT cells at 10 and 20 hours post activation. 
 Next we set out to study protein levels of cytokine secretion by γδ T cells 
in the WT versus Itk deficient cells.  It has previously been shown that NK1.1+ γδ 
T cells and CD4+ γδ T cells are responsible for the majority of cytokine secretion 
when compared to the negative subsets in γδ T cells (215-219).  In accordance 
to this information we decided to split up the WT and Itk deficient cells into NK1.1 
negative and positive [Figures 25C-F] and CD4 negative and positive [Figures 
25G-J].  We then activated these cells through the TCR and after three days 
checked for secretion of Th2 and Th1 cytokines.  We could readily see strong 
induction of Th2 cytokines IL-4, IL-10, and IL-13 in the Itk deficient NK1.1+ cells 
when compared to the WT cells.  Likewise, we saw a reverse effect involving 
higher induction of the Th1 cytokine IFNγ in the WT γδ T cells, both in the NK1.1 
positive and NK1.1 negative fractions now, when compared to those from the Itk 
deficient animal.  When looking at the CD4 positive subset, IL-4 induction was 
still higher and IFNγ secretion was impaired in the Itk deficient γδ T cells, when 
compared to those from the WT.  However, there seemed to be no differences  
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Figure 25: Itk-/- γδ T cells are functionally impaired following ex vivo 
activation 
Pooled LNs and spleens from wild type and Itk-/- mice were harvested and sorted 
for TCRγδ+ cells [A and B] or NK1.1+TCRγδ+ and NK1.1-TCRγδ+ cells [C-F]. 
[A-B] 2 x 105 cells were stimulated with 10 μg/ml of anti-TCRγ for 0, 10 and 20 
hours.  IL-4 [A] and IFNγ [B] mRNA expression levels were determined by real-
time quantitative PCR.  Data shown are normalized to β-actin mRNA levels in 
each sample.  Data is representative of at least 2 individual experiments. 
[C-F] 5 x 104 cells were stimulated with 10 μg/ml of anti-TCRγ for 72 hours and 
supernatants were analyzed for the presence of IL-4 [C], IL-10 [D], IL-13 [E], and 
IFNγ [F] by CBA [Cytometric Bead Array].  Data is representative of 3 
independent experiments. 
[G-J] Pooled LNs and spleens from wild type and Itk-/- mice were harvested and 
sorted for CD4+TCRγδ+ and CD4-TCRγδ+ cells.  3 x 104 cells were stimulated as 
in C-F.  Supernatants were analyzed for the presence of IL-4 [G], IL-10 [H], IL-13 
[I], and IFNγ [J] by CBA.  Data is representative of 1 independent experiment. 
[K] Unstimulated [NS] and stimulated [P/I] wild type [left] and Itk-/- [right] γδ T cells 
were analyzed for intracellular IL-4 and IFNγ production.  Stimulated wildtype and 
Itk-/- NK1.1+γδ T cells were also stimulated and analyzed for intracellular IL-4 and 
IFNγ production.  Cells were stimulated with 10 ng/ml PMA and 2 μg/ml 
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Ionomycin [P/I] for 4 hours.  Data are representative of two independent 
experiments, each with three mice per group. 
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amongst the other Th2 cytokines [IL-10 and IL-13].  Cytokine secretion was also 
assessed for the CD8+ subset of γδ T cells, but this subset was found to produce 
less cytokines and the differences between the WT and Itk deficient cells were 
minimal [data not shown]. 
 Given that Itk functions proximal to the T cell receptor upon TCR 
engagement in conventional αβ T cells and the defects in signaling through these 
cells can be fixed by bypassing proximal TCR signaling through PMA and 
Ionomycin, cytokine secretion post PMA and Ionomycin activation was studied in 
γδ T cells from WT and Itk deficient cells [Figure 25K].  This experiment helps 
predict whether the differences seen in the Itk deficient γδ T cells are due to just 
defects in signaling upon TCR stimulation, in which case WT and Itk deficient 
secretion profiles should be the same, or due to altered development and 
cytokine secretion profiles in the Itk deficient animals, in which case the 
differences in cytokine secretion can still be seen by bypassing the TCR.  As it 
can be seen, PMA and Ionomycin activation in the whole γδ T cell population 
[center square] yields similar amounts of IFNγ in the WT and Itk deficient cells, 
indicating a rescue of IFNγ secretion.  However, a slight increase in IL-4 positive 
cells can be detected in the Itk deficient cells.  If one gates on the NK1.1+ γδ T 
cells then the increase in IL-4 secretion and decrease in IFNγ in the Itk deficient 
cells becomes more evident.  This data is seems to indicate that the increase in 
IL-4 secretion is due to developmental issues rather than issues with signaling 
upon TCR activation.  It is somewhat perplexing that the Itk deficient cells are not 
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producing as much IL-4 as observed in the TCR activation experiments, but this 
might be due to differences in length of activation, as the PMA/Ionomycin 
activated cells cannot be activated for prolonged periods of time due to toxicity. 
 
Itk deficient γδ T cells have an upregulation of markers involved in B cell help 
 In the previous figures it has been shown that the Itk deficient γδ T cells 
are geared towards secretion of Th2 cytokines.  Given this information we set out 
to investigate if these cells had other characteristics of Th2 immunity, particularly 
expression of markers needed for humoral immunity.  As mentioned in the intro, 
human γδ T cells can upregulate B cell costimulatory molecules CD40L, CD70, 
OX40, and ICOS (5).  In order to asses Itk deficient γδ T cell potential for 
upregulation of B cell costimulatory markers, WT and Itk deficient thymocytes 
and splenocytes were evaluated directly ex vivo or placed in culture for 24 hours 
in the presence and absence of TCR stimulus. 
 Neither the Itk deficient nor the WT γδ T splenocytes were able to 
upregulate B cell costimulatory markers in this assay [data not shown].  
Interestingly, levels of ICOS were upregulated in a large proportion of the Itk 
deficient γδ T cell thymocytes directly ex vivo when compared to those from the 
WT [Figure 26A, gray fill].  24 hour in vitro stimulation [Figure 26A, solid line] 
didn’t seem to alter the high levels of ICOS in the Itk deficient γδ T cell 
thymocytes and didn’t seem to induce expression in the WT γδ T cells.  Longer  
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Figure 26: Itk-/- γδ T cells upregulate markers involved in B cell help 
[A-C] TCRγδ+TCRβ- T cells from pooled thymocytes from wild type and Itk-/- mice 
were stimulated with 10 μg/ml α-TCR 0 and 24 hours.  Unstimulated and 
stimulated TCRγδ+TCRβ- T cells were then analyzed for the expression of ICOS 
[A], CD40L [B], and OX40 [C]. 
[D-F] The high [solid line] and low fractions [dashed line] [from A-C [respectively 
under]] from Itk-/- TCRγδ+TCRβ- T cells were further analyzed for CD4 [top] and 
NK1.1 [bottom] expression. 
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stimulations had the same pattern of expression [data not shown].  Evaluation of 
the ICOShi fraction in the Itk deficient γδ T cells indicated that nearly all of them 
were CD4+ and NK1.1+ [Figure 26D top and bottom respectively]. 
 Little to no difference was seen in the basal levels of CD40L [Figure 26B, 
gray fill] and OX40 [Figure 26C, gray fill] expression when comparing the thymic 
Itk deficient γδ T cells to those of the WT.  However 24 hour in vitro stimulation in 
α-TCRγδ coated plates led to upregulation of both CD40L and OX40 in the Itk 
deficient thymic γδ T cells, while this had no effect on the WT γδ T cells [Figure 
26B and C respectively, solid line].  Of note, albeit the increase was less 
noteworthy, 24 hour in vitro culture in uncoated plates also led to an increase of 
these molecules in the thymic Itk deficient γδ T cells while having no effect on the 
WT cells.  This seems to indicate that, at least in part, the increases in 
expression of CD40L and OX40 might not just be TCR mediated but rather 
adhesion molecule mediated or cytokine mediated [as the cultures contain IL-2].  
Regardless of this, the CD40Lhi fraction of Itk deficient thymic γδ T cells is 
composed mostly of CD4+ and NK1.1+ cells [Figure 26E, top and bottom 
respectively].  The OX40hi fraction of the Itk deficient thymic γδ T cells was 
composed mostly of NK1.1+ cells [Figure 26F, bottom], but unlike with ICOS and 
CD40L only half of the OX40hi thymic γδ T cells were CD4+ [Figure 26F, top].  No 
upregulation of CD70 was seen in either the WT and Itk deficient thymic γδ T 
cells [data not shown]. 
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γδ T cells are largely responsible for the hyper IgE and enriched GC phenotype 
seen in the Itk deficient mice 
 The Th2 cytokine secretion potential and ability to upregulate B cell 
costimulatory molecules exhibited by the Itk deficient γδ T cells seems to be 
indicative of these subset of cells having a role in humoral immunity in the Itk 
deficient mice.  Of consequence, previous work has shown spontaneously high 
levels of IgE in the Itk deficient mice (140).  IL-4, which as shown here is highly 
secreted by the Itk deficient γδ T cells, greatly enhances IgE class-switching and 
production (220, 221).  Given this information, Itk deficient mice were crossed to 
TCRδ deficient mice, which have no γδ T cells, in order to see if the γδ T cells 
are, at least in part, responsible for the spontaneously high levels of IgE. 
 As shown in figure 27[A], we can recapitulate the high IgE titers described 
previously on the Itk deficient mice [third column compared to first column].  
Strikingly, the Itk-TCRδ double deficient mice have an extremely significant 
reduction in serum IgE levels when compared to those of the Itk single deficient 
mice [fourth column compared to third column].  Individual cohorts of mice were 
tested at 2 months of age, 3.5 months of age, and 5 months of age all yielding 
the same pattern of IgE titters [data not shown]. 
 IgE class-switching and secretion requires B cell activation and 
proliferation, and given that data shown here indicates that B cell costimulatory  
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Figure 27: Hyper IgE and enriched germinal center phenotype in Itk-/- mice 
largely due to γδ T cells 
[A] Serum obtained from wild type [WT], TCRδ-/- [labeled GD-/-], Itk-/-, and Itk-/-
TCRδ-/- [Itk-/-GD-/-] mice were analyzed for the presence of IgE by ELISA. 
[B] Splenocytes from wild type [WT], TCRδ-/- [labeled GD-/-], Itk-/-, and Itk-/-TCRδ-/- 
[Itk-/-GD-/-] mice were stained with -B220 and -PNA for detection of germinal 
center B cells.  Each data point represents a different animal, and the bars 
represent the mean.  Numbers of animals analyzed are indicated as N values at 
the bottom. 
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molecules are upregulated in the Itk deficient γδ T cells, changes in GC formation 
were also evaluated.  As seen in figure 27[B], there is a quite significant increase 
in the proportion of GC B cells [B220+PNA+] seen in the Itk deficient mice when 
compared to the WT mice.  Again, the Itk-TCRδ double deficient mice exhibited a 
significant decrease in the proportion of GC B cells when compared to the Itk 
single deficient mice [fourth column compared to third column].  All in all, this 
data indicates that the spontaneous B cell activation and IgE class switching is 
strongly subdued by the absence of γδ T cells in the Itk deficient mice. 
 
Discussion 
 
 The previous chapters have delineated a complex role for Tec family 
kinases, particularly Itk, in innate immune development and function (69, 71-74, 
174, 184, 185).  In the case of CD8+ αβ T cells, absence of Itk seems to promote 
generation of an innate subset of these cells that is dependent on hematopoietic 
cells and SAP signaling for selection.  On the other hand absence of Itk seems to 
be detrimental for the selection and survival of NKT cells.  In either case Itk 
seems to have a significant role in innate αβ T cell development and function; 
preventing it in the case of CD8+ T cells and aiding it in the case of NKT cells.  
Given the findings of these previous studies we wanted to investigate whether Itk 
had a significant role in another subset of innate T cells, γδ T cells. 
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 In this chapter we show that, much like in the CD8 studies, absence of Itk 
seems to promote γδ T cell development, yielding larger proportions and 
numbers of these cells.  The increases in γδ T cell numbers could be seen both 
in the thymus [little less than 3-fold] and spleen [little less than 2-fold].  The 
increase in numbers was not caused by a particular increase in the proportion of 
specific γδ T cell subsets as we didn’t see differences in the proportions of Vγ1.1, 
Vγ2, and Vγ3 cells [data not shown]. However, we saw increases in the 
proportion of NK1.1+ [thymus], CD8+ [both thymus and spleen], and CD4+ [both 
thymus and spleen] γδ T cells.  Of particular interest we see a population of 
NK1.1+CD4+ γδ T cells in the Itk deficient mice which is absent in the WT mice.  
Taking into account the overall increase in numbers, the increase in proportion of 
these populations of cells yields a pretty big increase in numbers in both the 
thymus and spleen.  It seems likely though that the enhancement of the NK1.1+, 
CD4+, and CD8+ subsets alone is not totally responsible for the overall increase 
in numbers as these can’t yield a 3-fold increase in the thymus and a two-fold 
increase in the periphery. 
 One previous study utilizes a model system that also capitulates an 
increase in the CD4+ compartment of γδ T cells (205).  In this study the increase 
in CD4+ γδ T cells is seen in TCRβ/CD5 doubly deficient mice.  CD5 expression 
in αβ T cells has been previously reported to suppress CD4+ T cell differentiation 
(213).  Given these two pieces of information it seemed likely that CD5 
expression in the Itk deficient γδ T cells might be decreased.  Not only it wasn’t 
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decreased, but rather CD5 was expressed in a much higher proportion of CD4+, 
and for that matter NK1.1+, γδ T cells than in the WT controls.  Differences 
between the two studies might be accounted by the fact that the previous study 
utilized TCRβ deficient mice, and double positive cells are required for proper 
selection and function of γδ T cells (222).  The increase in the proportion of CD5 
positive γδ T cells seen in our study could be indicative of the reason as to why 
we see increased proportions and numbers of γδ T cells.  CD5 is usually utilized 
as evidence of TCR signaling and signal strength during development of αβ T 
cells (223-225).  Studies utilizing γδTCR transgenes with altered signaling 
potential have shown that CD5 expression also correlates with TCR signal 
strength in γδ T cells (81, 226).  Perhaps the reason behind the increases seen 
in γδ T cells in the Itk deficient mice might be explained by increases in signal 
strength in γδ T cells in these mice.  This would however go against the mantra 
of Itk function in αβ T cells which states that Itk is required to boost signal 
strength downstream of the TCR (98).  An alternative, derived from completely 
opposite lines of thinking, could be that reduced signaling in the Itk deficient mice 
only allows the γδ T cells with highest affinity TCRs to develop, giving these cells 
a competitive advantage and explaining the higher proportions of CD5 positive γδ 
T cells.  However, more biochemical work and γδ TCR repertoire analysis would 
need to be done to conclude anything on this matter. 
 The increase in NK1.1+ γδ T cells prompted us to look at expression of 
Tec family kinases in these cells.  In the previous chapter we described 
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increases [particularly in the thymus, and to a much lesser extent in the spleen] 
of Itk, Rlk, and Tec kinases in the NK1.1 positive versus the NK1.1 negative NKT 
cells (174).  This is of interest because in NKT cells absence of Itk is detrimental 
and leads to an absence of NK1.1 positive cells.  On the other hand absence of 
Itk in γδ T cells seems to be advantageous and leads to generation of more 
NK1.1 positive cells.  Likewise, we saw the opposite kinase expression pattern in 
these cells, with the NK1.1 positive γδ T cells having less Itk, Rlk, and Tec than 
the NK1.1 negative γδ T cells.  Increases in NK1.1 expression have also been 
reported in the Itk deficient CD8+ “innate-like” αβ T cells (69).  Given this 
information it is tempting to speculate on the role Itk [negative in γδ and CD8+ T 
cells and positive in NKT cells] has in NK1.1 expression, and furthermore on 
selection of one innate subset versus the other.  A great deal more work remains 
to be done in order to validate this speculation. 
 Having defined a defect in regulation of γδ T cells in the Itk deficient mice 
we next set out to evaluate function of these cells.  Previous work on innate Itk 
deficient cells has shown defects in upregulation of T-bet in NKT cells and 
exacerbation of expression of another T-box family member, eomesodermin, in 
the “innate-like” CD8+ T cells (69, 174).  This drove us to investigate whether 
these transcription factors, and their Th2 counterpart, GATA-3, were aberrantly 
regulated in the γδ T cells.  Both T-bet and Eomesodermin were strongly 
downregulated in the Itk deficient NK1.1- γδ T cells, whereas no big differences 
were seen in the NK1.1+ cells.  GATA-3, on the other hand, was upregulated in 
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both the NK1.1- and [particularly] the NK1.1+ γδ T cells.  GATA-3 and T-bet have 
been shown to cross regulate each other.  While GATA-3 regulates T-bet through 
inhibition of Th1 cell-specific factors, T-bet regulates GATA-3 through kinase 
mediated interactions which prevent GATA-3 binding to the DNA (116, 227).  
This latter study also showed that Itk can phosphorylate T-bet and furthermore 
presence of Itk facilitates direct association between T-bet and GATA-3.  Another 
study claims that the reason γδ T cells produce IFNγ by default is simply that 
GATA-3 is not as efficient in cross regulating T-bet in these types of cells (228). 
 Given the previously stated information, the question then arises of what is 
the cytokine secretion outcome in a γδ T cell system in which T-bet cannot cross 
regulate GATA-3.  Clearly elevated levels of GATA-3 are seen in the Itk deficient 
mice, but according to the aforementioned study this alone does not preclude 
IFNγ dominance.  From our results it can be seen that when Itk is missing, and 
therefore T-bet regulation of GATA-3 is lost, the default cytokine secretion seems 
to turn to a more impressive IL-4 secretion profile.  However this matter is a bit 
more complicated than just Itk helping T-bet regulate GATA-3, as bypassing the 
TCR restores secretion of IFNγ.  The IL-4 secretion profile could also be 
enhanced by selection of a population of γδ T cells which preferentially secrete 
this cytokine.  CD4+ γδ T cells have been previously described to preferentially 
secrete Th2 cytokines (219).  Not only do we see an enhancement in the CD4+ 
population, but the NK1.1+ population of γδ T cells is also secreting Th2 
cytokines rather than Th1 cytokines in the Itk deficient mice.  It should be pointed 
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out that while the NK1.1+ Itk deficient γδ T cell population has increases in IL-4, 
IL-10, and IL-13, the CD4+ population has increases in only IL-4, and they are not 
as impressive.  Both populations have notable decreases in IFNγ production.  
This might indicate that the NK1.1+ and the CD4+ populations are two separate, 
both phenotypically and functionally, populations.  We do see a third elevated 
population of NK1.1 and CD4 double expressing cells the Itk deficient animals.  
Further separation and activation experiments would need to be done in order to 
narrow down the individual functions of each population of γδ T cells in the Itk 
deficient mice.  It should be said that the changes seen in cytokine secretion in 
the Itk deficient γδ T cells are not just due to lack of T-bet crossregulation of 
GATA-3, but also due to aberrant development in the Itk deficient mice as the 
NK1.1 negative γδ T cells, which usually don’t secrete Th2 cytokines, also have 
the capability of secreting IL-4, IL-13, and IL-5.  Exactly what is responsible for 
the new found ability of these cells to secrete cytokines remains a mystery which 
cannot easily be addressed by our current model [Figure 28] or any previously 
published data. 
 The high IL-4 and IL-13 produced by the Itk deficient γδ T cells explains 
part of the spontaneous high IgE secretion previously reported on the Itk deficient 
mice (140).  However, this alone cannot explain the phenotype as in order to 
produce and switch to IgE the B cells must first receive help from certain 
costimulatory molecules [ICOS, CD40L, CD70, and OX40].  Ability to upregulate 
such molecules has previously been reported on human γδ T cells (5).  When 
155 
 
studying thymic γδ T cells from the Itk deficient mice we found a large proportion 
of cells expressing ICOS.  A recent study has indicated that both T-bet and 
GATA-3 can positively regulate ICOS expression via ICOS promoter [T-bet] and 
a 3’-untranslated region element [GATA-3] (229).  In this study, overexpression 
of either T-bet or GATA-3 could enhance ICOS transcription.  It is important to 
note that the ICOShi γδ T cells in the Itk deficient mice are NK1.1+ and CD4+.  As 
mentioned earlier, although T-bet expression is not affected in the NK1.1+ cells 
[unlike in the negative cells], GATA-3 is specially upregulated in this group.  We 
do not however see ICOShi expressing cells in the spleens of these mice, but we 
speculate that perhaps high expression of ICOS is quickly downregulated in the 
periphery of the deficient mice, giving it a short window of time to activate the B 
cells.  We also observed upregulation of both CD40L and OX40 in the Itk 
deficient γδ T cells, but this was trickier as cytokine responsiveness or aberrant 
adhesion molecule signaling might be responsible for part of this as we also saw 
some upregulation of these molecules in wells that didn’t receive TCR stimulus.  
Regardless of the cause of this upregulation, the WT γδ T cells were not able to 
induce these molecules. 
 Taken together, only a proof of concept remained to show that the γδ T 
cells in the Itk deficient mice could induce aberrant B cell activation and class-
switching.  This was achieved by crossing the Itk deficient mice to the TCRδ 
deficient mice.  Sure enough a remarkable decrease was seen in the serum IgE 
concentrations of the Itk/ TCRδ doubly deficient mice.  This decrease was also 
156 
 
accompanied by a significant decrease in germinal center B cells.  Our study 
illustrates how aberrant expression of Itk in γδ T cells can lead to an excess in 
IgE production [Figure 28].  A similar spontaneous enhancement in IgE 
production mediated by γδ T cells was also recently reported in Itch deficient 
mice and a role for γδ T cells in systemic IgE responses in allergic eosinophilic 
airway inflammation has been previously described (230, 231).  Coupled to the 
detrimental role of IgE in allergic disease, and the fact that Itk inhibitors are being 
actively researched to fight allergy, it seems clear that a better understanding of 
the role of Itk in γδ T cells must be attained in order to address this pathology 
properly (232-237).  Moreover, the results presented in this chapter might 
illustrate how discrepancies in γδ signaling during development might incur 
pathologies later on in life through altering the balance between Th1 and Th2. 
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Figure 28: A model for the Th2 bias in Itk deficient mice 
γδ T cells develop from CD4-CD8- thymocytes.  Normally [blue background] a 
small proportion of CD4+ or NK1.1+ γδ T cells develop in the thymus.  Similar 
small proportions of CD4+ or NK1.1+ γδ T cells can be found in the periphery.  γδ 
T cells cannot normally upregulate B cell costimulatory molecules.  Upon TCR 
mediated activation, crossregulation of GATA-3 by T-bet, mediated by Itk, yields 
production of IFNγ and not IL-4. 
Absence of Itk in γδ T cells [red background] seems to enhance the 
development/selection of these cells yielding a larger number of total γδ T cells 
both in the thymus and periphery.  An increased proportion of γδ T cells 
expressing, CD4, NK1.1 or both is seen in the thymus, whereas in the spleen 
increased only increased proportions of CD4+ and CD4+NK1.1+ can be seen.  
ICOS is also upregulated in the thymus and other B cell costimulatory molecules 
[CD40L and OX40] can also be upregulated upon TCR stimulation.  This 
upregulation seems to be transient and is probably downregulated quickly in the 
periphery, but not prior to the γδ T cells providing the B cells “help”.  TCR 
stimulation in the Itk-/- γδ T cells yields primarily IL-4, probably due to the fact that 
T-bet can no longer crossregulate GATA-3 in the absence of Itk.  It might be 
possible that GATA-3 can now crossregulate T-bet, enhancing the Th2 bias.  The 
switch to IL-4 production now induces IgE class switching in the activated B cells, 
leading to the eventual secretion of abnormal amounts of IgE. 
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Chapter V Attributions and Copyright information 
 
One of the figures [Figure 30] on this chapter was previously published in a 
manuscript submitted by Julie Lucas and I [the experiment was performed by me] 
(238). 
 
Lucas, J. A., M. Felices, J. W. Evans, and L. J. Berg. 2007. Subtle defects in pre-
TCR signaling in the absence of the Tec kinase Itk. J Immunol 179:7561-7567. 
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Synopsis of the material 
 The work presented in the data chapters of this thesis clearly document an 
important, and novel, role for Tec family kinases in innate T cell lineage 
decision/selection, development, and function.  It is important to study the role of 
Tec family kinases in innate T cell subsets because it gives us an idea of how 
similar or different signaling pathways are downstream of the TCR in innate 
versus adaptive T cells.  Furthermore, better understanding of these kinases can 
help us expand our knowledge on the signaling processes required for 
conventional lineage choice as opposed to adaptive lineage choice.  Prior to this 
body of work, only one study existed documenting very briefly a possible role for 
Itk in an innate T cell subset, NKT cells (184).  We now know that Itk is critical for 
the development of conventional CD8+ T cells, is necessary for terminal 
maturation of NKT cells and proper cytokine secretion by said cells, and is 
necessary to maintain the Th1 cytokine secretion bias seen in γδ T cells. 
 Chapter II described the role of Itk and Rlk in CD8+ T cells.  We show that 
in the Itk-/- and the Itk-/-Rlk-/- mice CD8+ T cells develop with a memory like 
phenotype denoted by high expression of NK1.1, CD44, CD122, dependence on 
IL-15, and quick cytokine secretion.  Furthermore, CD44hi expression arises in 
the thymus [not the periphery], and there is high expression of the transcription 
factor Eomesodermin in these cells.  Another study, submitted side by side with 
ours, showed that the CD8+ T cells arising in these mice were selected on cells 
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from hematopoietic origin (71).  Finally this same group later on showed that the 
CD8+ T cells in the Itk-/- and the Itk-/-Rlk-/- mice are dependent on expression of 
SAP for their selection (73).  Taken together all these data demonstrate that 
mostly innate-like CD8+ T cells develop in the Itk-/- and the Itk-/-Rlk-/- mice, 
indicating that Tec family kinases Itk and Rlk have a critical role in conventional 
CD8+ T cell lineage decision. 
 Contrary to the detrimental role in the development of innate-like CD8+ T 
cells, chapter III described an important role for Itk and Rlk in terminal maturation 
of NKT cells.  The Itk-/- and Itk-/-Rlk-/- NKT cells had defects in: initial selection, 
denoted by a decrease in NKT cell numbers prior to the earliest developmental 
stage we could study; terminal maturation, illustrated by an inability to upregulate 
NK cells markers usually associated with this stage; cytokine secretion, a defect 
probably caused mostly by decreased signaling downstream of the TCR and not 
faulty development; peripheral survival, most likely caused by decreased levels 
of CD122, which is needed for signaling via IL-15; and the upregulation of T-bet, 
which probably governs, for the most part, a good amount of the terminal 
maturation associated defects.  This work, along with another study released at 
the same time, showed a clear role for Tec family kinase signaling in the proper 
development and function of NKT cells (185).  It also points to a less clear role 
for these kinases in initial selection of NKT cells. 
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 Work presented on the last data chapter [IV] shows that Itk is involved in 
maintaining the Th1 cytokine secretion profile of γδ T cells.  Whether or not this is 
due simply to altered development of these cells or just an inability of T-bet to 
crossregulate GATA-3 upon TCR mediated activation in the absence of Itk, it is 
not clear.  It is clear however that absence of Itk gives the γδ T cells a selective 
advantage, denoted by increased numbers of these cells.  Itk-/- mice also have 
increased numbers of NK1.1+ and/or CD4+ γδ T cells.  The increase in IL-4 
cytokine production, accompanied by the ability to upregulate B cell costimulatory 
molecules, in Itk-/- γδ T cells seems to be responsible for the spontaneously high 
levels of IgE seen in the Itk-/- mice.  Therefore, data in this chapter demonstrates 
that Itk is needed to maintain proper γδ T cell development and function. 
 Each of the data sections contained a grounded discussion, based on the 
data obtained and the literature available, about each of the subsets mentioned.  
Rather than regurgitate these discussions, the sections that follow in this chapter 
will be of a more speculative nature, attempting at times to reconcile a common 
role for Tec family kinases in all of these subsets, and at times merely 
speculating on why they differ. 
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A role for signal strength in conventional and innate T cell development 
 
 If one were to take a minimalistic approach to T cell selection, in which 
signal strength alone governs selection of innate T cells and conventional T cells, 
then the data presented on this thesis could be used to gauge and model the 
signaling requirements for different subsets of T cells.  The main assumption 
taken here would be that absence of Itk only causes a decrease in the overall 
signal strength downstream of the TCR, but changes nothing else.  Another 
assumption of this model system would be that all the subsets of T cells are 
interacting with equal amounts of MHC molecules to be selected and all TCR-
MHC interactions are of similar strength.  Given this model system [Figure 29] 
one could conclude that selection of conventional CD8+ T cells has the highest 
requirement for signal strength given the stark decrease in numbers upon 
decreasing signal amplitude (69, 71).  NKT cell selection is also decreased quite 
a bit in the Itk deficient animals, also denoted by a large decrease in numbers 
(174).  Although not as impressive as the decreases just discussed, selection of 
conventional CD4+ T cells is impaired as well (150).  γδ T cell selection is favored 
slightly by the decrease in signaling, indicating [in this model] that this subset of 
cells has lower signaling requirements for selection.  Finally, given the vast 
increase in innate like CD8+ T cells, we could infer that this subset of cells has 
the lowest requirement of signal strength for selection (69, 71).  Of course the 
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increase in the number of innate CD8+ T cells and γδ T cells is most likely 
dependent on the space created by the decrease in other T cell types. 
 There are several issues with this simplified model that would need to be 
addressed in order to make it more realistic.  For starters conventional T cells are 
selected on thymic stromal cells while innate T cells get selected on cells of 
hematopoietic origin, which have been shown to have lower levels of MHC 
expression on their surface (9, 75).  To normalize the difference in MHC 
expression levels, we would have to shift up the signaling strength of innate 
subsets selected on hematopoietic cells because these cells are getting selected 
on lower amounts of MHC.  One piece of evidence that demonstrates that 
signaling strength in innate subsets is modulated by MHC expression is based on 
a study which forces CD1d expression in the thymic epithelia, increasing the 
number of molecules NKT cells can be selected on (77).  The increase in CD1d 
molecules causes the NKT cells to undergo negative selection, indicating that 
their signal strength is normally quite high [or at least close to their threshold for 
negative selection], and increasing the number of selecting molecules pushes the 
signal above the acceptable threshold (76).  A separate matter, which has been 
studied in conventional CD4+ versus CD8+ T cell selection, is the importance of 
duration of signals for positive selection (239-243).  One could hypothesize that 
perhaps decreased amounts of MHC in the hematopoietic cells might cause a 
decrease in the duration of the signals transduced in the innate cells, thereby 
affecting selection of these cells. 
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Figure 29: A simplified model for signal strength modulating T cell 
selection 
Under circumstances where conventional amounts of signal are transduced 
downstream of the TCR [dashed window] large amounts of conventional 
[convent] CD8+ and CD4+ T cells are selected.  Smaller amounts of NKT cells 
and γδ T cells are also selected.  Finally, very few innate CD8+ T cells get 
selected.  Decreasing signal strength through ablation of Itk [dash, dot, dot, dash 
window] cause cells with high signaling requirements for selection to not be 
selected.  This allows other cells with lower signaling requirements, such as γδ 
and innate CD8+ T cells in this model, to fill the void. 
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 Another issue not addressed by a simple signal strength model is the role 
of other receptors in boosting signals downstream of the TCR.  Case in point, 
both CD4 and CD8 coreceptors have been shown to boost TCR signals by 
recruiting Lck to the TCR complex (244, 245).  In fact, the CD4 receptor can 
recruit Lck better than the CD8 receptor, causing increased signaling in the CD4+ 
T cells (246-249).  This might explain why the conventional CD4+ T cells are 
affected less than the CD8+ T cells in the Itk deficient mice.  Given that selection 
of some innate subsets is also dependent on SLAM family mediated signaling, 
then perhaps these receptors could also have a role in boosting the signals 
downstream of the TCR, albeit this has not been proved.  It should be pointed out 
that SLAM family receptors, like 2B4 [CD244], have also been shown [in NK 
cells] to have a negative role in signaling leading to activation(250-252), 
indicating that perhaps SLAM family receptors are actually involved in 
dampening signals rather than boosting them.  In this case, SLAM family 
signaling would theoretically lead to preventing certain T cell subsets 
[conventional CD8 T cells for instance], from undergoing a productive positive 
selection. 
 One final problem with the simplistic signal strength model is that it 
assumes that signaling in different T cell subsets utilizes the same molecules.  
As discussed in detail in the general intro, some innate T cell subsets, most 
notably NKT cells, have requirements for different signaling molecules.  This 
makes it quite hard to compare signaling requirement s of conventional T cells 
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versus innate T cells.  This model also assumes that absence of one set of T 
cells allows for expansion of another set of T cells, and does not take into 
account T cell lineage choice. 
 
Lineage choice in innate versus conventional T cells 
 
 The argument that Itk and Rlk might have a role in lineage choice of innate 
versus conventional T cells, or lineage choice amongst different types of innate T 
cell subsets, is also a valid one.  This idea, of course, does not exclude signal 
strength, as signal strength is bound to have an important role in this process.  A 
lineage choice model would, however, include the notion of signal quality.  In 
other words, it’s not just how strong the signals are downstream of the TCR that 
are of consequence to the lineage outcome, but also the signaling molecules, 
presenting cells, and coreceptors involved that will determine the final lineage 
decision.  To be perfectly clear, in this thesis signal strength refers to modulation 
of signals in a pathway where all the components are the same and are linearly 
ordered.  Signal quality in this thesis refers to modulation of signals in pathways 
were the components vary. 
 Since lineage decision occurs early on during thymic T cell development, 
DN stage for γδ bifurcation and DP stage for other T cell bifurcations, it is 
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important to know if Tec family kinases are even expressed at these stages.  
Figure 30 shows that not only are Tec family kinases Itk and Rlk expressed at the 
DN and DP stages, but they are expressed at significant levels at the DN1 stage, 
preceding any lineage bifurcation.  In fact, we have previously shown that 
absence of Itk has mild, yet noticeable, consequences on pre-TCR signaling 
(238).  However exactly how Tec family kinases influence lineage decisions 
remains a mystery. 
 Out of all the subsets of cells discussed in this thesis, the role of Tec 
family kinases in CD8+ T cell lineage decision seems the clearest.  As shown in 
chapter II, Itk and Rlk are required for the selection of conventional CD8+ T cells; 
their absence give rise to innate CD8+ T cells (69).  It seems apparent that Itk-/- 
CD8+ T cells get selected on hematopoietic cells rather than on the thymic 
epithelium (71).  As discussed in the previous section, this could be due to 
conventional CD8+ T cells requiring more signal strength, and therefore they are 
just not selected, while the innate CD8+ T cells, which are selected on the 
hematopoietic cells, require less signal strength and the gap generated by the 
lack of conventional CD8+ T cells allows for their expansion.  There are three 
problems with this line of reasoning.  First, given how small the innate CD8+ T 
cell population is usually, it seems more likely that another subset of T cells 
would be able to expand more efficiently.  Second, selection of innate CD8+ T  
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Figure 30: Expression of Tec family kinases in thymocyte subsets 
[A] Thymocytes were isolated from WT mice and were sorted into DN, DP, and 
SP subsets based on expression of CD4 and CD8.  Levels of Itk, Rlk, and Tec 
mRNA were determined by real-time quantitative PCR.  Data are normalized to 
β-actin mRNA levels in each sample.  
[B] Thymocytes isolated from WT mice were enriched for DN cells by 
complement depletion with anti-CD4 and anti-CD8 antibodies and sorted into 
DN1-DN4 subsets based on CD25 and CD44 expression.  Levels of Itk, Rlk and 
Tec mRNA were determined by real-time quantitative PCR.  Data shown are 
normalized to β-actin mRNA levels in each sample.  
Results shown are representative of three independent experiments. 
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cells is enhanced [both in percentages and numbers] in Itk-/-H-2Kb-/-H-2Db-/- mice 
when compared to H-2Kb-/-H-2Db-/- mice, a system in which only innate and not 
conventional, CD8+ T cells can give rise (71, 73).  Third, and most importantly, 
selection of the conventional CD8+ T cells is rescued in a large part [about half of 
them] by forcing selection on the thymic stroma or ablating expression of SAP, 
which is needed for selection of certain innate subsets like NKT cells (54-56, 73).  
If the decrease in conventional CD8+ T cells was governed alone by the 
decrease in signal strength in the Itk-/- mice, then absence of SAP shouldn’t have 
any influence in the selection of these cells [i.e.: selection of conventional CD8+ T 
cells should still be poor in the Itk-/- SAP deficient mice]. 
 The information just argued points to Itk having a qualitative role in the 
lineage choice of conventional CD8+ T cells rather than a quantitative role.  
Particularly, the dependence on SAP for generation of the innate CD8+ T cells in 
the Itk-/- mice seems to indicate that Itk might have a negative role in the SLAM 
family signaling pathway in early CD8+ T cells, preventing selection on 
hematopoietic cells and promoting it in thymic epithelial cells.  Alternatively, Itk 
could be critical in dampening SLAM family mediated signals, which are geared 
to prevent positive selection of conventional CD8+ T cells.  One big caveat in all 
of this is that SAP mediated signaling is needed for the generation of NKT cells, 
therefore if Itk is inhibitory to this pathway absence of Itk should promote 
expansion of NKT cells, but in the Itk-/- mice we see decreased numbers of NKT 
cells (174).  More regarding the negative role for Tec family kinases will be 
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discussed in a later discussion section.  It should however be pointed out that 
signal strength might also have some role in the generation of conventional CD8+ 
T cells as boosting signaling through use of a transgenic TCR in these cells can 
rescue the conventional phenotype [as described by the OT-1 experiments in 
chapter II] (69).  Another indication that signal strength has a role in conventional 
CD8+ T cell development is drawn from crosses of the Itk deficient mice to mice 
containing a hyperactive Erk mutant (71).  In this model system, where TCR 
signal strength is enhanced due to increased Erk activity, the conventional CD8+ 
T cell phenotype is also rescued, albeit only partially.  Most likely, the outcome of 
CD8+ T cell lineage selection is dependent on both quality and quantity of signals 
[Figure 31].  Further work needs to be carried out in order to clarify this issue, 
and make these speculations more convincing. 
 A lot less is known about the role of Itk in γδ and NKT lineage decision.  
One should point out that its mere conjecture that there is a lineage decision 
between these two subsets, and very little data exists on the subject.  It seems 
clear that selection of the NKT subset is impaired in Itk-/- mice as the proportion 
of NKT cells in the thymus is decreased from about 1% to 0.4% (174).  There is 
also a very large decrease in the proportion of NK1.1 positive NKT cells.  In 
contrast, selection of γδ T cells is promoted as proportions increase in the 
thymus from 0.3% to about 1-1.5% in the Itk-/- mice.  Proportions of NK1.1 
positive γδ T cells are also increased in the Itk deficient mice.  Of interest too is 
that where in NK1.1 positive NKT cells Tec family kinases are slightly  
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Figure 31: Tec family kinase influence on CD8+ T cell lineage decision 
For the majority of CD8+ T cells generated normally, Itk and Rlk might have a role 
in blocking signaling downstream of SLAM family receptors, inhibiting innate 
CD8+ T cell selection and promoting conventional CD8+ T cell development [top].  
Absence of Itk and Rlk under normal signaling circumstances allows for signaling 
downstream SLAM receptors and selection of innate CD8+ T cells [bottom].  
SLAM family signaling in the absence of Itk can be thwarted by enhanced TCR 
signal strength, leading to the generation of conventional CD8+ T cells [middle]. 
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upregulated [Figure 15B], the opposite is true in NK1.1 positive γδ T cells [Figure 
24A-C].  These opposing phenotypes prompt the question of whether absence of 
Itk causes a lineage diversion from NKT cells into γδ T cells.  This notion is not 
entirely unheard of as one study showed that ablation of selection of NK1.1+ αβ T 
cells which produce IL-4 [in other words NKT cells] gives rise to an increased  
proportion of NK1.1+ γδ T cells (215).   Another set of studies indicates that there 
could be a lineage decision between γδ T cells and another innate subset, NK 
cells (217).  Finally, albeit somewhat controversial due to the stage where 
enhanced signaling occurs, a third set of studies has shown a role for TCR signal 
strength in lineage decision between γδ and αβ T cells (81).  This data is at best 
speculative, but this information makes the possibility that Itk is influencing NKT 
versus γδ lineage decision somewhat plausible [Figure 32].  Present technology 
is not advanced enough to properly investigate this possibility, but some 
experiments are mentioned in the future directions section that might shed some 
light on the subject. 
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Figure 32: γδ versus NKT cell differentiation model 
The model depicted here shows a pool of early DN thymocytes either destined to 
become a γδ T cell or a NKT cell depending on the signals they receive.  When 
Itk is present [top], Itk mediated signals causes a lineage choice away from γδ T 
cells to DP thymocytes which eventually become NKT cells.  This decision must 
occur early on during development before the transition to the DP stage. 
Absence of Itk [bottom] allows for a lineage decision towards γδ T cells, 
decreasing the pool of cells that can eventually become NKT cells.  This decision 
again occurs early on in development prior to DP transition. 
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NK1.1 expression on Itk-/- T cells 
 
 Expression of NK1.1 seems to correlate well with the effects of the 
absence of Itk on T cell subsets.  Where presence of NK1.1 is enhanced on a 
number of Itk-/- innate CD8+ T cells and γδ T cells, which are developmentally 
favored in these mice, the majority of NKT cells in the Itk deficient mice lack 
NK1.1 expression, correlating with the developmental disadvantage seen in the 
NKT cells of these mice.  It is not known exactly what is controlling NK1.1 
expression in these subsets of cells and whether or not expression of NK1.1 has 
a role in their developmental outcome. 
As discussed in chapter III, in NKT cells expression of NK1.1 is linked to 
terminal maturation of the cells and the upregulation of T-bet (68, 174).  
However, how T-bet influences NK1.1 upregulation or what influences decreased 
expression of T-bet in the Itk deficient NKT cells remains a mystery.  Perhaps 
expression of T-bet is somewhat controlled by its phosphorylation by Itk or 
interaction with it (116), explaining the decreased levels seen in NKT cells and γδ 
T cells [Figure 20 and 24].  However this hypothesis is contradicted by the role Itk 
has in conventional differentiating CD4+ T cells in which absence of Itk seems to 
promote expression of T-bet (102). 
What regulates expression of NK1.1 on γδ T cells and innate CD8+ T cells 
is much greater of a mystery.  A previous study has identified regulatory 
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elements controlling expression of NK1.1 in different lineages, however it is not 
known how these elements are influenced (253).  Another study utilizing fetal 
thymic and fetal liver cultures has shown that induction of NK1.1 might be 
predetermined by exposure to the thymic micro-environment (254).  Given the 
differences in signaling caused by absence of Itk, it is entirely possible that the 
thymic microenvironment in Itk deficient mice is altered.  More experiments must 
be carried out to verify this possibility. 
 
A negative role for Itk in other innate subsets 
 
 Tec family kinases are typically thought to have a positive role in signaling 
(1, 98), granted the data utilized to make such a conclusion was derived from 
conventional T cell studies.  Given the developmental advantages seen in the γδ 
T cells and innate CD8+ T cells of Itk deficient mice, it is tempting to speculate 
that Tec family kinases might have a role in a negative signaling pathway, 
inhibiting development of these two subsets. 
 One subset of innate T cells where both positive and [especially] negative 
roles of Tec family kinases can be studied is mast cells.  Unlike T cells or B cells, 
mast cells express Btk, Itk, Rlk, and Tec together (93-95) [and data not shown].  
This prompts the question of whether or not all Tec family kinases share the 
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same role in this subset of cells.  Btk seems to have a positive role in mast cell 
signaling, as Btk-/- mast cells have defects in effector function (255-258).  A 
previous study seemed to indicate a positive role for Itk in mast cell signaling 
(259).  However, more recent [not yet published] work from two postdocs in our 
lab [Yoko Kosaka and Markus Falk] seems to indicate that Itk has predominantly 
a negative role in mast cell signaling.  Itk deficient mast cells show increased 
PLCγ activation and cytokine secretion capabilities.  Of importance, Markus Falk 
has shown that Itk can associate with SHIP-1 and can phosphorylate SHIP-1, 
Dok-1, and Dok-2.  Furthermore, he has demonstrated that Itk can co-localize 
with a negative signaling complex upon antigen mediated stimulation.  Evidence 
also exists indicating that Btk might also perform a negative regulatory role, 
although in dendritic cells, indicating that the ability to function in negative 
regulatory pathways is not restricted to Itk alone (260). 
 Research I performed on NK cells, albeit of a more preliminary nature, 
seems to indicate that Tec family kinase Rlk is involved in a negative regulatory 
pathway in this innate subset.  Expression of Rlk is much higher in NK cells than 
in αβ or γδ T cell subsets, but it still remains lower than expression of Itk [Figure 
33]; albeit the difference is much smaller now [2.5 fold versus 10 fold].  It should 
be noted that in these experiments NK1.1 positive γδ T cells were not excluded, 
but given that they express even less Rlk than αβ T cells, this can only dilute out 
the total expression of Rlk in NK cells; in other words, if the NK1.1 positive γδ T 
cells were taken out of the equation chances are that expression of Rlk in NK 
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cells would even be higher.  Phenotypic analysis of NK cells in Itk-/- and Itk-/-Rlk-/- 
mice did not reveal any significant maturation defects in the periphery [data not 
shown], however activating and inhibitory NK cell receptor expression was 
altered particularly in the Itk-/-Rlk-/- NK cells when compared to the WT or Itk-/- NK 
cells [Figure 34].  Of note expression of the activating receptor Ly49D was 
increased, while inhibitory receptors Ly49C/I and Ly49G2 were decreased.  
Again, this data should be taken with a grain of salt as NK1.1+ γδ T cells are 
included in this analysis. 
Functional in vitro assays utilizing platebound anti-NK1.1 to activate 
enriched NK cells showed increased IFNγ secretion on the cells from the Rlk-/- 
mice [data not shown].  To study in vivo function of NK cells in the different mice 
a previously described in vivo cytotoxicity assay was utilized (261, 262).  In order 
to specifically look at NK cell killing, CD8 T cells or NK cells were depleted a day 
before the experiment to verify that the killing seen in this experiment was NK 
cells mediated.  As it can be seen on Figure 35, Rlk-/- and Itk-/-Rlk-/- NK cells 
showed similarly high killing, when compared to the WT and the Itk-/- alone, of the 
alloreactive targets [Balb-c splenocytes labeled with a high dose of CFSE] while 
no self targets were lysed [B10 splenocytes labeled with a low dose of CFSE].   
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Figure 33: Tec family kinase expression in NK cells 
NK cells were sorted as TCRβ-NK1.1+ and CD8+ T cells were sorted as 
TCRβ+CD8+CD4- from splenocytes.  Levels of Itk, Rlk, and Tec mRNA were 
determined by real-time quantitative PCR.  Data are normalized to β-actin mRNA 
levels in each sample. Representative of two independent experiments. 
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Figure 34: Expression of NK receptors on Tec family kinase deficient NK 
cells is altered 
Splenocytes from WT, Itk-/-, and Itk-/-Rlk-/- mice were harvested, stained and 
gated on TCRβ-NK1.1+ cells.  Expression of several NK cell inhibitory [left 
column] and activating [right column] receptors was assessed on these cells.  
Red line represents the Isotype control while the blue represents the antibody 
mentioned in the X-axis.  Representative of at least 4 different mice. 
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When quantitated and normalized to a double depletion of both NK and CD8 T 
cells, NK cells from the Rlk-/- and Itk/Rlk-/- mice lysed about 60-70 percent of the 
target population in the assay time, while WT cells lysed from 30-40% and Itk-/- 
cells lysed just a bit more.  These results indicate to us that Rlk, and not Itk, has 
a negative role in NK cell signaling since its absence leads to increased cytokine 
secretion and lytic activity. 
Interestingly the functional phenotype of the Rlk deficient mice matches well that 
of the EAT-2 or ERT deficient mice quite well (263).  NK cells in EAT-2 and ERT 
deficient mice have increased potential for cytotoxicity and IFNγ secretion, much 
like that seen in the Rlk deficient mice.  Both EAT-2 and ERT are members of the 
SAP family of adaptors, and in NK cells EAT-2 transduces signals downstream of 
2B4, a SLAM family member (264, 265).  Unlike SAP, however, EAT-2 and ERT 
are actually negative regulators of NK cell function.  Of interest, negative activity 
of EAT-2 [and presumably ERT] requires tyrosine phosphorylation of its C-
terminus.  It is quite tempting to speculate, given the functional similarities in 
phenotype, that Rlk might be responsible for this phosphorylation event.  This, 
along with the presumed negative role of Itk in SAP signaling for the 
development of conventional CD8+ T cells [chapter II], would further link Tec 
family kinases in SLAM family mediated signaling. 
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Figure 35: NK cells from Rlk-/- mice lyse target cells more efficiently than 
those from WT or Itk-/- mice 
The in vivo cytotoxicity assay was performed as previously described (261, 262).  
Briefly, spleens were harvested from B10 or Balb-c mice and single-cell 
suspensions were prepared. Splenocytes were incubated with either 2 µM [B10] 
or 0.4 µM [Balb-c] CFSE [Sigma] for 15 minutes at 37°C. Splenocytes were 
washed and the populations were combined at equal ratios. Cells [2 x 107] were 
adoptively transferred I.V. into WT, Itk-/-, Rlk-/-, or Itk-/-Rlk-/- recipient mice. 
Spleens from recipient mice were harvested 20 hours later, and the survival of 
each transferred population was assessed by flow cytometry. To quantify 
alloreactive NK cell cytotoxicity in the absence of CD8+ T cell killing, CD8+ T cells 
were depleted 1 day prior to adoptive transfer of CFSE-labeled cells using anti-
CD8 antibody [not shown].  To quantify alloreactive CD8+ T-cell cytotoxicity in the 
absence of natural killer [NK] cell killing, NK cells were depleted 1 day prior to 
adoptive transfer of CFSE-labeled cells using anti-NK1.1 antibody [not shown].  
At the time points shown, roughly about 95% of the killing seen is NK cell 
mediated [not shown].  Data is representative from 2 experiments with three mice 
each [only one experiment with the Rlk-/- mice]. 
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Concluding remarks 
 
 The data presented in this thesis illustrates a substantial role for Tec 
family kinases in innate T cell development.  In the case of CD8+ T cells Tec 
family kinases Itk and Rlk are needed in order to maintain conventional 
development, as their absence ensues in an innate population of CD8+ T cells.  
For NKT cells, Itk and Rlk are critical for terminal maturation of these cells, and 
seem to be quite important for an initial selection step.  Finally, for γδ T cells Itk 
seems to be involved in maintaining the Th1 phenotype of these cells and 
keeping their development in check.  Given all the data presented, it is quite 
tempting to speculate about a role for these kinases in signaling downstream of 
SLAM family receptors, and how that might affect lineage decision of different 
conventional as well as innate T cells subsets.  Continuing these lines of 
research might help solidify instructive versus stochastic models in the field of 
innate T cell research. 
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Future directions 
 
A great deal of work needs to be undertaken in order to describe a 
mechanism and solidify a role for Tec family kinases in innate T cell subsets. 
Where some of the projects described here are probably reaching the end of the 
rope, others will start to ask the most interesting questions. 
Currently efforts are underway by a post-doc [Megan Enos] in the lab that 
could be utilized to look at lineage decision and generation of different innate T 
cell subsets.  She is setting up an OP9-DL1 system to look at the role of Itk in 
CD8 lineage decision, albeit this system [as described later] could be utilized to 
study NKT cells and γδ T cells.  Itk expression can be manipulated in these 
cultures in order to ascertain if indeed expression of Itk is necessary for 
conventional CD8+ T cell lineage commitment.  Furthermore the cultures could 
be used to study possible interactions between Itk and the SLAM-SAP-Fyn axis 
[through immuno precipitations [IP]].  To follow up on this work kinase assays [or 
insect cell expression assays] could be utilized to determine if Itk can 
phosphorylate members of this axis.  Finally, although quite tough, FRET could 
be used to look at direct interactions between these molecules.  This work could 
elucidate more conclusively if Itk is involved in dampening of the SLAM family 
axis in order to promote conventional T cell development. 
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Biochemical studies could help elucidate the role of Itk and Rlk in NKT cell 
development and function.  In order to get around the cell numbers issue Itk 
deficient mice could be crossed to RAG deficient Vα14Jα18 transgenic mice.  
Activation assays could then help describe specifically the components of the 
signaling cascade that are particularly affected [PLCγ, ERK, JNK, Ca2+, etc.].  
Furthermore, NKT cells from Itk sufficient, RAG deficient, Vα14Jα18 transgenic 
mice could be used to look at interactions [through IPs] between Itk and Fyn 
[perhaps elucidating a role for Tec family kinases early on NKT cell development] 
or interactions between Itk and T-bet [to study the later role of Itk in NKT cell 
terminal maturation]. 
The OP9-DL1 system could also be utilized to look at the possibility of Itk 
having a role in a theoretical lineage decision between NKT cells and γδ T cells.  
By over-expressing or ablating expression of Itk in the bone marrow derived T 
cell progenitors one could study if expression levels shift the balance of lineage 
decision between γδ and NKT cells.  It should be noted that the role of Itk in 
lineage decision might not just be restricted downstream of the TCR but could be 
involved downstream of a co-stimulatory pathway required for the selection of a 
specific subset [as implied with speculation of its role in SAP signaling].  What 
seems apparent is that if Itk is indeed involved in the lineage decision between 
γδ and NKT cells, its function has to be very early on in development [DN2-DN3 
stage].  Research utilizing Itk deficient mice to look at γδ versus NKT cell lineage 
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decision could perhaps be used to shed some light on the complicated stochastic 
versus instructive models present in both γδ and NKT cell fields. 
Use of bone-marrow chimeras will be crucial in future experiments in order 
to determine if the altered development of NKT and γδ T cells is caused by an 
altered thymic microenvironment in the Itk deficient mice, and whether or not this 
might also cause differences in NK1.1 expression.  As discussed in chapter II, it 
seems clear that the altered development of CD8+ T cells is cell intrinsic (71, 73), 
but to date we do not know for sure if this is the case for NKT cells and γδ T 
cells. 
One interesting question which is yet to be answered is whether γδ T cells 
need SLAM-SAP-Fyn signaling for their development.  Given the importance this 
signaling axis has on the development of innate CD8+ T cells in the Itk deficient 
mice, it would be interesting to investigate if the increase in γδ T cells can also be 
ablated by knocking out SAP in these mice.  If so, the OP9-DL1 system could be 
utilized to generate enough γδ T cells to look at interactions between Itk and 
members of this axis. 
Other experiment s also need to be carried out to address the Th2 
phenotype more clearly.  For instance, we need to insure that the IL-4 produced 
by the γδ T cells is responsible for causing the class switching to IgE, as 
increases in IL-4 and IL-13 production are also seen in Itk deficient γδ T cells.  
Albeit not the most conclusive experiment, verification that there are no systemic 
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levels of IL-4 [by looking at the blood] could help infer that the γδ T cells are 
responsible for the phenotype [just by virtue of localization].  It would also be 
great to verify that the γδ T cells in the Itk deficient mice are indeed entering the 
germinal centers and interacting with B cells [confocal microscopy].  Confirmation 
of interaction between Itk and T-bet in this subset of cells would help sell the 
hypothesis that this is what is maintaining the Th1 phenotype in this type of cells.  
Albeit some of these experiments are not completely conclusive, and other 
experiments cannot be performed yet due to technological limitations, this future 
work will help describe the role of Tec family kinases in the development and 
function of innate T cells to a much greater extent. 
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Chapter VI: Materials and 
methods 
 
  
197 
 
Mice:  
Itk-/- mice were generated previously in our lab (131) and were backcrossed >13 
times to the C57BL/10 background.  Itk-/-Rlk-/- mice (139) were a kind gift of Dr. 
Pamela Schwartzberg [NIH], and were backcrossed >10 times to the C57BL/6 
background.  Rlk-/- mice were derived from Itk-/-Rlk-/- mice.  Wild-type littermates 
and non-littermate C57BL/10 mice were used as controls.  Itk-/- mice were 
crossed to IL-15-/- [C57BL/6] mice obtained from Dr. Joonsoo Kang with 
permission from The Immunex Corporation.  OT-1 TCR [C57BL/6] transgenic 
mice were obtained from Dr. Kenneth Rock with permission from Dr. Frank 
Carbone.  CD45.1 congenic mice were purchased from Charles River 
Laboratories at NCI-Fredrick Animal Prodution Area [Fredrick, Maryland].  γTCR-
/- mice on the B57BL/6 background were purchased from Jackson Laboratories.  
γTCR-/- mice were crossed to Itk-/- mice to obtain γTCR-/-Itk-/- mice.   Wildtype 
mice used in the studies were γTCR+/-Itk+/- littermates or C57BL/10 mice 
purchased from Jackson Laboratories.  All mice used were between 6-12 weeks 
of age, with the exception of the IgE and GC study in which the mice were 2-3 
months of age [unless otherwise specified], and were maintained at the 
University of Massachusetts Medical Center animal facility under specific 
pathogen free [SPF] conditions after review and approval by the institutional 
animal care and use committee. 
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Antibodies, tetramer and flow cytometric analysis: 
Thymocytes and peripheral lymphocytes were obtained and stained as described 
previously [Lucas, 2002 #162]. The following antibodies and secondary reagents 
were purchased from BD Pharmingen [San Diego, CA]: CD8α-FITC, CD8α-
allophycocyanin, CD8-PerCP-Cy5.5, CD4-PE, CD4-allophycocyanin, CD4-
PerCP-Cy5.5, CD5- Chrome, CD44-Cy-Chrome, CD62L-PE, TCRβ-FITC, 
TCRβ-Cy- Chrome, TCR-allophycocyanin, TCR-PE, TCR-biotin (188), 
CD122-PE, HSA-biotin, HSA-FITC, NK1.1-PE, NK1.1-allophycocyanin, NK1.1-
PE-Cy7, CD3-biotin, CD8-Cy-Chrome, CD8-allophycocyanin, IFNγ-PE, IFNγ-
FITC, IFN- allophycocyanin, B220- allophycocyanin, Vβ2-PE, Vβ5-FITC, 
strepavidin-allophycocyanin, Bcl-2-FITC, CD69-FITC, CD1d-PE, SLAM-FITC, 
OX40-biotin, NKG2D-allophycocyanin, Ly49C/I-FITC, Ly49G2-FITC, Ly49-F-
biotin, IL-4-PE, AnnexinV-FITC, and 7AAD.  Anti-Bcl-xL-PE was purchased from 
Southern Biotechnology Associates [Birmingham, AL]. Anti-BrdU-FITC was 
purchased from BD Biosciences [Mountain View, CA].  ICOS-PE and CD40L- 
allophycocyanin were purchased from eBioscience.  PNA-FITC was purchased 
from Vector Laboratories, Inc.  Strep-Cascade Yellow was purchased from 
Invitrogen Molecular Probes.  CFSE was purchased from Molecular Probes.  
CD1d-PBS44-PE Tetramer used for preliminary experiments was provided by 
Albert Bendelac [University of Chicago, Chicago, IL].  CD1d-PBS57-PE and 
CD1d-PBS57-allophycocyanin Tetramers were provided by the NIAID Tetramer 
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Facility [Atlanta, GA].  Antibody staining was analyzed using a FACSCalibur or 
LSRII [BD Biosciences] and data analyzed using both Cell Quest [BD 
Pharmingen, San Jose, CA] and Flowjo software [Treestar, Ashland, OR].  
Thymocyte and splenocyte subsets were sorted on either a MoFlo [Cytomation] 
or a FACSVantage [BD Biosciences] cell sorter. 
 
Ex vivo stimulation and intracellular staining for IFNγ and Bcl-xL: 
Thymocytes were stimulated with PMA [5ng/ml] and ionomycin [50ng/ml] in 
media containing golgi-plug and golgi-stop [BD Pharmingen] for 5 h or with IL-15 
[40ng/ml, R&D Systems, Minneapolis, MN] for 36 h at 37o. Following stimulation, 
the cells were stained for surface antigens and then intracellulary for IFNγ or 
Bcl-xL using the intracellular stain Cytofix/Cytoperm kit protocol [BD 
Pharmingen]. 
 
NKT in vivo stimulation assays: 
NKT cells were activated in vivo for cytokine analysis by ELISA as previously 
described (191).  Briefly, wild type, Itk-/- and Itk-/-Rlk-/- mice were injected i.v. with 
1 µg anti-CD3 antibody [BD Pharmingen].  Spleens were harvested after 90 
minutes and a suspension of 107 cells was incubated at 37oC for 2hrs, at which 
time supernatants were collected and IL-4 and IFNγ were measured by ELISA 
[BD Biosciences].  For intracellular cytokine staining, mice were injected with 2 
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µg α -Galactosylceramide [αGAL; Alexis Biochemicals [distributed by Axxora]] i.v. 
in 0.025% PBS Tween, and spleens were harvested after 2 and 3 hrs.  Cells 
were then surface stained for either anti-NK1.1 and anti-TCRβ or anti-HSA and 
CD1d-tetramer, fixed and permeabilized using the Cytofix/Cytoperm Kit [BD 
Pharmingen], and stained for anti-IFNγ and anti-IL-4.  Splenocytes were also 
activated with PMA [10 ng/ml [SIGMA Chemicals]] and Ionomycin [2,000 ng/ml 
[CalTech]] for one hour and incubated with Golgi-stop [BD Pharmingen] for three 
hours, after which they were stained for cytokines as described above. 
γδ in vitro stimulation assays: 
Wild-type and Itk-/- TCRγ+NK1.1+, TCRγ+NK1.1-, TCRγ
+CD4+ and TCRγ+CD4- 
subsets from were activated in vitro with 10 μg/ml of anti-TCRγ biotin [BD 
Pharmingen].  Cells were incubated at 37 for 72 hours, at which time 
supernatants were collected and IL-4, IL-10, IL-13 and IFNγ were measured by 
cytometric bead array [CBA [BD Pharmingen]].  Cells used for quantitative PCR 
were stimulated for 10 and 20 hours and examined for IL-4 and IFNγ message.  
For intracellular cytokine staining, cells from wild type and Itk-/- mice were 
stimulated and stained as previously described in the in vivo stimulations.  In 
brief cells were stimulated with 10 ng/ml PMA [Sigma-Aldrich] and 2 μg/ml 
ionomycin [Calbiochem] for 1 hour and incubated with Golgi-stop [BD 
Pharmingen] for 3 hours.  Cells were then surface stained for anti-TCRγ and anti-
NK1.1, fixed, and permeabilized using a Cytofix/Cytoperm kit [BD Pharmingen] 
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and stained for IL-4 and IFNγ.  For ICOS, CD40L and OX40 expression on γδ T 
cells, cells were stimulated for 24 hours with 10μg/ml anti-TCRγ.  Cells were then 
surface stained with anti-ICOS, anti-CD40L and anti-OX40.  
 
BrdU incorporation: 
Mice were injected intraperitoneally with 2 mg of BrdU [Sigma Aldrich, St. Louis, 
MO] in PBS 12 h before harvest.  Cells were plated at 6 x 106/well and then 
stained for surface antigens.  Following extracellular staining the cells were 
washed in PBS and then fixed and permeabilized with Cytofix/Cytoperm for 20 
min at 4o C.  The cells were then washed with PBS and fixed again in 1%/0.1% 
paraformaldehyde/Tween-20.  To stain for BrdU, cells were spun down and 
washed twice in PBS at room temperature, and subsequently resuspended in 
200μl of DNase solution [750μl 5M NaCl, 105μl 1M MgCl2, 250μlμ1mM HCl, 
24mg DNase [Roche Applied Sciences, Indianapolis, IN], 23.9ml dH2O] and 
incubated at RT for 10 – 30 min.  The cells were then washed and incubated in 
50μl of a 1:10 dilution of anti-BrdU-FITC for 30 min. At the end of the incubation 
period, the cells were washed twice and analyzed by flow cytometry. 
 
Adoptive Transfer of CD8+ thymocytes: 
Single cell suspensions were generated from thymi isolated from wild-type and 
Itk-/- mice.  CD4+ and DP thymocytes were depleted by incubating with a 
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complement-fixing anti-CD4 antibody followed by incubation with rabbit 
complement [Cedarlane Laboratories, Inc. Hornby, Ontario, Canada].  Live cells 
were isolated by Lympholyte-M [Cedarlane Labs] gradient, stained for CD8 and 
CD44 expression and sorted into CD8+CD44lo and CD8+CD44hi subsets.  These 
sorted populations were then adoptively transferred [2x106 wild-type and Itk-/- 
CD8+ CD44lo thymocytes and 4x106 CD8+ Itk-/- CD44hi thymocytes] into separate 
wild-type CD45.1 congenic mice.  The presence of transferred CD45.2 donor 
cells in spleen, lymph node, and thymus of host mice was examined from day 1.5 
post-transfer to approximately 16 days post-transfer. 
 
Bone marrow chimeras: 
Bone marrow was isolated from femurs of CD45.2 wild-type, Itk-/-, and Itk-/-Rlk-/- 
mice and depleted for T cells using complement fixing anti-Thy1.2 antibody and 
rabbit complement.  1 x 106 cells were injected into lethally irradiated congenic 
[CD45.1] mice.  Mice were analyzed 8 – 12 weeks after reconstitution. 
 
Real-time quantitative PCR: 
Cells were prepared from thymi and spleens isolated from wild type, Itk-/- or Itk-/-
Rlk-/- mice and lysed for RBCs.  For the analysis on Chapter II, total RNA was 
prepared from 0.2-1.0x106 sorted thymocytes as previously described (138).  For 
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the analysis on Chapter III thymic NKT cells were first enriched by depleting with 
anti-CD8α-magnetic microbeads [Miltenyi BioTec, Auburn, CA] on an AutoMACS 
machine.  Splenic NKT cells were first enriched by labeling with anti-B220-biotin 
and anti-CD8α-biotin [BD Pharmingen] and depleting with anti-biotin-magnetic 
microbeads [Miltenyi BioTec, Auburn, CA] on an AutoMACS machine.  
Remaining cells were then sorted to >95% purity on either a Moflo [Cytomation] 
or a FACSVantage [BD Biosciences] cell sorter by gating on HSAlo CD1d/α-
Galactosylceramide [αGAL] tetramer+ cells.  For controls CD8+CD4- conventional 
T cells were sorted on Moflo cell sorter [Cytomation].  For chapter IV splenocytes 
and lymph nodes from 6-10 C57BL/6 or Itk-/- mice were sorted for NK1.1 and 
CD4 subsets based on expression.  TCRγ subsets were first enriched by labeling 
with anti-TCR biotin and anti-CD19 biotin [BD Pharmingen] and depleted with 
anti-biotin magnetic microbeads [Miltenyi BioTec] on an AutoMACS machine.  
Remaining cells were stained with anti-TCRγ-FITC, anti-NK1.1-PE and anti-CD4-
PerCP-Cy5.5 and sorted into TCRγ+NK1.1+, TCRγ+NK1.1-, TCRγ
+CD4+ or 
TCRγ+CD4- populations on a FACSVantage cell sorter [BD Biosciences].  Data 
shown in the discussion section [Chapter V] was prepared as follows.  For 
isolation of subsets based on CD4 and CD8 expression, thymocytes were 
stained with anti-CD4-PE and anti-CD8-CyCychrome and sorted into DN, DP, 
CD4+ SP, and CD8+ SP populations.  For DN1-DN4 subsets, thymocytes from 
twenty-five C57Bl/6 mice were pooled and depleted with complement-fixing anti-
CD4 and anti-CD8 antibodies, followed by incubation with rabbit complement 
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[Cedarlane Laboratories, Inc. Hornby, Ontario, Canada].  Live cells were isolated 
on a Lympholyte-M [Cedarlane Labs] gradient and sorted as described above 
into DN1-DN4 subsets on a high-speed MoFlo cell sorter [Cytomation, Fort 
Collins, CO].  In order to sort the DN thymocyte subsets, lineage-positive cells 
were stained with biotinylated Abs to CD3, CD4, CD8, B220, IgM, Ter119, Pan-
NK[DX5], Gr1[Ly6G], Mac1[CD11b], and CD11c, followed by staining with anti-
CD25, anti-CD44, and strep- allophycocyanin. All strep- allophycocyanin + events 
were gated out and the CD25 vs. CD44 profiles of the remaining cells were 
determined.  RNA and cDNA were prepared as described previously (138).  
Real-time quantitative PCR was performed on an i-Cycler [Bio-Rad].  Primers 
sequences were as follows, -actin sense 5’- CGA GGC CCA GAG CAA GAG 
AG -3’, antisense 5’-CGG TTG GCC TTA GGG TTC AG -3’; eomesodermin 
sense 5'- TGA  ATG AAC CTT CCA AGA CTC AGA -3', antisense 5'- GGC TTG 
AGG CAA AGT GTT GAC A -3’; T-bet sense 5’- GGG CTG CGG AGA CAT GCT 
GA -3’, antisense 5’– GGC TCG GGA TAG AAG AAA CG -3’; GATA-3 sense 5’- 
GAA GGC AGG GAG TGT GTG AA -3’, antisense 5’- TGT CCC TGC TCT CCT 
TGC TG -3’; IFNγ sense 5’- CCT GCA GAG CCA GAT TAT CTC -3’, antisense 
5’- CCT TTT TCG CCT TGC TGT TGC -3’; IL-4 sense 5’- CGA AGA ACA CCA 
CAG AGA GTG AGC T -3’, antisense 5’- GAC TCA TTC ATG GTG CAG CTT 
ATC G -3’; Itk sense 5’- CTC CGC TAT CCA GTT TGC TCC -3’, antisense 5’- 
GTC CTT GTT GAG CCA GTA GCC -3’; Rlk sense 5’- TCA ATC CAA CAG AGG 
CGG G -3’, antisense 5’- CCG CTC TCT TCA GTG CCA A -3’; and Tec sense 5’- 
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GTT TGG AGT GGT GAG GCT T -3’, antisense 5’- GGT AAC GAT GTA GAT 
GGG C -3’.  For the generation of standard curves, cDNA clones of each gene 
mentioned above were used. 
 
In vitro survival and proliferation assay: 
Cell preparations were made from spleens of wild type, Itk-/- and Itk-/-Rlk-/- mice.  
Cells were then labeled with CFSE [5- [and 6-] carboxyfluorescein diacetate 
succininyl ester], then 5 X 105 cells were plated per well in quadruplicate for each 
genotype and condition in a 96-well round bottom plate.  Cells were then 
incubated at 37oC in RPMI 10% FBS with: no stimulus [NS], IL-2 [20 ng/ml], IL-2 
[2 µg/ml], IL-7 [10 ng/ml [R&D]], αGAL [500 ng/ml], IL-2 [20 ng/ml] plus αGAL 
[500 ng/ml], and IL-2 [2 µg/ml] plus αGAL [500 ng/ml].  At day 2 post incubation, 
medium was replaced with RPMI 10% FBS containing no additions [for the NS 
group and αGAL group], or the appropriate cytokine alone [without αGAL].  Cells 
were then harvested at day 4 and day 6, quadruplicate samples were pooled, 
and cells were stained for anti-HSA and CD1d-tetramer and analyzed by flow 
cytometry. 
 
Serum analysis: 
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Blood was collected from wild type, γTCR-/-, Itk-/-, and γTCR-/-Itk-/- mice.  Serum 
was obtained by spinning the blood at 5,000 rpm for 5 min. and removing the 
supernatant.  Supernatant was analyzed by ELISA for IgE. 
 
Statistical analysis: 
Two-tailed non-parametric Mann-Whitney Tests were performed using In-Stat 
software [GraphPad]. 
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